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     Voltage-gated ion channels play a key role in neuronal function by regulating ion flux.  
My research has shown that the Drosophila Ether à-go-go (EAG) potassium channel has 
a distinct conductance-independent role as an upstream activator of intracellular signaling 
pathways.  Heterologous expression of EAG in NIH 3T3 fibroblasts results in increased 
proliferation and p38 mitogen-activated protein kinase activity, an effect that occurs even 
when the channel is rendered non-conducting by mutation of the selectivity filter.  
Importantly, analysis of mutations that shift the voltage-dependence of channel gating 
reveals that EAG signaling activity is regulated by the voltage sensor.  Targeted mutation 
of key residues in the intracellular EAG carboxyl terminus shows that signaling requires 
an intact calcium/calmodulin-dependent protein kinase II (CaMKII) binding domain, and 
biochemical assays confirm that the activity of membrane-associated CaMKII is 
modulated by voltage-dependent conformations of EAG.  Conductance-independent, 
CaMKII-mediated EAG signaling activity is also observed with the mammalian isoform 
of EAG.  Finally, in recordings at the Drosophila larval neuromuscular junction, EAG 
channels with mutations in the CaMKII binding domain largely failed to rescue the high 
levels of spontaneous activity characteristic of eag mutants, whereas non-conducting 
EAG channels rescued spontaneous activity with an efficiency nearly overlapping that 
observed for the wild type channel.  These results suggest that voltage-dependent, 
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conductance-independent EAG signaling activity plays a role in synaptic homeostasis in 
vivo and implicate EAG signaling as a novel mechanism for linking neuronal activity to 
the state of intracellular messenger pathways.  EAG signaling activity may contribute to 
the learning defects observed in Drosophila eag mutants, as well as to the oncogenic 






















     The Ether à-go-go (EAG) potassium (K+) channel is a truly distinctive biological 
molecule.  As a voltage-gated ion channel, EAG selectively facilitates the flux of K+ ions 
through its central pore and across the plasma membrane of cells.  This hyperpolarizing 
function contributes to setting the resting membrane potential, and in excitable cells, 
repolarizes the membrane during action potentials to limit repetitive firing.  EAG is 
different from other K+ channels in that it possesses unusually long intracellular domains 
that associate with proteins involved in key signaling pathways, including the calcium-
(Ca2+)-binding protein calmodulin (CaM), Ca2+/CaM-dependent protein kinase II 
(CaMKII), and protein kinase A (PKA).  The intracellular termini also include sequences 
required for association with scaffolding and adapter proteins, including membrane-
associated guanylate kinases (MAGUKs) and other Src-homology 3 (SH3) proteins, 
allowing EAG to potentially assemble large protein complexes at the plasma membrane.  
The ability of enzymes and second messenger systems to assemble with a voltage-gated 
ion channel opens up the possibility of translating changes in membrane potential into 
biological signals.   
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     While the modulation of ion channel activity via intracellular signals (e.g., 
phosphorylation) is well-characterized, this thesis proposes that EAG directly activates 
signaling pathways in a manner independent of its role as an ion channel.  My research 
suggests that EAG stimulates signaling even when the channel pore is mutated to prevent 
ion flux.  Most importantly, the voltage sensor of EAG - which does not require channel 
conductance to respond to changes in membrane potential - appears to be a “switch” for 
signal activation.  I present evidence for voltage-dependent, conductance-independent 
EAG signaling in Chapter II of this thesis, and evidence that EAG signaling is mediated 
via voltage-dependent regulation of CaMKII in Chapter III.   
     The first suggestion that Drosophila EAG (dEAG) may be acting in a capacity beyond 
that of a K+ channel came from early experiments done during my rotation in the Wilson 
lab.  Following heterologous expression of dEAG in mammalian NIH-3T3 fibroblasts, 
there was a dramatic increase in cell density compared with vector-transfected controls.  
Subsequent experiments using the proliferation marker 5-bromo-2-deoxyuridine (BrdU), 
found that EAG-transfected coverslips exhibit higher BrdU incorporation than controls, 
suggesting that EAG stimulates proliferation.  Because human EAG has been implicated 
in cell cycle progression and oncogenesis (Pardo et al., 1999), this was not an entirely 
unexpected result.  However, proliferation also was increased in coverslips transfected 
with non-conducting EAG mutants - an exciting and crucial finding suggesting that the 
increases in proliferation were independent of any effect of EAG conductance on 
membrane potential, which could itself influence Ca2+-dependent signaling via the 
activation of voltage-gated Ca2+ channels.   
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     These initial observations set the stage for further investigations into the mechanism 
of EAG-stimulated proliferation, which have now implicated the downstream activation 
of key regulatory proteins including CaMKII and p38 mitogen-activated protein kinase 
(MAPK).  Although this signaling activity results in the proliferation of NIH-3T3 cells in 
vitro, it is important to emphasize that cell growth is not necessarily the physiological 
role of EAG-mediated signaling in vivo.  Nevertheless, much of the evidence presented 
here for EAG signaling relies on assays of proliferation in mammalian cell culture during 
transient transfection of Drosophila eag constructs.  While this heterologous system may 
not at first seem physiologically relevant for the fly channel, it has provided a reliable 
system in which to test specific physical and mechanistic aspects of EAG signaling.  
Importantly, most of these results and conclusions have been duplicated in parallel 
studies using the mammalian ortholog of EAG, which suggests that this signaling 
function has been conserved throughout channel evolution.  Furthermore, in vivo 
experiments done by other members of the Wilson lab provide evidence that EAG-
mediated signaling underlies spontaneous activity at the larval neuromuscular junction, a 
well-characterized phenotype of eag mutants.   
     The aim of this thesis is to investigate the mechanisms by which EAG K+ channels 
activate intracellular signaling pathways.  Although the multifunctionality of EAG is 
unusual for an ion channel, the idea of channels with secondary roles is not without 
precedent.  In fact, there are now reports of channels and their associated proteins 
involved in transcription regulation, protein phosphorylation, vesicle fusion, and 
numerous other intracellular mechanisms not commonly associated with ion channels.  In 
this introduction chapter, I present a brief background of voltage-gated K+ channels, 
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followed by a review of known multifunctional ion channel activity.  This begins with a 
general discussion of ion channels correlated with proliferation, oncogenesis and 
apoptosis.  I then focus on individual examples of channels with physiological functions 
that are independent of conductance, emphasizing channels that influence intracellular 
signaling pathways.  Following is a discussion of channel auxiliary subunits and the 
signaling activity of multiprotein channel complexes.  Finally, I summarize the structural 
and physiological attributes of the EAG channel and its association with key regulatory 
proteins, in order to make the case for EAG as an upstream regulator of intracellular 
signaling.   
 
B. BACKGROUND & SIGNIFICANCE OF VOLTAGE-GATED K+ CHANNELS  
     Voltage-gated K+ channels comprise a large and diverse class of membrane proteins 
that are found in almost all living organisms, including animals, plants, fungi and 
bacteria.  These proteins are largely responsible for regulating K+ permeability in 
response to a variety of signals.  In neurons, K+ channels facilitate action potential 
repolarization, limit the rate of repetitive action potential firing, and maintain a negative 
(hyperpolarized) membrane potential when cells are at rest.  This resting potential 
effectively acts as a “battery” to provide the driving force for ionic movement that 
underlies the action potential.  However, the functions of K+ channels are not limited to 
excitable cells in the nervous system.  In addition to their role in membrane excitability 
and neurotransmitter release, K+ channels mediate heart rate, smooth muscle contraction, 
insulin secretion, epithelial transport and other diverse cellular processes (Shieh et al., 
2000).  Correspondingly, the loss or disruption of K+ channel activity has been implicated 
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in a range of diseases, including epilepsy, deafness, schizophrenia, Alzheimer’s disease, 
episodic ataxia, diabetes and cardiac arrhythmias such as long Q-T syndrome (Shieh et 
al., 2000). 
     The idea of a selective K+ conductance in excitable cells was first proposed in 1902 by 
Julius Bernstein (Bernstein, 1902), but the process by which membrane potential could be 
regulated by ions was not established until pioneering experiments on the squid giant 
axon were done by Alan Hodgkin, Andrew Huxley, Bernard Katz, Kenneth Cole, 
Howard Curtis and others during the mid-twentieth century (Cole and Curtis, 1939; 
Curtis and Cole, 1942; Fatt and Katz, 1953a,b; Hodgkin and Huxley, 1945; Hodgkin and 
Huxley, 1952a-d; Hodgkin et al., 1952; Hodgkin and Katz, 1949).  Without knowledge of 
ion channel proteins, these experimenters formulated an empirical model of the kinetics 
of membrane excitability that remains largely sound to this day.  As the modern era of 
cloning and molecular biology dawned, researchers began to realize that the proteins 
regulating ion permeation were far more diverse and functionally intricate than could 
have been envisioned by early biophysicists.  This especially holds true for K+ channels, 
which in most genomes far outnumber their sodium (Na+) and Ca2+ counterparts.  In the 
human genome, for example, there are 40 genes encoding voltage-gated K+ channel α-
subunits, whereas Na+ and Ca2+ channel α-subunits are represented by 10 genes each (Yu 
and Catterall, 2004).  This enormous diversity allows cells to express virtually unlimited 
combinations of different K+ channel subtypes, fine-tuning the electrical properties of 
their membranes to an exceptional degree. 
     K+ channels are historically classified by the type of current they produce.  However, 
it is useful to consider topology when discussing the various classes.  In general, K+ 
 5
channels are grouped by amino acid sequence relationships, separated into six-
transmembrane (6TM), four-transmembrane (4TM) and two-transmembrane (2TM) 
families.  These can then be further classified by their mechanism of activation or current 
properties.  The largest group, 6TM channels, includes voltage-gated delayed-rectifier 
(Kv) channels, Ca2+-activated K+ channels, hyperpolarization- and cyclic-nucleotide 
gated channels, and slow delayed rectifiers.  With a few exceptions, these channels form 
tetramers and generally produce outward K+ current upon activation.  Members of the 
2TM subfamily are tetrameric inward rectifying K+ channels, and include ATP-sensitive 
and G-protein coupled channels.  Finally, 4TM channels contain two pore domains per 
subunit and are thought to form dimers.  These channels are responsible for the so-called 
K+ leak current (Goldstein et al., 2001).  Due to the variable nomenclature that has 
resulted in many channels having more than one name, I refer to most human and 
mammalian channels throughout this thesis with names derived from the IUPHAR 
Compendium of Voltage-Gated Ion Channels (Gutman et al., 2003).  For Drosophila ion 
channels, including EAG and Shaker (the ortholog of mammalian Kv1 channels), I use 
the original phenotype-derived names. 
     All Kv channel subunits have 6TM topology, with a “P-loop” region between the fifth 
and sixth transmembrane domains that forms the K+ selectivity filter when four subunits 
assemble as a functional channel (Doyle et al., 1998; Heginbotham et al., 1994).  In 
addition, positively-charged residues in the fourth transmembrane segment constitute the 
voltage sensor, a domain that couples changes in membrane potential to conformational 
shifts in the channel pore, thereby controlling ion permeation (Liman et al., 1991; 
Papazian et al., 1991).  However, the biophysical mechanism by which the voltage sensor 
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moves charge within the membrane has been a subject of vigorous debate.  Based on 
numerous accessibility studies, sequence analyses and mutagenesis screens, most models 
proposed for voltage sensor movement prior to 2003 envisioned an axial translation or 
rotation of the positively charged helix within a gating canal formed by the other 
transmembrane domains (Gandhi and Isacoff, 2002).  The groundbreaking x-ray 
crystallization of the KvAP channel by Roderick MacKinnon and colleagues suggested 
that the voltage sensors are “paddles” extending outward from the channel core into the 
lipid bilayer (Jiang et al., 2003a,b).  More recent investigations using electron 
paramagnetic resonance to measure the position of individual KvAP voltage sensor 
residues in a native environment have called this model into question (Cuello et al., 
2004).  In contrast to the crystal structure, these studies found that the positively-charged 
residues of the fourth transmembrane domain do not extend into the membrane, but rather 
lie near the protein/lipid interface, shielded by the other domains.  Despite being partially 
protected from the membrane, these residues do not, however, appear to be enclosed 
within a gating canal, as proposed in classical models.  Together with accessibility 
studies of the Shaker voltage sensor (Gandhi et al., 2003), these results suggest that the 
actual mechanism may lie somewhere between the axial translation and paddle models.  
Although the debate is far from being resolved, the voltage sensor of ion channels is 
arguably one of the most important protein structures in all of biology. 
     Voltage-gated channels serve as the interface between biochemical and electrical 
signals, routinely interacting with second messenger systems, regulatory enzymes and 
adapter proteins to modulate ion flux in direct response to intracellular signals (Levitan, 
2006).  These interactions provide a sensitive mechanism by which a host of biochemical 
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events can adjust the electrical properties of a cell, shaping the firing patterns that 
transmit sensory and motor information in the nervous system.  Although channel 
modulation by signaling molecules has traditionally been viewed as a one-way process, a 
growing body of evidence suggests that some channels may, in turn, be able to influence 
cellular behavior and interact with signaling pathways in ways that are independent of the 
downstream effects of ion flux.  Channel proteins with secondary roles have now been 
identified within all the major classes of cation channels, including K+, Na+, Ca2+ and 
transient receptor potential (TRP) channels (Dolmetsch et al., 2001; Gomez-Ospina et al., 
2006; Kaczmarek, 2006; MacLean et al., 2003; Malhotra et al., 2000; Runnels et al., 
2001).  Several studies have shown that such channels affect cellular behavior, including 
proliferation and differentiation, oncogenesis, apoptosis, and homeostasis.  Many 
channels also associate with auxiliary proteins, and it has become increasingly apparent 
that some channel-protein complexes permit direct interaction with biochemical 
pathways via second messengers, cytoskeletal components and regulatory enzymes.  A 
few even have intrinsic enzymatic activity or undergo proteolytic cleavage to become 
transcription factors.  Remarkably, many of these effects are observed even when the 
channel pores have been altered to prevent conduction or blocked with specific inhibitors.  
Here I discuss the known secondary functions of ion channels, before focusing on the 
signaling activity of the EAG K+ channel and its associated proteins. 
 
C. ION CHANNELS THAT INFLUENCE THE CELL CYCLE 
     Although several classes of ion channel have been implicated in cell proliferation 
(Allen et al., 1997; Cahalan et al., 2001; Kaczmarek, 2006), K+ channels are by far the 
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most well-characterized as having key regulatory roles in the cell cycle progression of 
both normally proliferating (e.g., lymphocytes, Schwann cells and glia) and abnormally 
proliferating (cancerous) cell types (Chandy et al., 2004; Pardo, 2004; Vautier et al., 
2004; Wilson and Chiu, 1993).  Inhibition of Kv channels, through the use of peptide and 
small molecule blockers, potently and effectively decreases proliferation in immune cells 
as well as that of various types of tumors (Wonderlin and Strobl, 1996).  However, only 
certain classes of Kv channel appear to be involved in proliferation. 
     In human T-lymphocytes, the activity of Kv1.3 is responsible for the initiation of cell 
cycle progression in response to antigen presentation (Freedman et al., 1992; Lin et al., 
1993; Price et al., 1989).  Although other types of K+ channel are involved in sustaining 
lymphocyte proliferation, Kv1.3 is by far the most abundantly expressed voltage-gated 
channel in these cells, and its activation is considered a key step in the immune response 
(Chandy et al., 2004; Lewis and Cahalan, 1995).  In tumors, examples of K+ channel-
associated proliferation are more numerous.  The two-pore domain channel K2p9.1 has 
been shown to be expressed in approximately 40% of breast cancers (Mu et al., 2003), 
Kv10.1 is expressed in neuroblastoma, melanoma, breast carcinoma and cervical cancer 
cells (Farias et al., 2004; Meyer and Heinemann, 1998; Meyer et al., 1999; Pardo et al., 
1999), and Kv11.1 is found in endometrial tumors, leukemias, and colon cancer, among 
others (Cherubini et al., 2000; Lastraioli et al., 2004; Pillozzi et al., 2002).  Intriguingly, 
Kv11.1 also has been shown to play a role in apoptosis (Wang et al., 2002a).  Other 
classes of ion channel, including the Na+ channels Nav1.5 and Nav1.7 (Brackenbury and 
Djamgoz, 2006; Fraser et al., 2005) and the TRP family member TRPV6 (Schwarz et al., 
2006), are also associated with tumor proliferation.  In this section, I discuss the specific 
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roles of each of these channels, beginning with the best-understood example: Kv1.3 in 
lymphocytes. 
 
C.1. Channel-mediated proliferation in the immune system 
     The role of voltage-gated K+ channels in immune cell proliferation was first 
recognized in pioneering experiments done by the Cahalan group in 1984.  Applying the 
whole-cell patch clamp technique to human T-lymphocytes, these researchers identified a 
delayed-rectifying K+ conductance, the activation kinetics of which could be increased by 
introducing phytohaemagglutinin (PHA), a known stimulator of lymphocyte mitogenesis 
(DeCoursey et al., 1984).  Using 3H-thymidine incorporation as a marker for DNA 
synthesis, they found that PHA-stimulated proliferation was inhibited in a dose-
dependent manner by the organic K+ channel blockers tetraethylammonium (TEA), 4-
aminopyridine (4-AP) and quinine, suggesting that K+ channel activity is associated with 
lymphocyte mitogenesis (DeCoursey et al., 1984).  In a subsequent study, this effect was 
further characterized using 3H-lysine, providing evidence that the block of K+ channels 
with 4-AP also reduces protein synthesis, including the production of the cytokine 
interleukin-2 (IL-2), a protein known to play a major role in lymphocyte proliferation 
(Chandy et al., 1984).  The reintroduction of IL-2 in the presence of 4-AP only weakly 
rescued the mitogenic inhibition, and had no effect at high 4-AP concentrations, 
suggesting that K+ channel activity is crucial for the synthesis of proteins involved in 
lymphocyte proliferation (Chandy et al., 1984).   
     These experiments laid the groundwork for subsequent investigations of K+ channel-
regulated proliferation in the immune system, including further studies of human T-
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lymphocytes (e.g., Sidell and Schlichter, 1986), peripheral blood mononuclear cells 
(Price et al., 1989) and murine B-lymphocytes (Amigorena et al., 1990), which gave 
support to the conclusion that K+ channel inhibition correlates with reduced proliferation.  
However, the underlying mechanism remained elusive, and due to the cell-permeability 
of the organic inhibitors, there was uncertainty as to whether the observed reductions in 
proliferation were the direct result of K+ channel inhibition or nonspecific effects of the 
small molecules on other cellular processes.     
     To more precisely investigate the role of K+ channel activity in lymphocyte 
mitogenesis, several groups used high-affinity, membrane impermeable peptides to block 
K+ channels during lymphocyte activation.  Charybdotoxin (CTX), a scorpion venom-
derived blocker of both inactivating Kv channels and Ca2+-activated K+ channels, inhibits 
both lymphocyte proliferation and IL-2 production following PHA stimulation 
(Freedman et al., 1992; Price et al., 1989), consistent with results obtained using the less-
specific organic inhibitors.  Experiments using CTX in combination with margatoxin 
(MgTX), a selective Kv channel blocker, proved that the voltage-gated current is 
important for lymphocyte activation (Lin et al., 1993).  
     IL-2 expression is essential for G1 phase progression during the cell cycle in 
lymphocytes, strongly suggesting that the Kv channel promotes G1 entry (Wonderlin and 
Strobl, 1996).  In mitogen-stimulated murine B lymphocytes exposed to K+ channel 
inhibitors, Amigorena and colleagues detected early G1 markers such as Ia and FcγRII, 
but no expression of transferrin receptor, a marker of late G1 phase (Amigorena et al., 
1990).  Moreover, experiments with CHX show the peak effectiveness of the toxin on 
proliferation to be within 4 hours of mitogen stimulation (Lin et al., 1993; Price et al., 
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1989).  Together with reports of G1 cell cycle arrest in MCF-7 human breast cancer cells 
by K+ channel antagonists (Woodfork et al., 1995), these data suggest that the voltage-
gated channel may be essential for directing the transition from quiescence into the G1 
phase of the cell cycle.   
     Kv1.3 is the most abundant K+ channel in lymphocytes and underlies the previously 
characterized n type delayed rectifier K+ current (Lewis and Cahalan, 1995).  However, 
the exact role of this channel in proliferation has remained somewhat unclear.  Most 
theories suggest that membrane hyperpolarization following Kv1.3 opening provides the 
increased driving force on Ca2+ required for lymphocyte activation, and facilitates the 
generation of IP3 following antigen presentation.  In turn, the IP3-stimulated release of 
Ca2+ from intracellular stores is thought to open both Ca2+-activated K+ channels and 
Ca2+ release-activated (CRAC) Ca2+ channels, which together sustain the high 
intracellular Ca2+ concentrations ([Ca2+]i) required for initiating signaling cascades 
leading to proliferation (Chandy et al., 2004).   
     An alternative hypothesis is that K+ efflux during channel activation may contribute to 
cell cycle progression via the regulation of cell volume.  One study demonstrates that an 
osmotically-induced 25% increase in neuroblastoma cell volume inhibits proliferation by 
82%, an effect that can be mimicked by K+ channel block with TEA and 4-AP.  
Conversely, the reduction of cell volume stimulates increases in proliferation (Rouzaire-
Dubois and Dubois, 1998).  Despite these observations, the relative contributions of 
membrane hyperpolarization and changes in cell volume on proliferation remain elusive, 
as the two processes are certainly intertwined.  It is nevertheless established that changes 
in membrane potential and cell volume are both required for cell cycle progression 
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(Pardo, 2004) and that Kv1.3 plays a crucial role in lymphocyte proliferation, most likely 
via the regulation of IP-2-induced G1 progression (Wonderlin and Strobl, 1996).   
 
C.2. The role of K+ channels in cancer 
    In addition to its role in lymphocyte activation, Kv1.3 is expressed in a variety of 
tumors, including colon, prostate and breast cancers (Abdul and Hoosein, 2002a; Abdul 
et al., 2003; Yao and Kwan, 1999) as well as in melanoma and glioma cells (Artym and 
Petty, 2002; Preussat et al., 2003).  Because of the extensive research that has been done 
in lymphocytes, it has been proposed that Kv1.3 influences tumor growth via a similar 
mechanism, i.e., the regulation of Ca2+ pathways.  Using a combination of K+ channel 
antagonists and Ca2+ imaging in proliferating colorectal adenocarcinoma cells, Yao and 
Kwan were among the first to show that inhibitors of Kv1.3 at concentrations that reduce 
proliferation also decrease Ca2+ entry (Yao and Kwan, 1999).  Another role for Kv1.3 in 
tumors is suggested from fluorescence resonance energy transfer (FRET) experiments in 
melanoma cells.  These studies showed that Kv1.3 physically interacts with β-integrins 
on the membrane, implying that the effects of channel blockers on tumor cell behavior 
may be due to disruption of integrin-containing membrane structures, known to be 
involved in metastatic processes (Artym and Petty, 2002).   
     In addition to contributing to lymphocyte proliferation and oncogenesis, Kv1.3 and 
other Kv1 (Shaker-type) isoforms, including Kv1.4 and Kv1.5, are involved in the 
differentiation of  astrocytes and oligodendrocytes (MacFarlane and Sontheimer, 2000; 
Vautier et al., 2004), and enhance the ability of activated microglia to kill hippocampal 
neurons (Fordyce et al., 2005).  Interestingly, Kv1.3 knockout mice have much smaller, 
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but more numerous, olfactory glomeruli than wild type mice, resulting in a significantly 
decreased threshold for odorant detection (Fadool et al., 2004).  These mice also have 
elevated expression of several K+ channel-associated signaling and adapter proteins, 
including Src kinase, tyrosine kinase receptor B (TrkB), 14-3-3 and PSD-95, compared to 
wild type mice, suggesting that the function of Kv1.3 during development and 
differentiation may extend beyond ion conduction. 
     Another type of K+ channel, the two-pore domain K2p9.1, has been shown to have 
oncogenic properties.  The gene encoding K2p9.1 (KCNK9) was isolated in a genomic 
screen of several DNA probes isolated from a novel human breast cancer amplicon, and 
was subsequently found to be overexpressed between 5- and 100-fold in 28 of 64 breast 
cancers (Mu et al., 2003).  Furthermore, K2p9.1 promotes tumor formation when 
overexpressed in cells implanted into athymic mice, and confers serum-independence on 
C8 cells in culture (Mu et al., 2003).  However, the tumor-promoting ability of K2p9.1 
depends on K+ flux, because a point mutation introduced into the selectivity filter renders 
the channel non-conducting and abolishes any oncogenic effects (Pei et al., 2003). 
     Perhaps the most well-characterized K+ channels in tumorogenesis are Kv10.1 (EAG) 
and the related channel Kv11.1 (human EAG-related gene, hERG).  EAG was first shown 
to be involved in cell cycle progression during heterologous expression studies in 
Xenopus oocytes, which are physiologically arrested in G2 during the first meiotic 
division.  Subsequent activation of mitosis-promoting factor (MPF) relieves this arrest, 
but also dramatically reverses the rectification properties of heterologously expressed 
EAG: at more positive membrane potentials, EAG current is seen to decrease, rather than 
increase (Bruggemann et al., 1997).  This curious effect was found to be a result of 
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intracellular Na+ block of the channel pore, and similar to an effect on current that occurs 
during the M phase in mammalian cells (Pardo et al., 1998).  Although the relevance of 
these findings for cell cycle regulation by EAG are yet to be fully understood, it has been 
suggested that interactions with cytoskeletal elements during the M phase may underlie 
EAG’s involvement in proliferation (Pardo et al., 2005).  This theory is supported by the 
observation that the application of nocodazole or colchecine, drugs that disrupt 
microtubules, similarly affect the rectification of EAG in inside-out patches (Camacho et 
al., 2000).  
     Despite being preferentially expressed in the nervous system (Ludwig et al., 1994), 
EAG mRNA has been observed in many human somatic cancers, but absent from the 
corresponding healthy tissues.  These include breast carcinoma lines (MCF7, EFM-19 
and BT-474), cervical carcinoma (HeLa) and neuroblastomas (Pardo et al., 1999), 
melanomas (Meyer et al., 1999), and gliomas (Patt et al., 2004).  When heterologously 
overexpressed in mammalian cell lines, human EAG (hEAG) confers oncogenic 
properties such as increased proliferation, loss of contact inhibition and substrate 
independence, effects that can be reversed with hEAG-specific antisense oligonucleotides 
that down-regulate hEAG expression (Pardo et al., 1999).  In addition, CHO cells 
transfected with eag stimulate tumor growth when transplanted into immune-suppressed 
mice.  These findings have made EAG a promising target for novel cancer drugs, as well 
as a potential marker for early tumor detection and diagnosis (Pardo et al., 2005). 
     HERG is a K+ channel related to EAG that exhibits gating typical of EAG and other 
outwardly rectifying channels, yet has a fast inactivation mechanism that confers inward 
rectification properties (Smith and Yellen, 2002; Trudeau et al., 1995).  For this reason, 
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hERG function is thought to be similar to that of pacemaker channels, and mutations in 
the channel have been well-characterized as the basis of some forms of long Q-T 
syndrome in humans (Curran et al., 1995).  HERG was first suggested to be involved in 
the cell cycle with observations that shifts in its voltage-dependence of activation 
correlate with changes in the resting potential of cycling neuroblastoma cells (Arcangeli 
et al., 1995).  Subsequent investigations have found hERG overexpressed in primary 
cultures of myeloid leukemia, endometrial tumors and colon cancer cells (Cherubini et 
al., 2000; Lastraioli et al., 2004; Pillozzi et al., 2002), and hERG current is detected in a 
variety of tumor cell lines from human and murine sources, including neuroblastoma, 
adenocarcinoma, pituitary tumors, monoblastic leukemia and insulinoma β-cells (Bianchi 
et al., 1998).  Furthermore, the inhibition of hERG decreases proliferation of 
neuroblastoma cells (Crociani et al., 2003).  One proposed mechanism for hERG in 
mediating oncogenesis is that by maintaining hyperpolarized resting potentials, tumor 
cells expressing hERG have a selective advantage in surviving the ischemic environment 
that is typical of tumors (Bianchi et al., 1998).  Another study suggests that hERG affects 
tumor growth by promoting the membrane surface expression of tumor necrosis factor 
receptor 1 (TNFR1), which enhances TNFα-stimulated tumor proliferation (Wang et al., 
2002a) 
      Further evidence implicating hERG in proliferation includes known interactions 
between hERG and cell cycle-related proteins, such as Src kinase (Cayabyab and 
Schlichter, 2002) and 14-3-3 signaling adapter proteins (Kagan et al., 2002), as well as 
the finding that hERG and a splice-variant isoform lacking the N-terminus are expressed 
in a cell-cycle dependent manner (Crociani et al., 2003).  In that study, the truncated 
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isoform (HERG1B) was upregulated during S-phase, while expression of the full-length 
channel (HERG1) increased during G1 (Crociani et al., 2003).  HERG1B lacks the N-
terminal PAS domain, which is conserved in the EAG channel family and is postulated to 
serve as an oxygen sensor (Morais Cabral et al., 1998).  As tumor progression often 
involves hypoxia (Guillemin and Krasnow, 1997), the PAS domain of HERG1 may sense 
environmental oxygen during hypoxic events by altering the heterotetrameric ratio of 
HERG1B to HERG1, thereby shifting the channel’s activation curve to limit K+ loss 
(Crociani et al., 2003).   
     Von-Hippel-Lindau (VHL), a tumor-suppresor protein implicated in the hypoxic 
response, has been shown to induce the differentiation of neuroblastoma cells into 
functional neurons.  Neuroblastomas overexpressing VHL show increased expression of 
neuronal markers such as neuropeptide Y, grow neurite-like processes and exhibit a 
secretory response to depolarization or cholinergic stimulation (Murata et al., 2002).   
Intriguingly, the activation of EAG channel activity in these cells is also diminished, and 
can be restored with VHL inhibition, suggesting that the PAS domain of EAG may also 
serve a functional oxygen-sensing role (Crociani et al., 2003).  To date, hypoxia is the 
only cellular response known to modulate the activity of all four of the tumor-associated 
K+ channels discussed here: Kv1.3, K2p9.1, Kv10.1 and Kv11.1 (Pardo, 2004).   
 
C.3. Other channels involved in oncogenesis  
     Although the role of voltage-gated ion channels in cell cycle progression and tumor 
growth has mainly focused on the expression and activity of K+ channels, other classes of 
channel are associated with oncogenesis, including some voltage-dependent Na+ channels 
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and at least one TRP channel.  High expression levels of Na+ channels, especially Nav1.5 
and Nav1.7, are detected in human prostate and breast cancers in vivo (Abdul and 
Hoosein, 2002b; Fraser et al., 2005), and are found in melanoma, lymphoma and small 
cell lung cancer cell lines (Allen et al., 1997; Fraser et al., 2004; Onganer and Djamgoz, 
2005).  These studies show that, in general, pharmacological Na+ channel block decreases 
tumor proliferation, as is observed for K+ channels.   
     Na+ channels in tumor cells are thought to contribute to metastatic cellular behavior.  
This hypothesis was recently tested in the MDA-MB-231 breast cancer line using assays 
of motility, endocytosis and invasion, all of which were significantly reduced following 
treatment with the Na+ channel blocker tetrodotoxin (TTX) (Fraser et al., 2005).  Three 
channel isoforms were isolated from these cells: Nav1.6 and Nav1.7, which are TTX-
sensitive in the nanomolar range, and Nav1.5, which requires higher (micromolar) TTX 
concentrations for inhibition.  Using RT-PCR, Nav1.5 was detected as the predominant 
isoform in human breast cancer biopsy sections (Fraser et al., 2005).  Nav1.5 is also the 
most prevalent Na+ channel in Jurkat cells, a human T-cell leukemia line, in which 
channel activity was found to be essential for lymphocyte invasiveness (Fraser et al., 
2004).  Furthermore, a recent study of Nav1.7 in Mat-LyLu rat prostate cancer cells 
found that TTX inhibition reduces cell migration in Transwell assays, indicating that this 
isoform may also be important for conferring metastatic potential (Brackenbury and 
Djamgoz, 2006).  
     Although Na+ channels are thought to regulate cell proliferation through the effects of 
Na+ flux on cell volume (Soroceanu et al., 1999), they have been shown to contribute to 
other cellular behaviors associated with oncogenic invasiveness, including motility 
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(Fraser et al., 2003), secretion (Mycielska et al., 2003) and cell adhesion (Malhotra et al., 
2000).  The specific interactions between Na+ channel β-subunits with cell adhesion 
molecules such as ankyrin is explored in detail below.   
     Another ion channel with an established involvement in oncogenesis is TRPV6, a  
highly selective Ca2+ channel likely to be involved in endothelial Ca2+ reuptake 
(Hoenderop et al., 2005).  In situ hybridization of prostate cancer biopsy sections show 
that transcription of the TRPV6 is significantly upregulated compared to benign prostate 
tissues (Fixemer et al., 2003).  A recent study indicates that overexpression of TRPV6 in 
HEK-293 cells increases proliferation in a Ca2+-dependent manner (Schwarz et al., 2006), 
suggesting that the channel may exert oncogenic effects via the stimulation of Ca2+ 
pathways, as in the case of lymphocyte activation (Cahalan et al., 2001).   
 
C.4. Channel-mediated apoptosis and tumor suppression  
     In addition to having roles in the stimulation of proliferation and oncogenesis, some 
ion channels have been shown to mediate apoptotic events or the suppression of tumor 
growth.  Remarkably, several of these are the same K+ channel subtypes that are 
associated with proliferation, including Kv1.3, K2p1.9 and Kv11.1.  Here I discuss 
several studies that implicate ion channel involvement in apoptosis and tumor 
suppression.   
     As discussed in C1 above, Kv1.3 channels play an essential role in lymphocyte 
proliferation following antigen presentation, a process that requires K+ conductance 
through the channel (Lewis and Cahalan, 1995).  In addition, however, cell shrinkage due 
to K+ effux has been identified as being crucial for apoptosis in lymphocytes (Bortner et 
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al., 1997) as well as in neurons (Yu et al., 1997).  Could Kv1.3 mediate both processes?  
Experiments in Jurkat T-lymphocytes show that activation of Fas receptors to initiate the 
apoptosis signaling cascade doubles Kv1.3 current amplitude (Storey et al., 2003).  This 
effect was found to depend on the expression of the Fas-associated death domain protein 
(FADD), as well as the activation of caspase 8, both key components of the apoptotic 
signaling pathway.  However, blocking Kv1.3 activity does not prevent apoptotic 
decreases in cell volume, suggesting that K+ flux through other channels may contribute 
to apoptosis in these cells (Storey et al., 2003).   
     In fact, another K+ channel has been shown to promote cell shrinkage: K2p9.1.  In 
addition to its involvement in breast cancer cell proliferation (Mu et al., 2003), K2p9.1 
activity regulates apoptotic volume decreases in mouse embryos (Trimarchi et al., 2002).  
These authors showed that pharmacological K+ channel blockers such as quinine prevent 
cell shrinkage following exposure to H2O2, a known apoptotic stimulus.  Currents similar 
to K2p9.1 were identified as the source of the K+ efflux from these cells, suggesting that 
apoptotic cell shrinkage involves the recruitment of channels (such as K2p9.1) that 
regulate cytoplasmic volume (Trimarchi et al., 2002). 
     In neurons, apoptosis may be regulated by Kv2.1 channels.  Primary cultures of 
cortical neurons expressing dominant negative Kv2.1 are resistant to the apoptosis-related 
enhancement of K+ current observed in control cells, and are also protected from oxidant-
induced apoptosis, as measured by luciferase assays of viability (Pal et al., 2003).  
Confirming its specific role in promoting cell death, CHO cells expressing Kv2.1 also 
exhibit enhanced apoptosis, an effect that does not occur in Kv1.4-expressing controls 
(Pal et al., 2003). 
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     Kv11.1 (hERG) has been shown to regulate apoptosis in various tumor cell lines, 
including human SK-BR-3 breast cancer cells, SH-SY5Y neuroblastomas and HL-1 rat 
atrial tumor cells (Wang et al., 2002a).  In fluorescent labeling assays of DNA 
fragmentation, a hallmark of apoptosis, these cell lines show substantially increased 
apoptosis upon H2O2 exposure compared to tumor cells not expressing hERG.  This 
increase can be eliminated by applying a specific hERG inhibitor, Dof, which has no 
effect on control cell apoptosis (Wang et al., 2002a).  Other experiments using herg-
transfected HEK cells show that hERG expression confers apoptotic sensitivity to H2O2, 
an effect that is not observed using a non-conducting mutant (Wang et al., 2002a).  These 
results suggest that the function of hERG in promoting apoptosis may be related to 
changes in cell volume accompanying K+ flux, similar to that of other K+ channels 
described above. 
     TRP channels are also involved in apoptosis and the inhibition of tumor growth.  
TRPM1 is a Ca2+-selective channel whose expression appears inversely correlated with 
metastasic behavior in B16 murine melanomas: TRPM1 mRNA is substantially 
decreased in more aggressively metastatic cells, despite being expressed at much higher 
levels in weakly metastatic cell variants (Duncan et al., 1998).   The related channel 
isoform TRPM2 is permeable to Na+ and K+, as well as Ca2+, and has been implicated in 
the stimulation of apoptosis in monocytic leukemia cells (Zhang et al., 2006).  In these 
cells, functional TRPM2 channel expression confers an enhanced susceptibility to 
oxidative stress or TNFα-induced apoptosis, which correlates with increased [Ca2+]i.  
Furthermore, biochemical analysis of downstream cell death signaling molecules show 
that TRPM2 activation results in the cleavage of procaspase-8, -9, -3 and -7, as well as 
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the inactivation of PARP, indicating that TRPM2 expression activates both intrinsic and 
extrinsic apoptotic pathways (Zhang et al., 2006). 
     Lastly, two other TRP family members, TRPP1 and TRPP2, are shown to suppress 
cell proliferation.  Also known as polycystin-1 and -2, these proteins are typically found 
in renal tubules, where they are thought to be involved in fluid sensing (Huang, 2004).  
While not functional channels individually, TRPP1 and TRPP2 subunits coassemble to 
form a functional, Ca2+-permeable channel (Hanaoka et al., 2000).  However, mutation or 
loss of either protein results in the formation of cysts due to overproliferation of epithelial 
cells in renal tubule walls (Wilson and Falkenstein, 1995).  As one piece of evidence 
explaining this negative regulation, TRPP1 has been shown to induce cell cycle arrest in 
MDCK kidney cell lines via stimulation of the JAK-STAT signaling pathway, an effect 
that requires TRPP2 expression (Bhunia et al., 2002).  In addition, a recent study by the 
Caplan group shows that TRPP2-expressing kidney cells exhibit reduced proliferation 
and diminished tubule branching morphology compared to control cells.  This effect 
occurs independently of the presence of serum, and is correlated with nuclear exclusion 
of phosphorylated extracellular signal-regulated kinase (ERK), a known component of 
proliferation pathways (Grimm et al., 2006).   
 
D. NON-CONDUCTING FUNCTIONS OF ION CHANNEL PROTEINS 
     So far, I have discussed numerous cases in which certain ion channels encompass a 
nontraditional role, acting outside the nervous system to affect cell proliferation and 
apoptosis.  In many of these situations, the proposed mechanisms require ion movement 
through the channel pore, and therefore it could be argued that these channels are not 
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truly “multifunctional”.  However, it is important to recognize that many of the effects on 
proliferation or apoptosis by these channels cannot be explained solely by a changing 
membrane potential, nor replicated when other channels with similar current properties 
are substituted (Kaczmarek, 2006).  Here, I focus on several examples of channels that 
have physiological functions wholly independent from their roles as ion conductors.  
These include the enzymatic activity of TRPM channels, homeostatic regulation of 
channel expression by Kv4 (Shal) channels, modulation of synaptic facilitation by HCN 
channels and the coupling of Ca2+ channel gating to muscle contraction and synaptic 
vesicle fusion.  A discussion of non-conducting channel functions that are mediated via 
auxiliary subunits is presented in part E. 
 
D.1. TRP channels have intrinsic enzymatic activity 
     Perhaps the most striking examples of ion channels operating independently of ion 
conduction are certain members of the TRP superfamily that have intrinsic enzymatic 
functions.  TRP channels, first discovered in Drosophila phototransduction studies 
(Cosens and Manning, 1969), are cation-selective channels formed by the association of 
four six-transmembrane domain α-subunits with intracellular N- and C-terminal domains.  
While topologically similar to voltage-gated K+, Na+ and Ca+ channels, TRP channels 
lack the complete set of positive S4 residues responsible for voltage sensing (Huang, 
2004).  TRP channels are grouped into six families based on amino acid sequence 
similarity (TRP-C, -V, -M, -P, -ML and -N), and have a diverse range of functions, 
including heat, cold and taste sensation, epithelial Ca+ transport, ciliary mechano-
sensation, and vesicle sorting (Huang, 2004).  I have already discussed the role of TRPV6 
in proliferation (Fixemer et al., 2003; Schwarz et al., 2006), the regulation of tumor 
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suppression by TRPP1/2 (Grimm et al., 2006; Wilson and Falkenstein, 1995) and 
apoptotic stimulation via TRPM2 (Zhang et al., 2006). 
     TRPM subfamily members have a high degree of amino acid sequence conservation, 
including several conserved N-terminal subdomains and a C-terminal coiled-coil domain.  
In addition, the C-terminal sequences of TRPM6 and TRPM7 contain a zinc-finger 
domain with strong homology to α-kinases, suggesting that these proteins may function 
as both ion channels and protein kinases (Runnels et al., 2001; Schmitz et al., 2004).  
TRPM7 (TRP-PLIK) was first characterized by the Clapham group, which found that 
TRPM7 expresion in CHO cells produces a steep outwardly rectifying current carried by 
magnesium (Mg2+) and Ca+ ions (Runnels et al., 2001).  Using radiolabeled ATP assays 
of kinase activity, they also found that TRPM7 can phosphorylate itself as well as other 
substrates such as myelin basic protein (MBP).  This kinase activity appears to be 
essential for channel activity; removal of ATP from the pipette solution or mutation of 
putative ATP-binding and catalytic residues substantially reduces both outward and 
inward current in TRPM7-expressing cells (Runnels et al., 2001).  Subsequent 
investigation of TRPM7 has characterized it as a serine/threonine kinase and shows that 
Mg2+, which permeates the channel, also modulates kinase activity in vivo (Ryazanova et 
al., 2004).  In contrast to TRPM7, the kinase activity of TRPM6 has not been well-
characterized, in part due to difficulties with functional expression (Schmitz et al., 2004).  
Some evidence exists that the isolated kinase domain exhibits phosphotransferase 
activity, and can even phosphorylate TRPM7, but not vice versa (Riazanova et al., 2001; 
Schmitz et al., 2005).   
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     Although the physiological roles of TRPM6 and TRPM7 remain unclear, a growing 
body of evidence suggests that these channel kinases are important for Mg2+ homeostasis 
(Schmitz et al., 2004).  Autosomal-recessive hypomagnesemia, in which patients are 
unable to absorb Mg2+ in the distal tubule of the kidney, is associated with mutations in 
TRPM6.  TRPM6 maps to the genomic disease locus and is expressed primarily in 
regions known to be involved in Mg2+ absorbtion (Schlingmann et al., 2002).  
Furthermore, TRPM7-deficient B-lymphocytes exhibit Mg2+ deficiency and die within 48 
hours, but can be restored to wild type growth with Mg2+-supplemented media, in 
analogy to hypomagnesemia patients who can live healthily with a Mg2+-supplemented 
diet (Schmitz et al., 2003).  However, expression of TRPM6 in these cells cannot rescue 
the Mg2+ deficiency caused by TRPM7 deletion, indicating that the channels have 
nonredundant functions in Mg2+ regulation, even though they can modulate each other 
(Schmitz et al., 2005).  While much is yet to be learned about the effect of intrinsic Mg2+-
sensitive kinase activity on TRPM6/7 channel activation, it is tempting to speculate that 
the kinase portions of the channels respond to Mg2+ levels by modulating current density 
to facilitate Mg2+ reuptake. 
     Finally, one other TRPM family member is shown to have intrinsic enzymatic 
activity: TRPM2.  Also called LTRPC2, TRPM2 is a Ca2+-permeable channel containing 
a C-terminal region with a high degree of sequence homology to ADP-ribose 
pyrophosphatases.  Perraud and colleagues showed that this enzymatic domain is not only 
able to cleave the ribose-5-phosphate from ATP-ribose, but that the remaining bound 
ADP-ribose enhances channel activation (Perraud et al., 2001).  TRPM2 can also bind 
nicotinamide adenine dinucleotide (NAD+), which activates the channel and stimulates 
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Ca2+ influx into monocytes (Sano et al., 2001).  As discussed above, TRPM2 also 
contributes to immune cell death by stimulating the pro-apoptotic caspase signaling 
pathways (Zhang et al., 2006).  Thus, although the function of these channels is still 
unclear, the pyrophosphatase activity of TRPM2 may serve to integrate information from 
nucleotide signaling molecules in the regulation of Ca2+ influx in the immune system. 
       
D.2. K+ channels regulate homeostatic channel expression  
    Shal is a member of the Shaker family of K+ channels, and the invertebrate ortholog of 
the mammalian Kv4 channel, which underlies the rapidly-inactivating A-type K+ current, 
IA.  These channels are predominantly inactivated at rest, but during prolonged bursts of 
activity the inhibition is removed,  allowing IA to slow the rate of action potential firing 
(Hille, 2001).  Several recent studies have shown that Shal may coordinate neuronal 
excitability in the lobster stromatogastric ganglion (STG) via the upregulation of HCN 
channels.  In the STG neuronal network, pyloric dilator (PD) neurons provide 
pacemaking activity that generates rhythmic muscle contraction in the stomach (Ayali 
and Harris-Warrick, 1999).  This is accomplished via the coordination of slowly 
oscillating membrane potentials and action potentials bursts within the circuit, which 
relies on the proper arrangement of synaptic inputs as well as the combination of ion 
channels expressed (Selverston and Moulins, 1985).  In the STG, the IA current provided 
by Shal is essential for maintaining rhythmic activity. 
     Surprisingly, the Harris-Warrick group recently found that overexpressing Shal in PD 
neurons does not change the rhythmic firing of action potentials, despite providing a 
significant increase in IA (MacLean et al., 2003).  Upon further examination, they 
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observed an increase in the hyperpolarization-activated current, Ih, which acts to 
counterbalance the enhancement of IA following Shal overexpression, an effect not seen 
when overexpressing Shaker.  Conversely, overexpression of HCN channels in PD 
neurons increases Ih without affecting IA, suggesting that the homeostatic compensation is 
unique to Shal (Zhang et al., 2003).  In addition, pharmacological block of Ih uncovers 
the increased latency and interspike interval that are characteristic effects of IA (MacLean 
et al., 2003).  These results suggest that Shal increases the expression of 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which conduct Ih to 
offset the enhanced IA, thereby maintaining rhythmic firing patterns.  Subsequent 
mathematical modeling studies confirmed that increased Ih via HCN upregulation can 
sufficiently compensate for increases in IA in the STG circuit, ruling out the alternative 
explanation that IA is somehow mislocalized to electrically isolated cellular 
compartments (MacLean et al., 2005).   
     Importantly, the Shal-induced increase in Ih is still observed when using a non-
conducting mutant channel, indicating that the mechanism underlying the effect does not 
itself depend on IA (MacLean et al., 2003).  Shal therefore provides a conductance-
independent intracellular signal to influence HCN expression.  Because the Shal-
mediated increase in Ih is not affected by blockers of transcription (MacLean et al., 2003), 
this mechanism likely involves the regulation of HCN channel translation, localization or 
activation by Shal.  However, because the increase in Ih is approximately 20-fold, 
recruitment of an existing pool of HCN channels does not adequately explain the 
enhancement.  It seems more likely that Shal and HCN channels are co-translated or co-
assembled prior to membrane insertion, or that Shal reduces the steady-state removal of 
 27
HCN channels from the membrane (MacLean et al., 2003).  Regardless, it is clear that the 
activity-independent role of Shal in regulating HCN channel expression is an important 
homeostatic mechanism in the STG.  It remains to be seen whether this type of 
compensatory expression is mediated by ion channels in other oscillating neuronal 
circuits.  
      
D.3. HCN channels contribute to synaptic facilitation  
     As well as being the target for Shal-mediated homeostasis in the STG, HCN channels 
may have a secondary function of their own.  As discussed above, HCN channels conduct 
the hyperpolarization-activated K+ current, Ih (Hille, 2001).  These channels are 
modulated in response to elevations of intracellular cyclic adenosine monophosphate 
(cAMP), which shifts the voltage-dependence of activation in a positive direction upon 
binding, permitting channel activation at more depolarized potentials. This effect of 
cAMP is thought to occur via the displacement of a C-terminal linker region that partially 
inhibits the channel in the absence of cAMP (Accili et al., 2002).     
     Studies by the Zucker group have shown that cAMP stimulation of presynaptic HCN 
channels affects synaptic facilitation at the crayfish neuromuscular junction in a manner 
not obviously related to membrane potential changes.  Application of seratonin or 
forskolin to presynaptic crayfish motor neurons stimulates adenylyl cyclase to produce 
cAMP, and causes a significant and sustained increase in excitatory junctional potentials 
(EJPs) recorded from the postsynaptic muscle fiber (Beaumont and Zucker, 2000).  A 
similar EJP enhancement is seen following high-frequency tetanic stimulation of the 
presynaptic cell, which elicits a brief hyperpolarization via the increased activity of 
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Na+/K+ ATPase (Beaumont et al., 2002).  In both cases, the onset of the enhancement is 
mediated by HCN channels, because specific HCN channel blockers prevent the effect if 
present during stimulation.  However, HCN channels are not required for sustaining the 
increased neurotransmitter release, because application of HCN blockers after the initial 
enhancement has no effect (Beaumont et al., 2002).   
     Other experiments show that HCN involvement in initiating facilitation is a result of 
interactions with the cytoskeleton.  Application of actin depolymerizers blocks synaptic 
enhancement by HCN channels induced by tetanic stimulation, but not by cAMP, 
suggesting that a second cAMP-stimulated pathway may be a component of the long-
lasting phase of facilitation (Beaumont et al., 2002).  This phenomenon, by which 
previous stimulation of HCN channels renders subsequent cAMP stimulation of 
facilitation HCN- and actin-independent, is known as “synaptic tagging” and may be an 
important form of synaptic plasticity (Zhong and Zucker, 2004).   
     Together these results suggest that the effects of HCN channels in synaptic tagging 
may be independent of changes in the membrane potential.  Serotonin-stimulated HCN 
activation only results in a 10 mV depolarization, yet induces EJP enhancement; this 
amount of depolarization in the absence of cAMP has no effect (Beaumont and Zucker, 
2000).  Moreover, although increases in cAMP following serotonin application cause a 
rise in [Ca2+]i through HCN channels, chelation of Ca2+ with BAPTA does not prevent 
the enhancement of transmitter release, and HCN-mediated depolarization is insufficient 
to open voltage-gated Ca2+ channels (Zhong et al., 2004).  Whether activation of HCN 
channels results in voltage-dependent signaling that is independent of channel 
conductance remains to be determined, and the mechanism by which this could occur is 
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far from clear.  However, experiments showing that actin polymerizers can substitute for 
HCN activation in the induction of synaptic enhancement suggest that channel activity 
may lead to cytoskeletal rearrangements crucial for the delivery of vesicles to the 
synaptic terminal (Zhong and Zucker, 2004).   
 
D.4. Ca2+ channels regulate muscle contraction and vesicle fusion 
    In the immune system, Ca2+ release from the sarcoplasmic reticulum and influx via the 
activation of CRAC channels stimulates pathways leading to proliferation and T-
lymphocyte activation (Chandy et al., 2004).  I have already discussed how K+ channel 
activation sustains the driving force for Ca2+ entry in these cells; however, the molecular 
identity of CRAC channels has remained elusive until recently.  No voltage-gated Ca2+ 
channels are expressed at significant levels in T-lymphocytes (Lewis and Cahalan, 1995), 
but expressed sequence tags encoding a TRPC channel were isolated from human B-cells 
and mouse T-cells, initially suggesting that CRACs are Ca2+-permeable TRPC channels 
(Cahalan et al., 2001).  Recent investigations have disproved this hypothesis, finding 
instead that the 4TM Drosophila protein Orai forms the pore subunit of the channel 
mediating the CRAC current (Prakriya et al., 2006; Yeromin et al., 2006).  
     Regardless of their molecular identity, the function of CRAC channels in the immune 
system implicitly depends on the ability to conduct Ca2+, which initiates the wide array of 
Ca2+-dependent signaling pathways involved in T-cell proliferation.  In contrast, voltage-
gated Ca2+ (Cav) channels were probably the earliest recognized channel with a function 
that does not require ion flux.  In skeletal muscle, Cav1 (L-type) channels mediate 
excitation-contraction (E-C) coupling, in which the depolarization of transverse (T) 
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tubules by motor neurons induces the release of Ca2+ from intracellular stores, thereby 
activating the contractile actin/myosin machinery underlying muscle contraction 
(Berchtold et al., 2000; Schneider, 1981).  Initiating this process are Cav1 channels on the 
T-tubule membrane, called dihydropyridine receptors (DHPRs), that are physically linked 
to ryanodine-sensitive Ca2+ release channels (RyRs) controlling Ca2+ release from the 
sarcoplasmic reticulum (Berchtold et al., 2000). These junctions, or Ca2+-release units 
(CRUs), exist both in skeletal and cardiac muscle.  However, whereas EC coupling in 
cardiac tissue requires a large Ca2+ current through DHPRs, skeletal muscle CRUs can 
operate in the absence of extracellular Ca2+, implying that DHPRs there act solely as a 
voltage sensor for RyR opening (Flucher and Franzini-Armstrong, 1996). 
     The idea of a voltage-dependent interaction between DHPRs and [Ca2+]i was first 
proposed in a pioneering 1973 study that characterized the charge movement across the 
membrane of frog muscle fibers using a three-electrode voltage clamp technique 
(Schneider and Chandler, 1973).  Although the researchers did not know at the time that 
the small current they detected was the gating of a Ca2+ channel itself, they speculated 
that it could be associated with a molecule extending from the T-tubule to the 
sarcoplasmic reticulum, translating voltage changes into intracellular Ca2+ release 
(Schneider and Chandler, 1973).  Further investigations revealed that DHPRs are the 
source of the charge movement, and can pass a slow Ca2+ current themselves (Rios and 
Brum, 1987; Tanabe et al., 1988).  Bidirectional interaction between DHPRs and RyRs 
was subsequently confirmed in studies showing that DHPRs control RyR channel gating 
(Grabner et al., 1999) and that RyRs, in turn, enhance the slow Ca2+ current through 
DHPR channels (Nakai et al., 1996).  However, this slow current is not necessary for 
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depolarization-induced Ca2+ release by RyRs, which consistently occurs in skeletal 
muscle following removal of Ca2+ from extracellular solutions (Rios and Pizarro, 1991). 
     Recently, conformational coupling between the two channels has been physically 
demonstrated using freeze-fracture to examine the relative position of DHPRs bound to 
RyR channels.  Within the CRU, four DHPR molecules bind to a single RyR channel, 
forming a “tetrad” of DHPRs that can be easily identified using electron microscopy.  
Treatment with ryanodine, which inactivates RyR channels by locking them in a non-
conducting conformation, results in a ~2 nm uniform shift in DHPR spacing compared 
with untreated tetrads, providing strong evidence for a conformational link between the 
two channels (Paolini et al., 2004).   
     Neuronal Cav2 (N-type) channels have also been shown to link their voltage-sensing 
ability to a cellular function, namely neurotransmitter release, independently of Ca2+ flux.  
Presynaptic Cav2 channels interact directly with the soluble NSF attachment receptor 
(SNARE) proteins syntaxin and SNAP-25, via an intracellular loop called the synprint 
domain (Rettig et al., 1996).  The synprint domain also binds to synaptotagmin on the 
vesicle membrane (Sheng et al., 1997).  These interactions are regulated via 
phosphorylation by protein kinase C (PKC) and CaMKII (Yokoyama et al., 1997) and 
likely allow docked vesicles to be positioned near Ca2+ channels at synaptic terminals to 
facilitate rapid Ca2+-mediated exocytosis (Catterall, 2000).   
     Although activity-dependent neurotransmitter release is typically triggered by a local 
increase in [Ca2+]i, neurotranmitter release also can occur in the absence of a Ca2+ signal. 
For example, in superior cervical ganglion (SCG) neurons, synaptic vesicle fusion can be 
induced by sucrose solutions in the presence of the Ca2+-chelater BAPTA, and recorded 
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as miniature excitatory post-synaptic potentials (mEPSPs) (Mochida et al., 1998).  
Tetanic stimulation of the presynaptic cell enhances this Ca2+-independent 
neurotransmitter release, as indicated by increases in mEPSP frequency that are 
proportional to the frequency of the stimulation.  This enhancement is prevented by 
injection of a synprint peptide inhibitor, which disrupts the association between Ca2+ 
channels and SNARE proteins (Mochida et al., 1998), suggesting that gating of the 
channel may be linked to SNARE activity.  Supporting this conclusion is a study in 
dorsal root ganglion neurons that used measurements of membrane capacitance to show 
that depolarization is sufficient to induce neurotransmitter secretion in the absence of 
Ca2+ (Zhang and Zhou, 2002).  Together, these findings suggest that the physical 
association between Cav2 channels and SNAREs at synaptic terminals allows voltage-
dependent changes in channel conformation to be directly translated to the activity of 
vesicle fusion machinery.   
 
D.5. Other voltage-sensing proteins  
     In contrast to ion channels that have linked their voltage sensing ability to secondary 
functions, including enzymatic catalysis and the activation of intracellular signaling 
pathways, there are evolutionary instances of signaling proteins that have coupled their 
activity to voltage sensing domains.  One example of this phenomenon was discovered in 
the ciliate Paramecium tetraurelia, which generates cAMP upon hyperpolarization of the 
plasma membrane (Schultz et al., 1992).  This process is generated by an unusual 
adenylyl cyclase that, when purified from ciliary membranes and reconstituted in lipid 
bilayers, shows single-channel activity very similar to K+ channels.  Cyclic nucleotides 
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generated in response to hyperpolarization are thought to increase the Ca2+ influx that 
controls ciliary motility (Bernal and Ehrlich, 1993).  
     A more recently discovered example of voltage-sensing in non-channel proteins is the 
phosphoinositide phosphatase of the aquatic invertebrate Ciona intestinalis.  This enzyme 
contains an intrinsic voltage-sensing domain, and was named C. intestinalis voltage-
sensor-containing phosphatase (Ci-VSP).  Initial examination of the Ci-VSP sequence 
revealed four transmembrane domains, including a region rich in positively charged 
residues that aligns well with the S4 voltage sensor of Kv1 channels.  The transmembrane 
domains of Ci-VSP are followed by a phosphatase-like sequence instead of the more 
typical channel pore.  When heterologously expressed in Xenopus oocytes, Ci-VSP, while 
lacking an ionic current, displays transient outward and inward currents very similar to 
the gating currents of voltage-gated channels, indicating that the voltage sensor of Ci-
VSP is functional (Murata et al., 2005).  In addition, phosphate release assays show that 
the protein is able to dephosphorylate phosphatidylinositol-3,4,5-trisphosphate 
(PtdIns(3,4,5)P3) to form PtdIns(4,5)P2, paralleling the activity of phosphate and tensin 
homologue (PTEN), with which Ci-VSP also shares sequence similarities.  Mutation of a 
cysteine residue of Ci-VSP corresponding to the catalytic cysteine of PTEN disrupts the 
phosphatase activity, confirming that its catalytic mechanism is similar to that of PTEN 
(Murata et al., 2005).  
    Most relevant to studies of EAG signaling activity, the voltage sensor of Ci-VSP 
appears to modulate phosphatase activity.  To investigate whether Ci-VSP phosphotase 
activity is voltage-dependent, Murata and colleagues coexpressed Ci-VSP in oocytes with 
inwardly rectifying K+ channels, which are activated by phosphoinositides.  In these 
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experiments, changes in a membrane potential resulted in a PtdIns(4,5)P2-dependent 
enhancement of K+ current that was not observed using catalytically-inactive Ci-VSP 
mutants (Murata et al., 2005).  Because Vi-CSP is expressed primarily in C. intestinalis 
sperm tail, the coupling of a voltage-sensor to phosphotase activity is thought to regulate 
sperm motility in response to hyperpolarizing sperm-attracting steroid signals (Murata et 
al., 2005).   
     Human and mammalian orthologs of Ci-VSP have been identified, and appear to be 
functional proton channels.  Both the human channel, Hv1, and the mouse voltage-
sensor-only protein (mVSOP) have four transmembrane domains that include the voltage 
sensor, exhibit proton-selective outward current and are gated by pH and divalent metal 
ions (Ramsey et al., 2006; Sasaki et al., 2006).  Hv1 channels are expressed in immune 
cells and likely mediate the phagocytotic oxidative burst response (Ramsey et al., 2006).  
However, the voltage-sensing domains of these channels do not appear to be structurally 
linked to any enzymatic activity, and likely function solely as proton channels.  Future 
studies addressing the evolutionary roles of these proteins may reveal other examples of 
voltage-sensitive proteins and shed light on the emergence of voltage-gated ion channels.  
 
E. AUXILIARY SUBUNITS AND ION CHANNEL SIGNALING  
Most endogenous ion channels have one or more auxiliary subunits that associate 
with the channel core to form larger macromolecular complexes, and are often essential 
for normal channel function.  These subunits typically contribute to the modulation of 
channel activity, but also facilitate interaction with cytoskeletal elements, enzymes and 
signaling pathway components, allowing channel function to be integrated into myriad 
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biochemical processes (Isom et al., 1994).  Here I discuss several examples of proteins 
that confer unusual properties on the channel complexes they comprise, allowing the 
principal channel subunits to participate in functions not typically associated with ion 
channels themselves.  This includes the cell adhesion properties of Na+ channel β-
subunits, the enzymatic functions of various K+ channel subunits, and the role of 
calmodulin, the ubiquitous signaling pathway component that also associates with several 
ion channel complexes.  Finally, I will discuss another mechanism by which ion channel 
complexes can interact with biochemical pathways: proteolytic cleavage of channel 
proteins or their subunits to yield free peptides with numerous roles. 
 
E.1. Na+ channel β subunits are cell adhesion proteins 
     Na+ channels became the first known ion channel complexes with the discovery of the 
β1 and β2 subunits, which copurify with the channel in brain preparations (Hartshorne 
and Catterall, 1984).  β1 and β2 are membrane-spanning proteins with long, glycosylated 
extracellular regions and short intracellular C-termini, and are physically attached to the 
Na+ channel α-subunit; β2 is linked via disulfide bonds, while β1 associates 
noncovalently (Isom et al., 1994).  These proteins regulate Na+ channel expression and 
enhance activation kinetics, but are also members of the immunoglobin (Ig) family of cell 
adhesion molecules (CAMs), as they contain characteristic Ig domains in their 
extracellular N-termini.  These regions mediate cell adhesion via homotypic interactions, 
demonstrated in experiments in which β1 or β2 overexpression induces cell aggregation, 
an effect not observed when expressing the α-subunit alone (Malhotra et al., 2000).  
Many studies have shown that the β1 and β2 subunits also participate in heterophilic 
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associations with other CAMs, including contactin, connexin-43, N-cadherin and 
neurofascins (Malhotra et al., 2004; McEwen and Isom, 2004; Ratcliffe et al., 2001). 
Intracellularly, the C-domains of β1 and β2 bind to the cytoskeletal protein ankyrin, 
promoting the recruitment of ankyrin to points of contact between cells (Malhotra et al., 
2000).   
     The complex interactions between β-subunits, ankyrin and extracellular CAMs may 
help to coordinate extracellular matrix proteins and intracellular cytoskeletal components 
around Na+ channel complexes, and provide a mechanism for the accumulation of Na+ 
channels at nodes of Ranvier.  An ankyrin-G binding motif in Na+ α-subunits has been 
shown to be essential for targeting channels to axonal initial segments and nodes of 
Ranvier (Garrido et al., 2003), and a nearly identical motif is present in Kv7 channels, 
suggesting a convergence of ankyrin-based targeting mechanisms during axonal 
evolution (Pan et al., 2006).  In addition, β1 subunits colocalize with neurofascin at nodes 
in sciatic nerve axons, and these proteins coimmunoprecipitate from rat brain lysates 
(Ratcliffe et al., 2001).  β2 subunits contain sequences similar to contactin, a CAM that 
binds the oligodendrocyte molecules tenascin-C and tenascin-R, which have both 
fibronectin and epidermal growth factor (EGF)-like binding domains.  β2 interacts 
strongly with the fibronectin domains, but not EGF domains (Srinivasan et al., 1998), 
resulting in a dynamic interplay during cell migration.  Because β-subunits are expressed 
in neurons prior to myelination, this interaction may be important for repelling tenascin-
secreting oligodendrocytes, thus maintaining nodes of Ranvier during myelin formation 
(Xiao et al., 1999).  Together, these studies imply that β-subunits are essential for 
targeting Na+ channels to electrically active axonal domains, not only by promoting 
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ankyrin recruitment to Na+ channels, but also by associating extracellularly with 
neurofascins and repelling oligodendrocytes at nodes of Ranvier. 
     Finally, another role for β-subunits in development was suggested by the finding that 
β1 stimulates neurite outgrowth in dissociated cerebellar granule cells (Davis et al., 
2004).  In this study, neurons from wild type or β1 (-/-) mice were grown on a monolayer 
of support cells expressing β1.  Compared to the wild type, neurite extension in the β1 
knockout cells was significantly reduced, implying that homotypic β1-mediated adhesion 
promotes growth.  Interestingly, β2-transfected monolayer cells inhibit wild type neurite 
extension and suggest that the two subunits have anagonistic influences during neuronal 
organization (Davis et al., 2004).  In summary, these studies provide evidence that the 
cell adhesion properties of Na+ channel β-subunits allow the channel complex to be 
involved in more than ion conduction.  Certainly, the β-subunits may contribute to the 
localization of Na+ channels into cellular domains where ion flux is needed; however, 
whether channel gating is linked to β-subunit function remains an open question.  As 
discussed below, Na+ channel β-subunits are also cleaved by certain secretases, yielding 
free peptides that can influence Na+ channel expression and membrane excitability. 
      
E.2. K+ channel β-subunits have enzymatic activity  
     As the most diverse class of voltage-gated ion channels, K+ channels correspondingly 
associate with a multitude of ancillary proteins, including signaling molecules, second 
messengers and scaffolding proteins.  However, certain K+ channels possess native 
auxiliary subunits that are considered essential channel components, contributing to 
voltage-dependence, kinetic properties and membrane localization (Kaczmarek, 2006).  
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Several of these β-subunits exhibit intrinsic enzymatic activity and signaling properties, 
suggesting that the non-conducting roles of K+ channels in intracellular signaling 
pathways may be in part mediated through β-subunits.  In addition, regulatory enzymes 
such as PKA, PKC, CaMKII and others frequently associate with K+ channels and 
modulate channel activity in response to a variety of biochemical cues (Levitan, 2006).  
While not considered bona fide β-subunits, these are often important for the fine-tuning 
of K+ channel complexes, and can also contribute to certain non-conducting signaling 
roles, as in the case of EAG and CaMKII.   
     Before exploring the secondary roles that individual K+ channel β-subunits have in the 
activation of intracellular signaling, it will be useful to briefly discuss the association of 
kinases and phosphatases with ion channel complexes.  Some initial evidence that 
channels interact with such enzymes came from the Levitan group, who found that large 
conductance Ca2+-activated K+ (BK) channels, when reconstituted in artificial lipid 
bilayers, exhibit increased open probability upon application of ATP (Chung et al., 1991).  
This observation, which can be reversed by the addition of protein phosphatase 1 (PP1), 
suggested that kinase activity is somehow associated with the channel.  Subsequent 
experiments determined this activity to be similar to that of PKC, which itself mimics the 
effect when applied to the preparation.  Moreover, microcystin and other phosphatase 
inhibitors enhance channel modulation by ATP, implying the presence of a PP1-like 
phosphatase (Reinhart and Levitan, 1995).  These findings were consistent with other 
observations of the effects of ATP on purified channels, although it was not initially 
known whether the kinase and phosphatase activities were mediated by the channels 
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themselves or by tightly associated proteins that copurified with the channels (Levitan, 
2006).   
     Numerous coimmunoprecipitation studies have since confirmed that K+ channels 
commonly associate with protein kinases and phosphatases that affect channel activity 
and expression.  For example, the tyrosine kinase Src associates with K+ channels via 
short, proline-rich Src-homology 3 (SH3) domain binding motifs; in the case of Kv1.5, 
Src-mediated tyrosine phosphorylation suppresses current (Holmes et al., 1996).  The 
overexpression of Kv1.3 in HEK 293 cells decreases endogenous tyrosine 
phosphorylation in a manner dependent on Kv1.3 conductance, providing evidence of a 
role for K+ channels in Src-mediated signaling (Holmes et al., 1997).  The Drosophila 
Slowpoke (dSlo) channel also binds Src, as well as the catalytic subunit of PKA, and both 
kinases phosphorylate tyrosine residues in dSlo to affect channel localization (Wang et 
al., 1999).  PKA itself frequently associates with channels via A kinase anchoring 
proteins (AKAPs), which serve as scaffolding for the recruitment of PKA and other 
enzymes to channel complexes (Wong and Scott, 2004).  One AKAP in particular, 
Yotiao, has been shown to enhance Kv7 current independently of PKA activity, 
suggesting a critical role for such adaptor proteins in K+ channel complexes (Kurokawa 
et al., 2004). 
     Serine/threonine phosphorylation is another common mechanism of channel 
regulation.  Small-conductance Ca2+-activated K+ (SK) channels, which mediate the slow 
afterhyperpolarization of action potentials, are regulated by protein kinase CK2 and 
protein phosphatase 2A.  These bind in a complex with calmodulin (CaM), and alter the 
Ca2+ sensitivity of channel activation by regulating CaM phosphorylation (Bildl et al., 
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2004).  Another kinase, CaMKII, associates with EAG and enhances current via C-
terminal threonine phosphorylation of the channel (Wang et al., 2002c).  This EAG/ 
CaMKII interaction provides a striking example of K+ channels as signaling complexes, 
because EAG also regulates the kinase activity of CaMKII (Sun et al., 2004).  The 
consequences of this two-way communication are a central tenet of my thesis, and are 
examined in detail below.   
     These studies highlight the fact that K+ channels can associate with a variety of 
promiscuous regulatory enzymes, providing a useful mechanism for the regulation of 
cellular excitability by signaling molecules.  However, like Na+ channels, K+ channels 
also have endogenous auxiliary subunits that are critical for proper channel function.  I 
now focus on several examples of K+ channel β-subunits that have secondary roles, 
including enzymatic activity and transcription regulation.   
     One of the first K+ channel β-subunits to be characterized, Drosophila Hyperkinetic 
(Hk), was identified on the basis of a mutant leg-shaking phenotype similar to that 
observed for Shaker and eag mutants (Kaplan and Trout, 1969). When coexpressed with 
Shaker in Xenopus oocytes, Hk shifted the voltage-dependence of activation and 
inactivation, and dramatically increased current amplitudes by approximately 2-fold 
(Chouinard et al., 1995).  The mammalian ortholog, Kvβ1, was cloned from the rat 
nervous system and confers fast inactivation to some variants of the Kv1 family, the 
corresponding orthologs of Drosophila Shaker channels (Rettig et al., 1994).  Deletion 
and substitution analyses showed that this effect occurs via an N-terminal structure that 
occludes the ion conduction pathway, similar to that seen in Shaker via its own C-
terminal ball domain (Hoshi et al., 1990).  Mutation of an oxidation-sensing cysteine 
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residue eliminates the inactivation by Kvβ1, implying that its effects are sensitive to the 
redox environment of the cytoplasm (Rettig et al., 1994).  The x-ray crystal structure of 
Kvβ1 confirms that the subunit has structural similarities to aldo-keto reductases (AKRs), 
enzymes that convert aldehydes to alcohols using nicotinamide cofactors (Gulbis et al., 
1999).  This finding suggests that Kvβ1 can function as an enzyme coupled to the 
voltage-sensing α-subunit, perhaps modulating excitability in response to changes in 
redox potential.   
     Although enzymatic activity has not yet been established for Kvβ1, the structurally 
similar Kvβ2 has recently been shown to have AKR activity.  Intriguingly, the effects of 
Kvβ2 on Kv1 channel function more closely parallel the effects previously observed for 
Hk on Shaker channels; UV absorption spectroscopy reveals that Kvβ2 converts bound 
NADPH to NADP+ when presented with aldehyde substrates (Weng et al., 2006).  Kvβ2-
mediated oxidation occurs independently of the Kv1 α-subunit, but when expressed with 
the channel pore, the reaction has been shown to modulate channel current (Weng et al., 
2006).  These results demonstrate a functional link between channel gating and 
enzymatic activity mediated by a K+ channel β-subunit, with the implication that Kv1 
channels are modulated as a response to oxidative stress.  However, this association also 
suggests the possibility that channel gating could in turn affect the oxidizing activity of 
the β-subunit, influencing redox pathways during prolonged depolarization. 
      Another example of a K+ channel β-subunit with enzymatic function was discovered 
in the nematode Caenorabditis elegans.  MPS-1 was identified in C. elegans as an 
ortholog of mammalian MinK-related peptides (MiRPs), which are β-subunits of the 
Kv3, Kv7 and Kv11 classes of channels (Kaczmarek, 2006).  MPS-1 forms a complex 
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with the nematode voltage-gated channel KVS-1, and is critical for neuronal activity, 
because RNA interference of the MPS1 gene results in impaired chemotaxis and 
locomotion (Bianchi et al., 2003).  Initial examination of the MPS-1 amino acid sequence 
revealed ATP-binding and catalytic domains characteristic of kinases, and radiolabeled 
ATP assays confirmed that MPS-1 is a serine/threonine kinase that can phosphorylate 
KVS-1 as well other substrates such as MBP (Cai et al., 2005).  Moreover, MPS-1-
mediated phosphorylation of KVS-1 modulates the channel by decreasing open channel 
probability, thereby contributing to inactivation of the whole-cell current in heterologous 
expression systems.  Inactivation or deletion of the catalytic domain of MPS-1 does not 
completely abolish its effect on KVS-1 current properties, emphasizing its bifunctional 
role as both a functional kinase and a channel subunit (Cai et al., 2005).  To date, MPS-1 
is the only MiRP known to have such a role, as none of its mammalian orthologs exhibit 
kinase activity (Kaczmarek, 2006)  
     Slowpoke (dSlo), the Drosophila ortholog of SK channels, not only associates with 
Src kinase and the catalytic domain of PKA, but also has at least two β-subunits that 
modulate its activity.  Slowpoke-interacting protein (Slip) was identified in a yeast two-
hybrid screen and reduces dSlo current by affecting membrane trafficking of the channel 
complex (Xia et al., 1998a).  The slowpoke-binding protein (Slob), also identified using 
yeast two-hybrid, increases channel activity (Schopperle et al., 1998) and is a protein 
kinase.  In vitro, Slob weakly phosphorylates itself and histone substrates, but this 
activity is greatly enhanced when the protein is pretreated with the catalytic subunit of 
PKA (Zeng et al., 2004).  Mutation of a candidate serine residue in Slob abolishes the 
effect, which can be restored by the introduction of a phospho-mimic aspartate residue, 
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suggesting that PKA phosphorylation regulates Slob kinase activity (Zeng et al., 2004).  
Slob also recruits the scaffolding protein 14-3-3 to the dSlo complex, which can itself 
modulate channel function in a manner dependent on the phosphorylation of Slob by 
CaMKII (Zhou et al., 1999).   
     This intricate regulation of dSlo activity by its associated proteins obviously speaks to 
the dynamic regulation of the channel complex in vivo.  In the Drosophila CNS, dSlo 
modulation may have a role in circadian pathways.  Slob expression in photoreceptors 
and pars intercerebralis (PI) neurons cycles in tandem with circadian-regulated proteins, a 
pattern not observed in clock gene mutants (Jaramillo et al., 2004).  Another clue may 
come from the adaptor proteins in the dSlo complex.  Because 14-3-3 also binds various 
nuclear signaling proteins, including Raf, a key component of mitogen-activated protein 
kinase (MAPK) signaling pathways (Fu et al., 1994), it is interesting to consider the 
potentially central role for the dSlo complex in stimulating these pathways in Drosophila.   
Slob also binds EAG (Schopperle et al., 1998), further suggesting the possibility that β-
subunit-regulated phosphorylation is important for EAG/CaMKII-mediated intracellular 
signaling, discussed below. 
     A final example of bifunctional K+ channel β-subunits is the K+ channel-interacting 
protein (KChIP) family of proteins.  The multifunctional nature of these proteins is hard 
to deny, as they have been independently discovered three times; first as a Ca2+-binding 
protein that regulates presenilin, a protein involved in Alzheimer’s disease (Buxbaum et 
al., 1998), then as a Ca2+-mediated transcriptional repressor of nociception genes (Carrion 
et al., 1999), and finally as a β-subunit of the Kv4 family of K+ channels (An et al., 2000).  
Each of the four known KChiP isoforms contains four characteristic EF-hand Ca2+-
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binding domains that allow them to serve as Ca2+ sensors in several capacities.  As Kv4 
β-subunits, KChIP1 and KChIP2 increase channel conductance and recovery from 
inactivation in a manner that depends on the presence of the EF-hand domain (An et al., 
2000).  KChIP3, also called calsenilin, binds and regulates the activity of presenilin, a 
component of the transmembrane γ-secretase complex that is implicated in early-onset 
Alzheimer’s disease (Buxbaum et al., 1998).  Calsenilin binding to presenilin has several 
effects, including the reduction of IP3-mediated Ca2+ release from intracellular stores, 
stimulation of apoptosis and the formation of amyloid β plaques (Buxbaum, 2004).   
     As a transcription factor, KChIP3 binds to downstream regulatory element (DRE) 
sequences to repress the transcription of various genes, including the human 
prodynorphin gene involved in memory acquisition and pain, and the early response gene 
c-fos (Carrion et al., 1999).  The transcription repression function of KChIP3, also called 
DRE-agonist modulator (DREAM), is relieved after binding of Ca2+ to the EF hands, 
which disrupts binding to the DRE (Buxbaum, 2004).  A similar role in transcriptional 
control has been found for KChIP2, which along with DREAM regulates proliferation 
and the expression of IL-2 and interleukin in T-lymphocytes (Savignac et al., 2005).  
Remarkably, DREAM knockout mice exhibit less sensitivity to pain, as measured by tail-
flick and paw withdrawal assays (Cheng et al., 2002), and suggest that DREAM is an 
integral part of the modulation of pain signaling pathways.  It is clear that KChIPs have 
diverse functions in addition to their role in Kv4 channel modulation.  Because Kv4 is the 
mammalian ortholog of Shal, which regulates HCN channel expression in the lobster 
STG, it will be of interest to know whether KChIPs or their orthologs are involved in 
homeostatic compensation mechanisms. 
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E.3. Calmodulin-mediated channel signaling  
     While not traditionally considered an auxiliary ion channel subunit, the ubiquitously 
expressed Ca2+ sensor protein calmodulin (CaM) constitutively binds and modulates the 
functions of several voltage- and ligand-gated ion channels.  These include some Ca2+-
sensitive K+ and Na+ channels, Cav channels, cyclic nucleotide-gated (CNG) channels 
and N-methyl-D-aspartate (NMDA) glutamate receptors (Levitan, 2006).  CaM is a small 
protein that binds a maximum of four Ca2+ ions in two lobe-like pairs of EF-hand 
domains connected by an α-helix, which give CaM a dumbbell-like shape (Saimi and 
Kung, 2002).  Typically, Ca2+ binding causes a conformational shift that opens each lobe, 
revealing hydrophobic stretches of amino acids that bind and activate target molecules.  
However, in the absence of Ca2+, CaM can bind certain peptide sequences called 
isoleucine-glutamine (IQ) motifs, permitting the constitutive binding of CaM to some 
proteins, including ion channels (Saimi and Kung, 2002).  This association allows Ca2+-
induced conformational shifts in CaM to modulate channel activity in response to 
changes in [Ca2+]i.  CaM-associated channel complexes may, in turn, be able to influence 
the downstream activity of Ca2+-mediated signaling pathways such as those mediated by 
MAPK (Dolmetsch et al., 2001).  Here I describe the role of CaM as a regulator of 
voltage-gated channels, highlighting its ability to link channel activity and intracellular 
Ca2+ signaling.   
     One role of CaM as a voltage-gated channel regulatory subunit is in the activation of 
small (SK) and intermediate (IK) conductance Ca2+-activated K+ channels.  SK channels 
are both voltage- and Ca2+-dependent, and are thus able to modulate the membrane 
potential in response to changes in Ca2+concentrations, a property that is essential for the 
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fine-tuning action potentials during the afterhyperpolarization (Hille, 2001).  However, it 
was not initially known whether this sensitivity is conferred by direct binding of Ca2+ to 
the channel α-subunit, as in BK channels, or via another protein.  Using yeast two-hybrid 
analysis and immunoprecipitation experiments, the Adelman group identified CaM as a 
binding partner of all three SK isoforms (Xia et al., 1998b).  Surprisingly, this association 
is not mediated via the canonical IQ motif, but rather a novel domain consisting of four 
α-helices; mutations introduced into this region abolish Ca2+ gating of the channel.  Also, 
CaM mutants with altered Ca2+-binding affinity shifted the dose-response curves of SK 
Ca2+ gating, demonstrating the integral role of CaM as an SK subunit (Xia et al., 1998b).  
Subsequent experiments found that CaM regulates IK channels in a similar manner 
(Fanger et al., 1999).   
     In light of the phospho-dependent regulation of CaM by protein kinase CK2 and 
protein phosphatase 2A in SK protein complexes (Bildl et al., 2004), it is clear that CaM 
plays a pivotal role in SK activity.  However, this role is not limited to functional 
modulation - CaM also affects SK assembly and trafficking.  In SK4-transfected CHO 
cells, overexpression of a peptide containing the CaM-binding domain decreases the pool 
of CaM available to bind channels and prevents SK4 membrane expression (Joiner et al., 
2001).  This redistribution results in decreased whole-cell current, an effect that can be 
rescued by overexpression of CaM.  Moreover, immunoprecipitation experiments showed 
that SK4 multimerization is regulated by the presence of CaM, implying that CaM-
mediated subunit assembly may underlie the effects on channel trafficking (Joiner et al., 
2001). 
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     CaM also plays a fundamental role in the Ca2+-dependent inactivation of Cav1 (L-
type) Ca2+ channels.  Initially, researchers believed that this type of inactivation was a 
result of Ca2+ itself, in part because the lack of perturbation by Ca2+ chelators suggests the 
site of inactivation is very close to the pore, and also due to the presence of a putative EF-
hand motif on the α1C pore-forming subunit (Levitan, 1999).  However, several groups 
have since confirmed that CaM activity underlies inactivation of these channels, offering 
a model in which CaM is constitutively bound to the α1C subunit via an IQ motif and 
influences gating via Ca2+-mediated conformational shifts (Peterson et al., 1999; Pitt et 
al., 2001; Qin et al., 1999).  CaM has also been reported to contribute to frequency-
dependent facilitation of L-type Ca2+current, suggesting that it exerts both positive and 
negative effects on Ca2+ channel gating (Zuhlke et al., 1999).   
     In addition to mediating Ca2+-dependent inactivation, the association of CaM with 
Cav1 channels also appears to be able to stimulate transcription via Ca2+-dependent 
signaling pathways.  Evidence for this type of signaling was found by the Tsien group, 
who discovered that a brief burst of stimulation applied to hippocampal CA3/CA1 
neurons causes nuclear translocation of CaM and the phosphorylation of cAMP response 
element-binding protein (CREB) (Deisseroth et al., 1998).  This effect is specific to the 
activation of Cav1 channels, because antagonists of other voltage-gated Ca2+ channels 
have no effect on CaM mobilization or CREB activation.  Subsequent experiments 
showed that the activation of CREB by Cav1 stimulates the transcription of a CRE-
activated reporter gene, and that signaling is mediated via the activation of Ras and 
MAPK pathways (Dolmetsch et al., 2001).  Furthermore, signaling requires the 
functional association of CaM with the Cav1 IQ motif, because mutation of this domain 
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or of CaM disrupts MAPK activation (Dolmetsch et al., 2001).  These results imply that 
Ras/MAPK activators interact with the channel complex, where they are directly or 
indirectly stimulated by CaM in response to channel activation.   
     Lastly, it should be noted that CaM is crucial for other forms of channel-mediated 
signaling due to its role as an activator of the multifunctional Ca2+/CaM-dependent 
protein kinase II (CaMKII).  CaMKII activity is central to many Ca2+ signaling pathways, 
and is thus an essential component of numerous cellular functions, including 
carbohydrate and fatty acid metabolism, muscle contraction, neurotransmitter release and 
synaptic plasticity, among others (Braun and Schulman, 1995).  As mentioned above, 
CaMKII also binds and phosphorylates EAG, which increases current in the presence of  
Ca2+-bound CaM.  Once Ca2+ levels decline, EAG-bound CaMKII retains catalytic 
activity (Sun et al., 2004).  In addition, CaM can bind directly to the C-terminus of both 
Drosophila and mammalian EAG and inhibits channel activity in response to increases in 
[Ca2+]i (Schonherr et al., 2000; Stansfeld et al., 1996).  My results, discussed below and 
detailed in the following chapters, show that the interaction of EAG and CaMKII 
stimulates intracellular signaling pathways in response to fluctuations in the membrane 
potential.  Taken together, these studies suggest that CaM is not only a dynamic regulator 
of ion channel activity, but also plays key roles in channel-mediated signaling to the 
nucleus. 
 
E.4. Proteolysis of channels and subunits 
     To conclude my overview of multifunctional ion channel subunits, I now turn to one 
other mechanism by which channels and their associated proteins have been shown to 
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influence cellular functions: the proteolytic cleavage of intracellular domains to yield free 
cytoplasmic peptides.  This type of regulation is well-characterized for the Notch/Delta 
signaling pathway during development.  In that case, the binding of Delta ligand to Notch 
membrane receptors stimulates proteolytic cleavage of the Notch intracellular domain 
(NICD), which translocates to the nucleus and converts certain transcriptional repressors 
to activators, initiating the expression of developmental genes (Mumm and Kopan, 2000).  
Some ion channel proteins, including Cav1 channels, TRPP channels and Na+ channel β-
subunits, undergo proteolysis to generate signaling molecules.  Here I will discuss the 
regulated cleavage of these proteins, which may underlie their ability to function outside 
their normal roles as ion channels or subunits. 
     As described above, Na+ channel β-subunits can function as cell adhesion molecules, 
in addition to their role in channel modulation (McEwen and Isom, 2004).  The β-  
subunits are also substrates for presenilin/γ-secretases, enzymes that contribute to the 
formation of amyloid β plaques in Alzheimer’s disease via the sequential cleavage of β-
amyloid precursor protein (APP) (Wong et al., 2005).  Each β-subunit isoform has amino 
acid sequences similar to APP that allows them to undergo a comparable series of 
proteolytic events.  In cortical neurons, the extracellular N-terminus of β2 is removed 
first by α-secretase, leaving only the short intracellular C-terminal region, which is then 
cleaved by γ-secretase to yield a free peptide of about 10 kD (Kim et al., 2005).  This 
peptide has recently been shown to stimulate transcription and expression of Nav1.1, 
leading to increased surface expression in neuroblastoma cells (Kim et al., 2007).  
However, in transgenic mice overexpressing γ-secretase to mimic Alzheimer’s, increased 
β2 cleavage decreases the overall channel surface expression and Na+ current density in 
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neuroblastoma and hippocampal neurons.  This finding is consistent with the altered 
Nav1 levels in human Alzheimers’ patients, and suggests a mechanism by which 
membrane excitability may be regulated by proteolytic events (Kim et al., 2007).  The 
inhibition of γ-secretase also inhibits cell adhesion and migration in several motility 
assays, implying that proteolysis is also important for cellular functions requiring β-
subunits, such as neurite outgrowth (Davis et al., 2004).   
     TRPP and Cav1 channels also undergo proteolysis to yield molecules with signaling 
abilities.  TRPP channels, as discussed above, are expressed in renal tubules, where they 
may function as ciliary mechanosensors (Huang, 2004).  One study suggests that 
proteolysis of these channels influences intracellular signaling pathways.  In kidney 
epithelial cells of mice overexpressing full length TRPP1, a C-terminal fragment is 
cleaved and accumulates in the nucleus, as observed with fluorescent tissue labeling and 
western blots of nuclear fractions (Chauvet et al., 2004).  When TRPP1 is heterologously 
expressed in CHO cells, nuclear translocation corresponds to increased activation of the 
AP-1 and JNK signaling pathways, an effect that is eliminated when a putative nuclear 
localization signal (NLS) in the TRPP1 C-terminus is mutated.  Moreover, the signaling 
activity of the TRPP1 fragment is regulated by the pore-forming TRPP2 subunit, because 
nuclear translocation and AP-1 signal activation are prevented when both subunits are 
coexpressed in CHO cells, and TRPP2 knockout mice exhibit higher nuclear TPP1 
staining than wild type mice (Chauvet et al., 2004).  These results implicate a dynamic 
interaction between TRPP subunits in the regulation of the AP-1 and JNK pathways, 
although the physiological role of this signaling remains to be clarified.  However, 
because these channels have also been implicated in cell cycle regulation and 
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differentiation (Bhunia et al., 2002; Grimm et al., 2006), it is possible that those effects 
are a result of proteolysis-mediated signaling via TRPP1. 
     Lastly, Cav1 channels have been shown to undergo intracellular C-terminal cleavage 
to generate fragments with multiple effects.  In hippocampal neurons, Hell and colleagues 
showed that postsynaptic Ca2+ channels are converted to a shorter form by calpain 
following the stimulation of NMDA receptors (Hell et al., 1996).  This result confirmed 
previous reports that truncation of these channels increases conductance (Wei et al., 
1994), and supports a role for proteolytic cleavage in the enhancement of postsynaptic 
Ca2+ current during neuronal activity.  Subsequent studies of Cav1.1, which is expressed 
in skeletal muscle, used mass spectroscopy and deletion analysis to identify the site of 
proteolytic cleavage in the C-terminus and showed that the fragment remains bound to 
the channel complex as a scaffolding protein (Hulme et al., 2005).  The cleaved C-
terminal peptide helps to form the leucine zipper motif that targets PKA to the channel 
via AKAP15, contributing to the enhancement of current by PKA phosphorylation 
(Hulme et al., 2002).   
     In addition to regulating channel function, the proteolysis of L-type Ca2+ channels has 
recently been shown to yield a transcription factor (Gomez-Ospina et al., 2006).  The 
Dolmetsch group found that a fluorescently labeled C-terminal fragment of Cav1.2 is 
enriched in the nucleus of cortical neurons.  The nuclear expression of this Ca2+ channel-
associated transcription regulator (CCAT) is regulated by changes in Ca2+; chelation of 
extracellular Ca2+ increases nuclear CCAT labeling, while the stimulation of Cav1.2 
channel activity using KCl or glutamate has the opposite effect (Gomez-Ospina et al., 
2006).  In coimmunoprecipitation experiments, CCAT interacts with the nuclear protein 
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p54(nrb)/NonO, which regulates transcription and RNA splicing.  Interaction between the 
proteins induces the expression of a luciferase reporter gene.  Moreover, microarray 
analysis show that CCAT-mediated transcription affects the expression of many 
endogenous genes, including gap junction proteins, axon guidance factors, K+ and TRP 
channels, glutamate receptors, several kinases, and a host of other proteins involved in 
neuronal function (Gomez-Ospina et al., 2006).  Clearly, CCAT provides an important 
mechanism for coupling Ca2+ channel activity to protein expression and may contribute 
to neuronal homeostasis or plasticity.  Although Cav1.2 conductance is technically 
required for CCAT activation, CCAT itself, rather than Ca2+ influx, regulates 
transcription. 
 
F. THE EAG POTASSIUM CHANNEL 
     To this point, I have reviewed many examples of ion channels that function beyond 
their classic role as arbitrators of membrane excitability, including channels that affect 
cell cycle regulation, channels with specific ion-independent functions, and channel-
associated proteins that contribute to nontraditional channel activity.  I now focus on 
EAG, a multifunctional K+ channel that encompasses all of these properties.  As 
described above, EAG contributes to oncogenesis and cell cycle progression (Pardo et al., 
1999), and also binds and locally activates CaMKII (Sun et al., 2004).  The central focus 
of this thesis is that EAG activates intracellular signaling pathways via voltage-dependent 
regulation of CaMKII activity, and that this function is independent of ion flux.  Here,  I 
provide a general background of the  EAG channel, including discussions of its electro-
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physiological properties, topology and amino acid sequence, associated proteins, and 
putative role in vivo.   
 
F.1. Characterization and physiological significance 
     The Drosophila Ether à-go-go (EAG) K+ channel is the founding member of a 
superfamily of K+ channels related to both voltage-gated and cyclic nucleotide-gated K+ 
channels (Ganetzky et al., 1999).  The eag gene was originally discovered in Drosophila 
mutants that exhibit leg-shaking behavior under ether anesthesia (Kaplan and Trout, 
1969), but its identity as an ion channel gene was not appreciated until later studies that 
found an enhancement of neurotransmission defects in eag/Shaker double mutants when 
compared to either individual mutation (Ganetzky and Wu, 1983).  Motivated by these 
phenotypes, the EAG polypeptide was cloned using chromosomal analysis (Drysdale et 
al., 1991; Warmke et al., 1991) and soon thereafter, an eag homology screen identified a 
family of highly conserved genes in several invertebrate and mammalian species, which 
could be separated into three subfamilies: eag, eag-related gene (erg), and eag-like K+ 
channel (elk).  The amino acid sequences encoded by these genes contain the 
characteristic transmembrane, pore-forming and voltage sensing domains found in 
Shaker-like voltage-gated channels, as well as a cyclic nucleotide-binding domain similar 
to that of CNG channels (Warmke and Ganetzky, 1994).  Interestingly, sequence 
comparison suggests that the EAG family of channels is more closely related to CNG 
channels than voltage-gated K+ channels (Guy et al., 1991), and consequently they are 
now considered part of the same phylogenetic branch of channel evolution (Yu and 
Catterall, 2004).  
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     In addition to leg shaking behavior, Drosophila eag mutants display hyperexcitability 
in recordings from the larval neuromuscular junction (NMJ).  This is characterized by 
both a high degree of spontaneous action potential firing from the motor neuron and 
broadened spontaneous and evoked excitatory junctional potentials (EJPs) in the body 
wall muscle fibers (Ganetzky and Wu, 1985).  Both of these defects have been attributed 
to increases in excitability, and consequently neurotransmitter release, in the motor 
neurons in the absence of the hyperpolarizing influence of EAG.  In contrast, Shaker 
mutants also exhibit repetitive neuron firing, but only do so in response to motor neuron 
stimulation (Ganetzky and Wu, 1985).  Finally, in the absence of EAG, several K+ 
currents in muscle are also down-regulated (Wu et al., 1983).  However, this effect 
appears to be an indirect, activity-dependent regulation of the expression of multiple K+ 
channels in muscle, given that EAG protein is undectable in wild type muscle fibers (Sun 
et al., 2004; Wang et al., 2002c).  The physiological role of this down-regulation remains 
unclear. 
     Consistent with its role in neuronal excitability in Drosophila, EAG is expressed 
throughout the fly neuropil and optic lobes, and is present in the axon and terminals of 
motor neurons innervating body wall muscle (Sun et al., 2004; Wang et al., 2002c). 
Importantly, in the larval ventral ganglion, the distribution of EAG overlaps with that of 
synaptobrevin, a marker for pre-synaptic terminals.  In mammals, EAG is widely 
expressed in the nervous system, including the CA1 and CA3 regions of the 
hippocampus, neocortex, olfactory bulb, retinal ganglion, photoreceptors, cochlear spiral 
ligament, and skeletal muscle (Frings et al., 1998; Lecain et al., 1999; Ludwig et al., 
1994; Occhiodoro et al., 1998).  As discussed above, EAG is also expressed in several 
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cancer cell lines, including human neuroblastoma and melanoma cells (Meyer and 
Heinemann, 1998; Meyer et al., 1999).   
     The presence of EAG throughout the sensory and motor systems suggests that it may 
be important for behavior.  In fact, adult eag mutant flies display a number of behavioral 
phenotypes, which include defects in olfactory discrimination (Dubin et al., 1998), 
locomotion (Wang et al., 2002b) and habituation of the giant fiber escape pathway (Engel 
and Wu, 1998).  Moreover, eag mutants have impaired associative learning in courtship 
conditioning assays (Griffith et al., 1994).  In these experiments, male flies are paired 
with previously mated females, which are unresponsive to male courtship behavior.  Wild 
type males quickly respond to these cues by decreasing courtship, whereas eag flies 
exhibit an overall increase in courtship over the same period, indicating that learning is 
disrupted (Griffith et al., 1994).  This deficiency is very similar to that seen in flies 
overexpressing ala, a peptide corresponding to the CaMKII autoinhibitory domain.  
Because larvae expressing ala exhibit an increase in EJP frequency that is similar to eag 
mutants, and double mutants do not have an additive effect, EAG and CaMKII are likely 
to be part of a common pathway mediating synaptic plasticity and homeostasis (Griffith 
et al., 1994).   
     
F.2. Electrophysiological properties 
     The heterologous expression of Drosophila EAG (dEAG) in Xenopus oocytes results 
in a voltage-dependent outward K+ current that activates between -40 and -50 mV and 
increases with depolarizing voltage steps (Robertson et al., 1996; Wilson et al., 1998).  
Both dEAG and mammalian EAG (mEAG) isoforms exhibit relatively slow activation 
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and partial inactivation, although this inactivation is much less pronounced than in 
Shaker channels.  Despite the presence of the cyclic nucleotide-binding domain, 
application of cAMP or cGMP has no effect on EAG gating, and unlike CNG channels, 
EAG shows a much higher selectivity for K+ over Na+ ions (Robertson et al., 1996).  
Given the absence of specifically pharmacological blockers of the EAG channel, the most 
distinctive electrophysiological indicator of the presence of EAG channels in native 
tissues (Bauer and Schwarz, 2001) is a phenomenon reminiscent of the Cole-Moore shift 
first described  for K+ currents of the squid giant axon (Cole and Moore, 1960; Ludwig et 
al., 1994).  Specifically, the Cole-Moore effect is characterized by increasingly delayed 
activation kinetics in response to increasingly hyperpolarized prepulse potentials, and is 
enhanced by increasing extracellular concentrations of Mg2+ or H+ (Terlau et al., 1996).  
Recent studies have identified the Mg2+ binding site in the S3-S4 linker region, and 
suggest that modulation is due to the stabilization of a closed channel state that results in 
slower transitions to open states in the presence of Mg2+ (Schonherr et al., 2002; Tang et 
al., 2000).  Pharmacologically, EAG is sensitive to Ba2+ and quinidine (Ludwig et al., 
1994), and although specific EAG blockers have remained elusive, the tricyclic 
antidepressants imipramine and astemizole have been shown to selectively inhibit human 
EAG channels by binding the intracellular side of the channel pore (Garcia-Ferreiro et al., 
2004).  In addition, human EAG (hEAG) current in both heterologous and native tissue 
can be blocked by increases in intracellular Ca2+ concentrations (Meyer et al., 1999; 
Stansfeld et al., 1996), due to a C-terminal interaction between hEAG and Ca2+-bound 
CaM, discussed below (Schonherr et al., 2000). 
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     In heterologous expression systems, EAG also has been shown to interact with the K+ 
channel β-subunit, Hyperkinetic (Hk) (Wilson et al., 1998).  Hk coimmunoprecipitates 
with EAG, and produces an increase in amplitude and activation kinetics of EAG current 
when coexpressed in oocytes.  Hk also enhances mEAG and hERG currents, as well as 
those of Shaker (Chouinard et al., 1995) suggesting a promiscuous role for Hk in the 
modulation of different K+ channels.  It should be noted, however, that the interaction of 
Hk with EAG family members has yet to be established for channels in vivo.  As 
discussed above, Hk has sequence similarity to aldo-keto reductases (Chouinard et al., 
1995). 
     In contrast to EAG, ERG only exhibits small outward current upon depolarization, yet 
produces large tail currents when repolarized to negative potentials (Trudeau et al., 
1995).  This is the result of an inactivation mechanism that is more rapid than activation, 
which confers inward rectification properties on ERG (Schonherr and Heinemann, 1996; 
Smith and Yellen, 2002).  The resulting inverse current (compared to outward rectifiers) 
has important implications for ERG in cardiac tissue, where it functions alongside HCN 
pacemaker channels to regulate rhythmic contractions (Trudeau et al., 1995).  Indeed, 
mutations in human ERG have been well-characterized as contributing to long Q-T 
syndrome in humans (Curran et al., 1995).  The current properties of ELK channels are 
less well-characterized but seem to depend on the isoform expressed: ELK1 channels, 
which are expressed throughout the human nervous system, are EAG-like but do not 
exhibit the Cole-Moore shift (Engeland et al., 1998; Zou et al., 2003).  ELK2 appears to 
be intermediate of EAG and ERG, producing large outward currents that then rapidly 
inactivate (Trudeau et al., 1999).  This fast inactivation mechanism is similar to that of 
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ERG, but shifted to more positive potentials, accounting for the delayed inactivation upon 
depolarization (Engeland et al., 1998).   
 
F.3. Topology and amino acid sequence  
     The complete amino acid sequence of Drosophila EAG is presented in Figure 1.1, and 
highlights structural domains, putative sites of protein-protein interaction, and specific 
residues mutated for experiments throughout this thesis.  Each EAG subunit contains 
1174 amino acids that form six transmembrane helices (S1-S6) with intracellular N- and 
C- termini.  A series of positively charged residues in S4 constitute the voltage sensor, 
and an additional hydrophobic domain between S5 and S6 contains the signature GFG 
motif that forms the K+ selectivity filter.  Using the crystallized KcsA structure as a 
model, four EAG subunits are thought to coassemble into a tetrameric protein that is able 
to selectively pass K+ ions through a central, water-filled pore (Doyle et al., 1998).   
     In its N-terminus, EAG contains a stretch of amino acids that form a PER-ARNT-SIM 
(PAS) dimerization domain.  This domain is particularly unusual for an ion channel, 
because nearly all eukaryote proteins that contain a PAS domain are transcription factors 
that reside within the nucleus or shuttle between the nucleus and cytoplasm (Crews and 
Fan, 1999).  PAS domains are usually found in proteins that act as internal sensors of 
light, hypoxia, and redox potential, such as the Drosophila circadian protein Period 
(Taylor and Zhulin, 1999).  In the case of Period, this domain facilitates dimerization 
with Timeless, another PAS-containing circadian protein.  This association reveals a  
nuclear localization signal (NLS) in the Per/Tim complex that allows it to directly 




Figure 1.1: Drosophila EAG amino acid sequence.  Regions of interest are highlighted 
in color; transmembrane domains are indicated in yellow.  Putative nuclear localization 
signals are boxed.  Point mutations used throughout this thesis are specified below the 
respective amino acids. 
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determined whether the EAG PAS domain is functional, although it is conserved 
throughout the EAG family of K+ channels (Bauer and Schwarz, 2001) and has been 
suggested to operate as an oxygen sensor in both EAG and hERG (Crociani et al., 2003; 
Morais Cabral et al., 1998). 
     The EAG intracellular C-terminus is nearly twice as long as those of K+ channels of 
the Shaker superfamily, and contains many putative protein interaction domains.  In 
addition to the cyclic nucleotide-binding domain, the C-terminus includes a region with 
high similarity to the autoinhibitory domain of CaMKII, a CaM binding domain, three 
putative nuclear localization (NLS) signals, a Src-Homology 3 (SH3) motif, and at least 
two potential PKA phosphorylation sites.  Additionally, there is a stretch of glycine 
residues with similarity to the conserved ATP-binding and catalytic domains of known 
kinases (Hanks et al., 1988).  Our lab and others have performed site-directed 
mutagenesis on key residues within these sites as a preliminary test of their functionality.  
As discussed below, EAG associates with CaM and CaMKII, as well as with the 
membrane-associated guanylate kinase (MAGUK) adapter protein Camguk (CMG), 
which binds to a novel SH3 motif.  I have also created and tested several point mutations 
in most of these domains for possible involvement in EAG-mediated signaling.  These 
experiments are described in detail in chapter III of this thesis.      
 
F.4. The EAG protein complex  
     EAG current is regulated via independent associations with CaM and CaMKII, which 
have opposing effects on channel function: Ca2+/CaM binding acutely decreases EAG 
current, most likely by shifting the voltage-dependence of activation to more positive 
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potentials (Schonherr et al., 2000) while phosphorylation by CaMKII enhances current by 
increasing the surface expression of EAG channels (Schonherr et al., 2000; Wang et al., 
2002c).  The rivaling modulatory effects of these proteins suggests that the relationship 
between intracellular Ca2+ and EAG function is finely tuned.  Here I discuss the 
interactions between EAG, CaM, CaMKII, and CMG, which together form a protein 
complex that may be capable of two-way communication between membrane excitability 
and Ca2+ signaling pathways.         
     As mentioned above, hEAG current is inhibited by increases in intracellular Ca2+, 
reaching half-maximal inhibition at approximately 100 nM (Stansfeld et al., 1996).  In 
Xenopus oocytes expressing hEAG, current is inhibited when inside-out patches are 
excised into a bath solution containing ~200 nM free Ca2+, but can restored by exposure 
to an EGTA-buffered Ca2+-free solution.  However, if the same patch is reintroduced to 
high [Ca2+], inhibition is not observed, suggesting that the loss of a cytosolic factor 
regulates the effect.  Indeed, if the patch is again exposed to the oocyte cytoplasm, Ca2+ 
inhibition is restored (Schonherr et al., 2000).  These experiments were the first 
indication that a cytoplasmic protein such as CaM might be mediating the Ca2+ inhibition 
of hEAG.  When excised patches washed in Ca2+-free solution are exposed to 
recombinant CaM protein, the Ca2+ sensitivity of hEAG current is reestablished, 
confirming that the inhibition is mediated by CaM (Schonherr et al., 2000).   
     In vitro binding assays identify a 20 residue CaM-binding domain in the hEAG C-
terminus (Schonherr et al., 2000).  This domain, which putatively forms an amphipathic 
helix, is conserved in all EAG channels, suggesting that Ca2+/CaM also inhibits 
Drosophila EAG current.  Experiments in our lab confirm this hypothesis (Marble et al., 
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in preperation).  It is interesting to point out that CaM inhibits EAG while at the same 
time activating Ca2+-regulated K+ channels, which can be expressed in the same cells 
(Meyer et al., 1999).  The explanation may lie in the stoichiometry of CaM binding; in 
EAG, the association of one CaM molecule per channel appears sufficient for inhibition 
(Schonherr et al., 2000), while SK channels may require four Ca2+-bound CaMs for 
activation (Keen et al., 1999).  This difference might establish a [Ca2+]i threshold below 
which EAG channels are active, but above which EAG is inactivated and SK channel 
activity is stimulated. 
     CaM also regulates EAG indirectly via CaMKII, which binds to EAG via a C-terminal 
region with homology to its own autoinhibitory domain (Sun et al., 2004) and enhances 
current by phosphorylating the channel at a key threonine residue (Wang et al., 2002c).  
As described above, the inhibition of CaMKII in Drosophila larvae produces 
supernumerary EJPs at the NMJ similar to those of eag mutants, and both mutants exhibit 
deficiencies in associative learning assays (Griffith et al., 1994).  These findings provided 
early evidence that CaMKII and EAG share a common pathway regulating synaptic 
function and plasticity.  Subsequent studies using radiolabeled ATP show that EAG is a 
CaMKII substrate, and that CaMKII phosphorylates the EAG C-terminus at threonine 
787 (Wang et al., 2002c).  In oocyte recordings, mutation of this residue prevents the 
inhibition of EAG current by the ala peptide, indicating that T787 is necessary for 
endogenous CaMKII-mediated increases in EAG current.  Subsequent biotinylation 
assays indicate that phosphorylation increases currents primarily by increasing the 
number of channels in the plasma membrane (Wang et al., 2002c) and suggest that, in 
contrast to the effect of CaM binding, which is readily reversible, the effects of CaMKII 
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on EAG current may be more long-term.  Moreover, the independent binding of CaM to 
EAG does not appear to prevent or enhance phosphorylation at T787 (Marble et al., in 
preperation).  In vivo, CaMKII phosphorylation of EAG is observed at the NMJ using 
phospho-specific antibodies, and can be enhanced by driving the neuronal expression of a 
constitutively active form of the kinase (Wang et al., 2002c).  Together these results show 
that CaMKII phosphorylation of EAG at T787 enhances current, and suggests that 
CaMKII regulates EAG function at synaptic terminals. 
     Coimmunoprecipitation assays from Drosophila heads confirm that CaMKII 
associates with EAG in native tissue, and in vitro binding assays show that this occurs via 
the region of the EAG C-terminus (K773-V794) with homology to the regulatory domain of 
CaMKII (Sun et al., 2004).  Initial CaMKII binding depends on the presence of 
Ca2+/CaM and therefore the kinase must be activated to associate with EAG.  However, 
sustained binding is Ca2+/CaM-independent, because CaMKII remains associated after 
EGTA washes, which strip CaM from the complex (Sun et al., 2004).  Recent studies in 
our lab have shown that EAG also associates with the MAGUK adapter protein Camguk 
(CMG), which is the Drosophila ortholog of mammalian CASK and nematode LIN-2 
(Marble et al., 2005).  When coexpressed in oocytes, CMG can increase EAG current and 
whole-cell conductance by as much as three-fold, and this effect requires the integrity of 
the T787 phosphorylation site (see Appendix, Fig A.1).  Biotinylation experiments show 
that, as with the effect of phosphorylation, the enhancement of EAG current is accounted 
for by an increase in channel surface expression (Fig A.2).  Indeed, CMG coexpression 
increases T787 phosphorylation and surface expression of EAG above the levels 
observed in the absence of the adaptor protein.  This suggests that CMG enhances or 
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stabilizes the interaction between EAG and CaMKII (Marble et al., 2005).  In vitro 
binding assays show that CMG binds to a novel SH3 domain on the EAG C-terminus 
(Fig A.5).  Mutation of this domain prevents the enhancement of current and, in addition, 
prevents the ability of EAG to recruit CMG to the membrane when heterologously 
expressed in COS-7 cells (Fig A.6). 
  
F.5. CaMKII activity is regulated by EAG 
     The association of EAG with CaMKII and CMG can not only regulate EAG current, 
but also the activity of CaMKII.  EAG-bound CaMKII retains catalytic activity, because 
it can still phosphorylate EAG and other substrates after Ca2+/CaM is removed (Sun et 
al., 2004).  This activity, which is approximately 5-10% of maximum Ca2+-stimulated 
activity, is independent of CaMKII autophosphorylation, suggesting that the physical 
association with EAG puts CaMKII into a catalytically active conformation (Sun et al., 
2004).  Thus, EAG-bound CaMKII remains locally active even after [Ca2+]i declines, 
providing a novel mechanism by which the kinase can function in a Ca2+-independent 
manner. 
     The interaction between CMG and CaMKII also regulates CaMKII activity, even in 
the absence of EAG.  CMG can activate CaMKII in the presence of Ca2+/CaM (Lu et al., 
2003).  However, in contrast to the effect of EAG on kinase activity, when Ca2+/CaM is 
removed, CMG promotes autophosphorylation-mediated CaMKII inactivation, resulting 
in a cytoplasmic pool of inactive kinase.  Although this inactivation may seems 
contradictory to the increases in EAG current mediated by CaMKII and CMG, it is 
possible that the role of CMG is to associate active CaMKII with EAG, creating a local 
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membrane compartment in which the EAG-kinase can remain active even when a decline 
in cytoplasmic Ca2+/CaM inactivates the remaining pool of CaMKII.  Alternatively, the 
association with EAG may prevent inactivation of kinase by preventing its release from 
the complex.  Either way, the protein complex has the potential of operating as a positive 
feedback loop: increased phosphorylation and surface expression of EAG would be 
predicted to recruit more CaMKII and CMG to the plasma membrane, which should 
further increase channel phosphorylation and surface expression.  These effects may 
extend to other, as yet uncharacterized, members of the protein complex as well as other 
targets of CaMKII. 
  
G. EAG REGULATES INTRACELLULAR SIGNALING PATHWAYS 
     In summary, substantial evidence exists to show that ion channels can have cellular 
functions that are independent of the regulation of ion flux.  Several lines of evidence 
suggest that the EAG K+ channel is able to affect the activity of intracellular signaling 
pathways.  First, as discussed above, the association between EAG and CaMKII can 
result in constituitively active kinase.  In addition, hEAG has been implicated in cell 
cycle regulation and cancer: hEAG can induce oncogenic transformation of NIH 3T3 and 
CHO cells, is present in certain human cancer cell lines (but absent in the corresponding 
healthy tissues) and favors tumor progression when EAG-expressing cells are implanted 
into immune-suppressed mice (Pardo et al., 1999).  My results also suggest that EAG 
channels have a direct role in intracellular signal transduction.  Specifically, when 
examining NIH 3T3 fibroblasts using 5-bromo-2'-deoxyuridine (BrdU), a fluorescent 
indicator of cell proliferation, transfection of wild type eag results in a dramatic increase 
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in the percentage of BrdU-labeled cells compared to that observed for vector-transfected 
controls.  Similar results are obtained using manual cell counts, suggesting that the 
increased incorporation of BrdU indeed reflects an increase in proliferation.  This effect 
is specific to EAG, because overexpression of Shaker does not significantly increase 
BrdU labeling compared to control cells.  The stimulation of proliferation by EAG is 
consistent with studies implicating a role for hEAG in cell cycle regulation (Pardo, 2004).  
     Previous studies have reported that K+ channels are able to indirectly influence 
intracellular signaling by changing the membrane potential, thereby controlling Ca2+ 
influx through voltage-dependent Ca2+ channels (Lewis and Cahalan, 1995).  In turn, 
Ca2+ influx through Ca2+ channels can stimulate several intracellular pathways.  For 
example, L-type Ca2+ channel activity has been linked to Ras activation and leads to 
sustained MAPK activation (Rosen et al., 1994), the subequent phosphorylation of 
CREB, and eventual expression of immediate early genes, including c-fos (Sheng et al., 
1990), which respond to environmental stimuli to direct cell growth and differentiation.  
Similarly, both K+ and Ca2+ channels are required for lymphocyte activation (Lewis and 
Cahalan, 1995).  However, the extracellular application of EGTA, a Ca2+ chelator, does 
not significantly affect EAG-stimulated proliferation.  My experiments provide evidence 
that EAG signaling is wholly independent of ion flux, and activated directly by the 
channel itself. 
Transfection of NIH 3T3 cells with EAG-F456A, a non-conducting EAG channel 
containing a point mutation in its selectivity filter, produces an increase in proliferation 
that is statistically indistinguishable from that observed in wild type-transfected cells.  In 
addition, a myc-epitope tagged EAG, which fails to conduct K+ for reasons as yet 
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unclear, produces an increase in proliferation that is similar in magnitude to that observed 
for wild type and EAG-F456A channels.  Therefore, the ability of EAG to stimulate NIH 
3T3 proliferation is independent of channel conductance.   
     Given that the signaling activity of EAG does not depend on the conduction of K+ 
ions, one would predict that changes in extracellular K+ concentrations ([K+]o) would 
have no effect on EAG-induced proliferation.  In preliminary experiments, the 
proliferation of eag-transfected cells, and thus activation of intracellular signaling, was 
highest in low [K+]o, when Vm is most hyperpolarized.  The response to [K+]o was 
bimodal: moderate [K+]o inhibited EAG-induced proliferation, while further increases in 
[K+]o increased proliferation in both vector and eag-transfected cells.  Consideration of 
these results led to the hypothesis that the conformational shift of EAG produced by the 
change in Vm regulates EAG signaling activity.  One goal of this thesis was to determine 
if the voltage sensor of EAG constitutes a switch for signal activation.  Experiments 
characterizing the voltage-dependence of EAG signaling are detailed in chapter II. 
     Although my results indicate that EAG stimulates the downstream activation of 
signaling pathways, it is unclear what domain of EAG is responsible for mediating the 
effect.  As noted above, EAG has unusually long intracellular regions containing several 
domains important for protein-protein interactions, transcription regulation, and kinase 
activation. The CaMKII-like autoinhibitory domain of EAG is the most promising region 
for EAG-mediated signal activation, because it has been shown to directly bind CaMKII, 
causing the kinase to remain active even at basal Ca2+ levels (Lu et al., 2003).  In the 
absence of EAG, disruption of constituitive kinase activity could account for, or at least 
contribute to, the similarity in the electrophysiological and learning defects observed in 
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eag mutants and ala transgenics (Griffith et al., 1994).  CaMKII has been shown to be an 
essential component of synaptic plasticity and learning in every organism examined 
(Griffith et al., 1993; Mayford et al., 1996; Nakanishi et al., 1997; Silva et al., 1992a,b; 
Vianna et al., 2000).  A second aim of this thesis was to characterize the mechanism by 
which EAG mediates signaling.  Experiments to investigate the EAG signaling domain 
are presented in chapter III.  
     A final goal of this thesis was to determine the function of EAG-mediated signaling in 
vivo.  Synaptic function and learning are obvious functions likely to be regulated by 
EAG, because eag mutants are impaired in these areas, and also because proliferation, 
neuronal plasticity and learning share common signaling mechanisms, such as the MAPK 
pathway (Morozov et al., 2003).  Chapter III describes experiments using Drosophila 






CHAPTER  II 
A VOLTAGE-DRIVEN SWITCH 
FOR ION-INDEPENDENT SIGNALING BY 




     Voltage-gated channels maintain cellular resting potentials and generate neuronal 
action potentials by regulating ion flux.  Here, we show that Ether à go-go (EAG) K+ 
channels also regulate intracellular signaling pathways by a mechanism that is 
independent of ion flux and depends on the position of the voltage sensor.  Regulation of 
intracellular signaling was initially inferred from changes in proliferation.  Specifically, 
transfection of NIH 3T3 fibroblasts or C2C12 myoblasts with either wild type or non-
conducting (F456A) eag resulted in dramatic increases in cell density and BrdU 
incorporation over vector- and Shaker-transfected controls.  The effect of EAG was 
independent of serum and unaffected by changes in extracellular calcium.  Inhibitors of 
p38 mitogen-activated protein (MAP) kinases, but not p44/42 MAP kinases (extracellular 
signal-regulated kinases), blocked the proliferation induced by non-conducting EAG in 
serum-free media, and EAG increased p38 MAP kinase activity.  Importantly, mutations 
that increased the proportion of channels in the open state inhibited EAG-induced 
proliferation, and this effect could not be explained by changes in the surface expression
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of EAG.  These results indicate that channel conformation is a switch for the signaling 
activity of EAG and suggest a novel mechanism for linking channel activity to the 
activity of intracellular messengers, a role that previously has been ascribed only to 
channels that regulate calcium influx. 
 
B. INTRODUCTION 
     Voltage-gated ion channels generate neuronal action potentials, the primary units of 
information transfer in the brain, by regulating ion flux (Hille, 2001).  Effects of ion 
channels on synaptic connectivity, transmitter release, plasticity, and other cellular 
processes are generally assumed to be a secondary consequence of ion flux.  Specifically, 
changes in membrane potential and action potentials alter Ca2+ influx and Ca2+ regulates 
multiple intracellular signaling pathways (Catterall, 2000; Deisseroth et al., 1998; 
Dineley et al., 2001; Dolmetsch et al., 2001; Hardingham and Bading, 2003; Sutton et al., 
1999).  Several recent studies, however, have indicated that some voltage-gated ion 
channels are bifunctional proteins (Dolmetsch et al., 2001; MacLean et al., 2003; 
Malhotra et al., 2000; Runnels et al., 2001; Wang et al., 1999).  These studies show that 
voltage-gated channels can contribute to transcriptional regulation, protein scaffolding, 
cell adhesion, and intracellular signaling, and the effects appear largely independent of 
ion conduction.  
     Recent studies of Ether à go-go (EAG, KCNH1) voltage-dependent K+ channels 
suggest that EAG may also be bifunctional.  First, a region of Drosophila EAG with 
similarity to the autoinhibitory domain of Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) can associate with activated, Ca2+/CaM-bound, CaMKII.  In vitro assays 
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indicate that once Ca2+ levels decline, EAG-bound kinase retains five to ten percent of its 
maximum Ca2+-stimulated activity (Sun et al., 2004).  Second, human EAG has been 
implicated in cell cycle regulation and cancer: transfection can induce oncogenic 
transformation, EAG is present in some cancer cell lines but absent in the corresponding 
healthy tissues, and implanting EAG-expressing cells into immune-suppressed mice 
results in tumor progression (Farias et al., 2004; Pardo et al., 1999).  These studies 
implicate EAG as a component of one or more intracellular signaling pathways. 
     Our investigation of the involvement of EAG in intracellular signaling was prompted 
by experiments in which we observed an increase in NIH 3T3 fibroblast density 
following transient transfection with Drosophila eag.  Our findings indicate that 
conformational changes of EAG associated with the position of the voltage-sensor may 




C.1. Transfection with EAG stimulates proliferation 
     Figure 2.1A shows a representative experiment demonstrating an increase in NIH 3T3 
cell density following transfection with eag.  Cell density was significantly higher for 
coverslips transfected with eag than for controls transfected with empty vector (p < 0.01; 
similar results obtained for two other experiments).  To determine the mechanism 
underlying this increase, cells were labeled with BrdU, a marker for proliferation.  
Coverslips transfected with eag displayed substantial increases in BrdU incorporation 





Figure 2.1: EAG stimulates proliferation of NIH 3T3 fibroblasts.   
(A) Differential interference contrast microscopy images and cell densities for coverslips 
transfected with pCS2-eag or vector alone.  For each condition, cell numbers were 
averaged across at least 6 visual fields (0.05 mm2 / field).  Similar results were 
documented for two additional experiments.  (B) Left, representative scans showing BrdU 
labeling of cells transfected as indicated.  BrdU labeling was detected by using secondary 
antibody conjugated to a fluorescent indicator.  Right, Average fluorescence intensities 
normalized to vector-transfected controls (n = 3).  Compared with fluorescence intensity 
measurements, the percent of BrdU-positive versus total cells was 14.0 ± 4.9, 47.1 ± 4.1 
and 18.3 ± 2.0, for vector-, eag-, and Shaker- transfected coverslips, respectively.   
(C) Left, BrdU incorporation in cells deprived of FBS. Right, Normalized fluorescence 
intensities for three experiments.  (Scalebar = 10 µm.)  Data are presented as the mean ± 
SEM.  * p < 0.05; ** p < 0.01, *** p < 0.0001; N.S., not significant (ANOVA); Ctrl, 
control.   
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contrast, transfection with the gene encoding Shaker, another voltage-dependent K+ 
channel, resulted in BrdU incorporation that was indistinguishable from control levels, 
indicating that the effect was specific to EAG.  Increased proliferation also was observed 
by using phospho-histone labeling, another marker for proliferation (data not shown).  
These results indicate that proliferation accounts, at least in part, for the observed 
increase in cell density.  EAG-induced proliferation was not limited to NIH 3T3 cells 
because EAG also increased proliferation in C2C12 myoblasts (data not shown).  Finally, 
increased proliferation was also observed in response to EAG when cells were 
“synchronized” in serum-free media before reintroduction of fetal bovine serum (FBS).  
However, proliferation was increased even in the complete absence of FBS (Fig 2.1C; p < 
0.0001, n = 3); thus, the growth factors present in serum were not required for the effect 
of EAG on signaling. 
 
C.2. EAG-induced proliferation is independent of ion flux 
     K+ currents are essential for the proliferation of numerous cell types, including T-
lymphocytes and Schwann cells (DeCoursey et al., 1984; Wilson and Chiu, 1993).  The 
role of  K+ channels in proliferation, as well as other cellular processes, is generally 
assumed to be indirect.  K+ channels alter the membrane potential to modulate Ca2+ influx 
through voltage-dependent Ca2+ channels, which, in turn, affects numerous intracellular 
messenger pathways (Lewis and Cahalan, 1995; Rosen et al., 1994).  However, in the 
present experiments, ion conduction was not required for the effect of EAG on 
proliferation.  Figure 2.2A shows recordings from Xenopus oocytes expressing wild type 
















Figure 2.2: EAG-mediated signaling is independent of K+ conductance. 
(A) Representative currents and average current-voltage relations for oocytes injected 
with eag (n = 10), myc-eag (n = 4), eag-F456A (n = 8), or water (n = 7) as indicated.  
Currents were elicited by using steps from -110 to +60 mV (holding potential of -120 
mV), and peak currents were plotted as a function of voltage.  (B) Left, Non-conducting 
channels increased BrdU incorporation similar to wild type EAG.  Right, Normalized 
fluorescence intensities (n = 3).  (C) SB-203580 (20 μM), an inhibitor of p38 MAP 
kinase, inhibits proliferation induced by non-conducting EAG in the absence of serum.  
Right, average data (n = 3).  (Scalebar, 10 µm.)  (D) Average data for the “p38 MAP 
kinase inhibitor” (25 μM, n = 3), the control compound SB-202474 (25 μM, n = 2), and 
PD-98059 (40 μM, n = 3) effects on EAG-F456A-induced proliferation in serum-free 
media.  (E) EAG increases p38 MAP kinase activity.  Left, Representative blots of NIH 
3T3 cell extracts run out in parallel were probed with antibodies for total p38 (1:500), 
phosphorylated (active) p38 (1:100), and actin, followed by anti-rabbit HRP-conjugated 




selectivity filter of the channel pore.  The selectivity filter sequence is conserved in all K+ 
channels (Doyle et al., 1998) and point mutations in this sequence eliminate conduction 
in Shaker, as well as numerous other K+ channels (Heginbotham et al., 1994; MacLean et 
al., 2003; Preisig-Muller et al., 2002).  Both myc-EAG and EAG-F456A failed to 
produce the outward currents characteristic of the wild type channel.  Comparison of 
current-voltage relations (Fig 2.2A, right) revealed little difference between myc-EAG 
and EAG-F456A currents and currents recorded from water-injected controls, which are 
carried by channels endogenous to oocytes.  Although the mechanism underlying the 
absence of current in myc-EAG is unclear, both myc-EAG and EAG-F456A produced  
detectable gating currents (data not shown), indicating that defects in the folding or 
trafficking of EAG cannot wholly account for the absence of K+ current.  
     Myc-EAG and EAG-F456A increased proliferation to a degree similar to wild type 
channels (Fig 2.2B).  The increases in BrdU incorporation were significant in 
comparisons to vector-transfected controls (p < 0.0001; n = 3).  Moreover, the effects of 
myc-EAG and EAG-F456A were not significantly different from the effect of the wild 
type channel.  In short, changes in K+ flux, and the changes in membrane potential and 
Ca2+ influx that are presumed to result, cannot account for the proliferation induced by 
EAG.  Additional evidence that the signaling mechanism of EAG does not include an 
indirect effect on Ca2+ influx was obtained by incubating cells in EGTA-buffered media 
prior to and during incubation of cells with BrdU.  EAG-induced proliferation in the 
presence of EGTA (1 mM, 5 hrs) was 90.1 ±11.2% and  95.1 ± 3.7% of the proliferation 
in standard Ca2+-containing media for wild type EAG and EAG-F456A channels 
respectively (n = 3, not significant).  Higher concentrations of EGTA caused cells to 
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detach and, therefore, were not assessed. 
 
C.3. EAG-induced proliferation requires the p38 MAP kinase pathway 
     MAP kinase signaling is central to proliferation in numerous cell types and in 
response to a variety of signals (Pearson et al., 2001).  To determine whether the 
proliferation induced by non-conducting EAG channels requires this pathway, cells were 
treated with inhibitors of MAP kinase signaling in serum-free media. The p38 MAP 
kinase inhibitor SB-203580 [4-(4-fluorophenyl)-2-(4-methylsufinylphenyl)-5-(4-pyridyl)-
1H-imidazole] (20 μM) blocked the proliferation observed in response to EAG-F456A 
(Fig 2.2C; p < 0.0001, n = 3), reducing proliferation to levels that were no different from 
the proliferation observed for controls (p > 0.05, n = 3).  Similar results were obtained by 
using the “p38 MAP kinase inhibitor” [2-(4-chlorophenyl)-4-(4-fluorophenyl)-5-pyridin-
4-yl-1,2-dihydropyrazol-3-one] (Fig 2D, left).  In contrast, although the control 
compound, SB-202474, [4-ethyl-2(p-methoxyphenyl)-5-(4’-pyridyl)-1H-imidazole] 
reduced the overall level of proliferation in both vector- and eag-F456A-transfected 
conditions, it failed to inhibit the EAG-specific increase (Fig 2.2D, center; p < 0.0001, n 
= 2).  Finally, although PD-98059 [2’-amino-3’-methoxyflavone], an inhibitor of the 
p44/42 extracellular signal-regulated kinases, reduced proliferation in the presence of 
FBS (data not shown), PD-98059 (40 μM) had little effect on the increase in proliferation 
specifically induced by non-conducting EAG in serum-free media (Fig 2.2D, right; p < 
0.01, n = 3).  These results suggest that p38, but not p44/42, MAP kinase signaling is 
required for the proliferation stimulated by non-conducting EAG-F456A channels.  
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     To determine whether EAG affects p38 MAP kinase activity, we immunoblotted NIH 
3T3 cell lysates with antibodies that detect either total p38 MAP kinase or, specifically, 
the phosphorylated, active kinase.  As shown in Figure 2E, p38 phosphorylation nearly 
doubled in the presence of either wild type or non-conducting EAG (Fig 2.2E; p < 0.05, n 
= 4) and the magnitude of the effect appeared to approximate the average increase in 
BrdU incorporation (Fig 2.2 B,C).  
 
C.4. EAG-induced proliferation is regulated by the position of the voltage-sensor 
     The observation that the signaling activity of EAG does not depend on ion conduction 
predicts that changes in extracellular K+ concentration ([K+]o) should not affect EAG-
induced proliferation.  However, although increased [K+]o increased proliferation in 
vector-transfected controls, increasing [K+]o by 10 mM inhibited EAG-induced 
proliferation, returning proliferation to control levels.  Specifically, at 15 mM (K+]o, 
EAG-induced proliferation was 93.9 ± 1.5 % of controls compared to 151.4 ± 7.3 percent 
in normal 5.3 mM [K+]o.  (Measurements were normalized to vector-transfected controls 
in 5.3 mM; p < 0.001).  Similar results were observed in two additional experiments.  
Because increases in [K+]o will depolarize the membrane and shift the position of the 
voltage sensor even in non-conducting EAG channels, we hypothesized that the signaling 
activity of EAG might depend on voltage-sensitive conformations of the channel.  
Specifically, the [K+]o experiments predict that increases in the proportion of channels in 
the open state should decrease EAG signaling activity. 
     To explore the possibility that the signaling activity of EAG might be regulated by the 
position of the voltage sensor, we examined the effects of EAG channels containing 
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mutations in the sixth transmembrane segment that shifted their voltage-dependence of 
activation.  Figure 2.3A shows representative currents obtained for the wild type channel 
and two mutants, EAG-TATSSA (T449S/K460S/T470A) and EAG-HTEE 
(H487E/T490E), when expressed in Xenopus oocytes.  Comparison of the conductance-
voltage (GV) relations (Fig 2.3B) reveals that the predominant effect of both mutations 
was to produce hyperpolarizing shifts in the midpoints of activation from 8.0 ± 1.1 mV 
(wild type, n = 6) to -10.8 ± 1.2 mV (n = 9) and -31.6 ± 2.0 mV (n = 7) for EAG-
TATSSA and EAG-HTEE channels, respectively.  In addition, the TATSSA and HTEE 
mutations also produced changes in kinetics; however, these changes were in opposite 
directions (Fig 2.3A).  Comparison of the average resting potentials of oocytes expressing 
EAG channels (Fig 2.3C) revealed that the resting potentials closely followed the 
changes in the V10 for activation (the voltage at which 10% of channels are activated; Fig 
2.3D).  This would be expected if EAG is the major channel contributing to the 
membrane potential.  Wild type EAG produced only a small shift in the resting potential 
from -44.5 ± 2.8 to -52.8 ± 1.9 mV.  In contrast, EAG-TATSSA and EAG-HTEE shifted 
the resting potential to -82.8 ± 1.1 and -90.7 ± 0.9 mV, respectively.  It is important to 
note that, given that K+ channel conformation and membrane potential act as a negative 
feedback loop, the proportion of channels in the closed state should be similar in each 
case, provided that each of the constructs contributes to the membrane potential to a 
similar extent.  
     The above EAG constructs were used to address whether the signaling activity of 
EAG is regulated by channel conformation.  As shown in Figure 2.4A, there was an 







Figure 2.3: Comparison of the properties of wild type and mutant EAG channels. 
(A) Recordings from oocytes expressing EAG constructs as indicated. Voltages were 
stepped from -110 to +80 mV (holding potential of -120 mV).  (Bar, 100 msec.)  (B) 
Normalized G-V relations obtained for EAG (●), EAG-TATSSA(○) and EAG-HTEE 
(▲).  GV curves were generated using the relation G = Ipeak/ (Vtest - EK), where EK was 
assumed to be -120 mV.  Conductances were normalized to the maximum conductance 
observed.  Boltzmann fits to the data had slopes of 20.7 ± 0.9 and 23.5 ± 1.0 for EAG  
and EAG-TATSSA, respectively.  For EAG-HTEE, the slope was constrained to 23. 
Horizontal dotted and dashed lines represent 10% and 50% maximal activation, 
respectively.  (C) Averaged resting potentials for the same oocytes.  (D) Average  





wild type eag, eag-TATSSA or eag-HTEE were used.  Given the negative feedback of 
conducting EAG channels on channel conformation, these results suggest that 
proliferation depends on the position of the voltage sensor of EAG channels rather than 
on a specific resting membrane potential.  Indeed, measurement of the resting potentials 
of NIH 3T3 cells transfected with these constructs indicated that, although EAG channels 
contributed to the membrane potential to a lesser degree than in oocytes, each construct 
shifted the resting potential closer to the respective activation threshold (Fig 2.4B). 
     Additional evidence in support of the hypothesis that channel conformation is a 
“switch” for the signaling activity of EAG was obtained using eag-TATSSA and eag-
HTEE constructs that had been rendered non-conducting by including the F456A 
mutation, in effect short-circuiting the negative feedback function of EAG.  As expected, 
the resting potentials of cells expressing these double mutants were similar to the resting 
potentials of vector-transfected controls (Fig 2.4B).  The shifted voltage-dependence of 
these channels, combined with their inability to shift the resting potential, should result in 
a larger proportion of TATSSA-F456A and HTEE-F456A channels in the open 
conformation.  On the basis of the prediction above, increasing the proportion of channels 
in the open state should decrease EAG-induced proliferation.  As predicted, both EAG-
TATSSA/F456A and EAG-HTEE/F456A failed to increase proliferation above control  
levels (Fig 2.4A).  In contrast, as observed in our earlier experiments, proliferation was 
robust for EAG-F456A.  Finally, neither changes in expression level or changes in the 
surface expression of EAG (Fig 2.4C) could account for the changes in proliferation 
observed with the double-mutant constructs.  Together, these results suggest that the 





Figure 2.4: EAG-mediated signaling is regulated by channel conformation.  
(A) Left, BrdU labeling for EAG, EAG-HTEE or EAG-TATSSA (upper panels) and 
corresponding non-conducting mutants (lower panels).  Right, Proliferation is inhibited 
when EAG is predominantly open but non-conducting (n = 3).  (Scalebar = 10 µm.)  
Asterisks and error bars as in Figure 1.  (B) Whole recordings of NIH 3T3 cell resting 
potentials.  Individual isolated cells were selected for recordings on the basis of EGFP 
fluorescence.  Resting potentials were more depolarized than observed in oocytes, 
presumably because of the presence of channels, in particular Ca2+ channels, endogenous 
to NIH 3T3 cells (Chen et al., 1988; Pemberton et al., 2000).  The number of oocytes 
examined for each condition were, from left to right, 16, 13, 8, 12, 11, 13, and 8.  (C) 
Total expression and surface expression of wild type and mutant EAG channels.  Left, 
Representative blots.  Right, average data for three experiments.  Before preparation of 
extracts and precipitation with streptavidin agarose, cells were labeled with biotin and 
then quenched with glycine as described in Methods.  Equal amounts of either the extract 
(upper panels) or the precipitates (lower panels) were separated by SDS-PAGE and 
probed with EAG (CT) or actin antisera.  Bands were quantified by densitometry and 




     Our results indicate that EAG is a bifunctional protein that not only regulates K+ flux, 
but also regulates intracellular signaling pathways.  The effect of EAG on intracellular 
signaling was evident as an increase in proliferation of NIH 3T3 cells and did not appear 
to be due to an indirect effect of K+ ions because it was observed even with non-
conducting channels.  To date, other examples of bifunctional channels include α1C Ca2+ 
channels whose carboxyl-terminal regions regulate transcription (Dolmetsch et al., 2001), 
a member of the TRP family of cation channels (TRP-PLIK) that contains a functional 
kinase domain (Runnels et al., 2001), and voltage-gated sodium channels whose β- 
subunits not only modulate channel function but also act as cell adhesion molecules 
(Malhotra et al., 2000).  EAG appears to differ from the above channels in that signaling 
activity is linked to channel conformations determined by the position of the voltage 
sensor.  The signaling function of EAG is a novel mechanism that may link channel 
gating to intracellular messenger pathways.  This role has typically been ascribed only to 
channels that regulate Ca2+ influx.  Recently, however, Ci-VSP, a novel protein 
containing a transmembrane voltage sensor linked to a functional cytoplasmic 
phosphatase and tensin (PTEN) domain, has been reported to regulate phosphoinositide 
turnover in a voltage-dependent manner (Murata et al., 2005). 
     The signaling activity of EAG characterized in the present study appears negatively 
correlated with the proportion of channels in the open state or, at the single channel level, 
the magnitude of the single channel open probability (po).  It is tempting to speculate that 
EAG-induced signaling is limited to channels in a specific conformation, presumably one 
of two previously characterized EAG closed states (Schonherr et al., 2002; Tang et al., 
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2000).  Comparison of NIH 3T3 cell resting potentials (Fig 2.4B) to the GV curves 
obtained in oocytes (Fig 2.3B) predicts that > 50% of the channels must be closed or that 
the single channel po must be < 50%  of the maximum for a significant increase in 
proliferation to occur.  However, given the reduced effect of EAG on the NIH 3T3 cell 
versus oocyte resting potentials, this correlation appears to break down for more 
quantitative comparisons.  For example, at the mean resting potentials of -12, -18, and     
-28 mV for cells expressing wild type, TATSSA, and HTEE channels (Fig 2.4B), the GV 
curves indicate that approximately 68, 56, and 49% of channels will be closed, 
respectively.  This observation predicts that proliferation response should be highest for 
wild type channels and lowest for EAG-HTEE, a trend that is not observed in our data.  
There are several possible explanations of this discrepancy.  First, the resting potentials 
measured in NIH 3T3 cells may not accurately reflect the resting potentials of cells in our 
proliferation assays given that the cells are treated differently.  Secondly, the GV curves 
obtained in oocytes may not be representative of channel behavior in NIH 3T3 cells.  
Unfortunately, EAG current could not be effectively isolated from the other outward 
currents endogenous to NIH 3T3 cells to address this concern.  Third, it is possible that 
proliferation is not as sensitive an indicator of voltage-dependence as the GV curve.  GV 
curves, which are continuous functions, represent the average behavior of a million or 
more channels, whereas proliferation, which is a step function, represents the average 
behavior of hundreds of cells at best.  Fourth, EAG-induced proliferation may be limited 
by the availability or activity of downstream components of the affected signaling 
pathway.  Finally, voltage-dependent enzymatic activity or protein-protein interactions 
may require that channels occupy a given conformation for a specific duration.  Although 
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channel conformation may serve as a switch for the signaling activity of EAG, the 
domain underlying signaling remains under investigation.  Possibilities include an amino-
terminal PER-ARNT-SIM (PAS) domain, several putative nuclear localization signals in 
the carboxy-terminal domain, and a region with homology to the autoinhibitory domain 
of CaMKII that has been shown recently to regulate kinase activity in in vitro assays 
(Wang et al., 2002c). 
     The proliferation induced by EAG was unaffected by changes in extracellular Ca2+, 
suggesting that increased Ca2+ influx is not an essential downstream component of EAG-
induced signaling.  Nonetheless, our experiments do not address intracellular Ca2+ 
concentrations or the possible role of Ca2+ released from intracellular stores.  Moreover, 
although Ca2+ influx may not be a downstream component of the EAG-induced pathway, 
our results suggest that any mechanism that regulates EAG surface expression or voltage-
dependence may be an upstream regulator of EAG signaling.  Indeed, Ca2+/calmodulin 
binding to EAG decreases EAG current by shifting channel activation to more positive 
potentials (Clyne et al., submitted) and, Ca2+, by increasing CaMKII activity and 
phosphorylation of EAG, increases EAG surface expression (Marble et al., 2005).  Thus, 
both of these Ca2+-dependent mechanisms could act upstream of EAG to increase EAG 
signaling in an activity-dependent manner, and the role of Ca2+ should be further 
explored. 
     In the present study, the voltage-dependent signaling activity of EAG increased 
proliferation of NIH 3T3 cells and C2C12 myoblasts; however, it is unclear whether 
EAG-induced signaling normally regulates proliferation in vivo.  No gross morphological 
defects have been observed in Drosophila eag mutants at any developmental stage.  It 
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should be noted, however, that a role for Drosophila ras in proliferation was only 
uncovered by using overexpression of mutant ras constructs (Karim and Rubin, 1998), 
despite the well-established role of ras in proliferation in other systems.  Although the 
developmental profile of EAG expression is unknown, EAG transcripts and protein 
appear most highly expressed in mature neurons in both Drosophila and mammals (Jeng 
et al., 2005; Ludwig et al., 1994; Saganich et al., 2001; Sun et al., 2004).  Thus, there is 
little evidence to suggest that EAG regulates proliferation in normal tissues at present.  
However, abnormally expressed EAG may have a role in proliferation and 
transformation, given that human EAG has been suggested to have an oncogenic 
potential and EAG appears abnormally expressed in several tumor cell lines (Pardo et al., 
1999; Patt et al., 2004).  
     Intracellular signaling pathways typically have a variety of possible roles; the output 
of a pathway in any given cell at any given developmental stage will depend on context 
and crosstalk between other pathways.  In the present study, proliferation may simply be 
the “read-out” of a change in the activity of one or more intracellular signaling pathways.   
Given that EAG appears largely neuron specific and localized at synapses (Jeng et al., 
2005; Sun et al., 2004; Wang et al., 2002c), and given that synaptic plasticity and 
memory acquisition are disrupted in eag mutants (Engel and Wu, 1998; Griffith et al., 
1994), EAG signaling may normally regulate activity-dependent changes in neuronal 
function.  Indeed, EAG-mediated proliferation was blocked by inhibitors of the p38 MAP 
kinase pathway, and transfection of EAG increased p38 MAP kinase activity.  An 
important future question concerns whether the link between EAG and p38 activity is 
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conserved in neurons.  MAP kinase signaling is central to not only proliferation but also 
synaptic plasticity and learning (Sweatt, 2004; Thomas and Huganir, 2004). 
 
E. MATERIALS & METHODS 
E.1. Plasmids and construction 
     pCS2-myc-eag contains a myc tag added to the amino-terminus (Wang et al., 2002c).  
For the wild type construct, EcoRI and XbaI sites flanking the coding sequence were 
used to subclone eag (without the myc tag) into the pCS2 vector.  A Kozak sequence 
(GCCACC) was added to improve channel expression.  Shaker was subcloned into pCS2 
by using EcoRI sites flanking the coding sequence of pGH19-Shaker (Chouinard et al., 
1995).  Eag-F456A, eag-H487E/T490E (HTEE), eag-T449S/A460S/T470A (TATSSA) 
and double mutants were generated by site-directed mutagenesis using QuikChange 
(Stratagene).  For oocyte expression, mutant constructs were subcloned into pGH19-eag 
(Wilson et al., 1998). All constructs were verified by sequencing. 
 
E.2. Immunocytochemistry and proliferation assays 
     NIH 3T3 fibroblasts were maintained at 37°C and 5% CO2 in Dulbecco's modified 
Eagle's medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS) 
as previously described (Chouinard et al., 1995).  For transfection, coverslips were 
washed with Opti-MEM and incubated for 8-10 hrs in 350 µl of Opti-MEM containing 
0.4 µl of the indicated cDNAs and 1.5 µl of LipofectAMINE (Invitrogen).  Coverslips 
were then washed and incubated in standard media for 12 hrs.  For serum-free 
experiments, this was followed by incubation in FBS-free DMEM for 12 hrs, with 1% 
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FBS added to a subset of wells as a positive control.  MAP kinase inhibitors or control 
compounds were added following washout of LipofectAMINE.   
     For BrdU labeling, 10 µM BrdU was added to each well for ~ 60 min.  Coverslips 
were washed with phosphate-buffered saline (PBS) and fixed with a 3:7 mixture of 50 
mM glycine (pH 2.0)/100% ethanol for 1 hr at room temperature (RT), then denatured 
with 4 M HCl for 15 min.  Cells were labeled with anti-BrdU fluorescein-conjugated 
antibody (Molecular Probes) for 45 min at 37 oC.  Labeling was visualized using an 
Olympus BX51W1 microscope equipped with a Qimaging Retiga Exi camera and IPlab 
3.6 software.  Coverslips from the same experiment were viewed using identical settings, 
and multiple representative scans were taken for each coverslip.  To quantify 
fluorescence, scans were background subtracted, and the intensity of all pixels above 
background was summed across the total area of each scan.  Total intensities were 
averaged across all scans for each condition before normalizing to the average intensity 
for controls.  Normalized data were then averaged across experiments (N).  Data were 
analyzed using a two-way analysis of variance (ANOVA) with Tukey’s post-hoc analysis 
with the condition and experiment number as variables (* p < 0.05, ** p < 0.01, *** p < 
0.0001; N.S., not significant). Data are presented as the mean ± SEM.  MAP kinase 
inhibitors were purchased from Calbiochem. 
 
E.3. Biochemistry 
     Cells grown on culture plates were dissociated with trypsin-EDTA 48 hrs  after 
transfection, washed and resuspended in PBS.  Biotinylation and precipitation of EAG 
was performed as described (Marble et al., 2005).  Briefly, cell suspensions were 
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incubated in 2 mM sulfo-NHS-LC-biotin (Pierce) and the reaction was quenched by 
washing with 100 mM glycine in PBS.  Cells were lysed in PBS supplemented with 1% 
IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT and protease 
inhibitors, and the homogenate was centrifuged twice for 10 min at 20,000 x g.  Protein 
concentrations of supernatants were determined by Bradford assay and diluted to ~ 0.5 
mg/ml.  Surface proteins were precipitated with strepavidin agarose and the precipitate 
washed extensively before addition of sample loading buffer.  Blots were probed with 
antisera directed against the carboxyl-terminal domain of EAG (EAG (CT); 1:2000) in 
blocking buffer, followed by horseradish peroxidase (HRP)-conjugated secondary 
antibody (1:2000), and visualized with ECL (Amersham Biosciences).  Protein bands 
were quantified by using Quantity One software (BioRad).  Assays of p38 MAP kinase 
activity were performed by using extracts prepared in buffer containing the following: 20 
mM Tris (pH 7.4), 100 mM NaCl, 50 mM NaF, 1 mM Na3V04, 1 mM EDTA, 1 mM 
DTT, 1 mM benzamidine, and 0.001 mM microcystin-LR with 1% IGEPAL CA-630, 
0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitors. 
 
E.4. Electrophysiology 
     Experiments using Xenopus oocytes were performed as described (Marble et al., 
2005).  Oocytes were typically injected with 0.1-0.2 ng of RNA; non-conducting 
constructs were injected at 1-2 ng.  The recording solution contained the following: 140 
mM NaCl, 2 mM KCl, 1 mM MgCl2 and 10 mM Hepes (pH 7.1 with NaOH).  Pipettes 
had resistances of 0.3 - 0.6 MΩ.  Experiments were performed at RT.  Leak and 
capacitative currents were subtracted using P/4 methods. 
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     For NIH 3T3 cell recordings with an Axopatch200B amplifier, cells maintained on 
plates were co-transfected with pCDNA3-EGFP and the indicated constructs and were 
then replated onto coverslips.  Pipette resistances ranged from 3 to 6 MΩ. The 
extracellular solution contained the following: 40 mM sodium aspartate, 100 mM NaCl, 4 
mM KCl, 1.5 mM MgCl2, 1 mM CaCl2, 2 mM glucose and 10 mM Hepes (pH 7.4 with 
NaOH).  The pipette solution contained the following: 35 mM potassium aspartate, 110 
mM KCl, 2 mM MgATP, 1 mM NaATP, 3 mM sodium phosphocreatine, 0.1 mM 

















CONDUCTANCE-INDEPENDENT GATING  
OF CAMKII ASSOCIATED WITH  
ETHER À GO-GO K+ CHANNELS 
 
 
A. ABSTRACT & INTRODUCTION 
     Recent studies suggest that voltage-gated channels can regulate biochemical events 
independently of ion flux (Dolmetsch et al., 2001; Gomez-Ospina et al., 2006; 
Kaczmarek, 2006; MacLean et al., 2003; Malhotra et al., 2000; Runnels et al., 2001).   
Drosophila Ether à go-go (EAG) potassium (K+) channels regulate intracellular signaling 
by a mechanism that is independent of conductance and is gated by the position of the 
voltage sensor (Hegle et al., 2006).  Here we present evidence that EAG signaling is 
mediated via voltage-dependent regulation of Ca2+/calmodulin-dependent protein kinase 
II (CaMKII), and that this signaling mechanism is conserved in mammalian EAG.  
Mutation of key residues in the EAG carboxyl-terminal CaMKII-binding domain 
abolishes EAG-mediated signaling, and biotinylation assays using mutations that shift the 
voltage-dependence of EAG suggest that membrane-associated CaMKII activity is 
modulated by voltage-driven conformational changes in EAG.  Although the above 
experiments assess signaling in NIH 3T3 cells heterologously expressing EAG, we also 
assessed the role of the EAG-CaMKII complex in transgenic Drosophila.  In recordings
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at the larval neuromuscular junction (NMJ), EAG channels with mutations in the 
CaMKII binding domain largely failed to rescue the high levels of spontaneous activity 
characteristic of eag mutants, whereas non-conducting EAG-F456A channels rescued 
spontaneous activity with an efficiency nearly overlapping that observed for wild type 
channels.  These results suggest that voltage-dependent, conductance-independent EAG 
signaling plays a role in synaptic homeostasis in vivo and implicate EAG signaling as a 
novel mechanism for linking neuronal activity to the state of intracellular messenger 
pathways.   
 
B. RESULTS 
     The EAG K+ channel was originally implicated as a possible bifunctional channel in 
studies showing a role for human EAG in cell cycle progression and oncogenesis (Farias 
et al., 2004; Meyer and Heinemann, 1998; Pardo et al., 1999; Patt et al., 2004), although 
the mechanism underlying the effects of abnormally expressed EAG remained unclear.  
In studies of the Drosophila ortholog, we have shown that EAG acts independently of 
conductance as an upstream regulator of the activity of p38 mitogen-activated protein 
kinase (MAPK) and proliferation (Hegle et al., 2006).  Specifically, when studies are 
performed in serum-free media to eliminate the possible confounding effects of growth 
factor stimulated pathways, both wild type EAG and the non-conducting selectivity filter 
mutant, EAG-F456A, increase p38 MAPK activity, and the proliferation induced by 
either channel is blocked by p38 MAPK inhibitors (Hegle et al., 2006).  However, p38 
MAPK is likely to be several steps downstream of the EAG events that mediate 
signaling.  To determine the EAG domain and mechanism directly mediating voltage-
 93
dependent, conductance-independent signaling, we first examined the effects of deletions 
and mutations in the cytoplasmic tails in BrdU assays of NIH 3T3 cell proliferation.  
Figure 3.1A shows a representative experiment comparing the effects of wild type and 
non-conducting channels with the effects of truncated channels that lack the cytoplasmic 
N- or C-terminal domains.  As observed previously, incorporation of 5-bromo-2'-
deoxyuridine (BrdU), a fluorescent indicator of cell proliferation, was significantly 
increased over control levels (p < 0.01, n = 6) for coverslips transfected with wild type 
EAG and EAG-F456A (Fig 3.1C).  In addition, although the N-terminal deletion (EAG-
ΔNT, containing amino acids 213-1174), which lacks the PER-ARNT-SIM (PAS) 
dimerization domain (Crews and Fan, 1999), failed to disrupt EAG-induced proliferation, 
the C-terminal deletion (EAG-ΔCT, containing amino acids 1-514) decreased 
proliferation (p < 0.05 in comparison to EAG, n = 3) to a level comparable to vector-
transfected controls (Fig 3.1A,C).  These results suggested that a key domain underlying 
EAG-induced proliferation resides in the cytoplasmic C-terminal tail of EAG. 
     The EAG C-terminus is nearly twice as long as that of Shaker channels and contains 
several domains that could mediate the signaling activity of EAG.  In addition to a 
domain with homology to the cyclic nucleotide-binding domains of other channels (Guy 
et al., 1991), it contains a functional CaMKII binding domain with high similarity to the 
autoinhibitory domain of the kinase (Hanks et al., 1988; Sun et al., 2004), a functional 
calmodulin (CaM) binding domain (Schonherr et al., 2000), three putative nuclear 
localization signals (NLS), and a series of putative Src-Homology 3 (SH3) motifs, one of 
which is known to interact with the Camguk/CASK adapter protein (Marble et al., 2005).  











Figure 3.1: CaMKII binding is essential for EAG signaling.  
(A) C-terminal domain is required for EAG signaling.  Representative scans showing 
BrdU labeling of coverslips transfected with the pCS2 vector, pCS2-eag, pCS2-eag-
F456A, and N- and C-terminal deletion mutants.  BrdU labeling was detected by using 
secondary antibody conjugated to a fluorescent indicator.  (Scalebar = 10 μm for these 
and all scans in subsequent figures.)  (B) Representative scans showing BrdU labeling of 
coverslips transfected with eag CaMKII-binding domain mutants as indicated.   
C) Average fluorescence intensities for coverslips examining the role of the N- and C- 
terminal cytoplasmic domains, normalized to vector-transfected controls (p = 0.0034 
overall; p < 0.01 for individual comparisons of WT-EAG and EAG-F456A to vector 
controls, n = 6; p < 0.05 for comparisons of the CT-deletion to WT-EAG, n = 3).   
(D) Average fluorescence intensities of coverslips transfected with all domain mutations, 
including those shown in (b), normalized to vector-transfected controls (overall p = 
0.0167, n = 5).  (E) Representative blots showing total expression and surface expression 
of wild type and mutant channels, with actin as the loading control.  (F) Average surface 
expression as in (e).  For each experiment, bands were quantified by densitometry and 
normalized to the band for wild type EAG in the extract, prior to determining the ratio of 
EAG in the streptavidin precipitate to total EAG (overall p = 0.4623, n = 3).  (G) 
Representative recordings from oocytes expressing wild type EAG or EAG-LAKK.  
Oocytes were stepped from -100 to +60 mV in 10 mV increments (holding potential, -80 
mV); every other trace is shown.  Capacitative and leak currents were subtracted using a 
P/4 protocol.  (Bars, 5 μA and 100 ms).  (H) Average conductance-voltage (GV) relations 
obtained for WT-EAG (n = 9) and EAG-LAKK (n = 4).  Conductances were calculated 
from currents using the relation G = Ipeak/ (Vtest - EK), where EK was assumed to be -100 
mV, and then normalized to the maximum conductance observed.  Boltzmann fits had 
midpoints of 1.2 ± 0.4 and 2.8 ± 3.2 mV and slopes of 16.1 ±0.3 and 19.9 ± 2.9, for EAG 
and EAG-LAKK, respectively.  Data are presented as the mean ± SEM.  N.S., not 




FIGURE 3.1   
 96
mutations in candidate domains, including the CaMKII (EAG-LAKK), CaM (EAG-
FFSS), and Camguk (EAG-RLKM) binding domains, the CaMKII phosphorylation site 
(EAG-T787A), and two putative NLS domains (EAG-NLS-1 and -2).  The third putative 
NLS overlaps with the Camguk binding domain and should also be disrupted by the 
RLKM mutation.  Subsequent assays of BrdU incorporation revealed that the most 
predominant inhibition was produced by the CaMKII binding domain mutation, EAG-
LAKK (Fig 3.1B,D; p <0.05 for EAG-LAKK, n = 5).  The proliferation observed using 
EAG-LAKK was statistically indistinguishable from that observed for vector-transfected 
controls (Fig 3.1D).  Further verification of the importance of the CaMKII binding 
domain was obtained using EAG-RQKK, in which residues neighboring LA were 
replaced with lysines.  This mutant also significantly inhibited proliferation (Fig 3.1B,D; 
p <0.05 for EAG-RQKK, n = 5).  
     The reduced proliferation observed with mutations in the CaMKII domain could not 
be explained by changes in surface expression, because precipitation of biotinylated cell 
extracts revealed no significant difference in expression levels between the various C-
terminal domain mutations (Fig 3.1E,F).  Furthermore, when expressed in Xenopus 
oocytes, the EAG-LAKK and EAG- RQKK mutants exhibited outward currents 
comparable to those observed for wild type EAG, although inactivation was slower and 
less extensive for EAG-LAKK channels (Fig 3.1G).  Comparison of normalized 
conductance-voltage (GV) relationships revealed no obvious difference in the voltage-
dependence of the CaMKII binding mutants and wild type channels (e.g., Fig 3.1H).  
Together, these data suggest that CaMKII binding is essential for EAG-mediated 
proliferation; however, they do not rule out possible contributions of other regions of the 
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channel.  In particular, a mutation in NLS-1 also inhibited EAG-induced proliferation, 
but surface expression of this construct was quite variable (Fig 3.1D,F). 
     The most notable feature of EAG-mediated proliferation is that EAG signaling is 
regulated by channel conformations associated with the position of the voltage sensor.  
Specifically, mutations in the sixth transmembrane domain that shift the voltage-
dependence of activation to more negative potentials (EAG-HTEE and EAG-TATSSA) 
disrupt EAG-mediated proliferation when coupled with the F456A mutation to render 
channels non-conducting (referred to as EAG-HFA and EAG-TFA, respectively).  By 
short-circuiting the negative feedback effect of ion conduction on membrane potential, 
EAG-HFA and EAG-TFA channels are forced into a predominantly open conformation 
and, in this state, EAG-mediated proliferation is inhibited (Hegle et al., 2006).  If 
CaMKII is the most immediate downstream target of EAG signaling, then either CaMKII 
activity or localization also should be regulated by voltage-dependent conformations of 
EAG.  Recent in vitro studies suggest that kinase activity may be regulated, because 
CaMKII associated with the C-terminal cytoplasmic tail of EAG retains 5-10% of its 
maximal activity when the complex is washed in Ca2+-free buffer (Sun et al., 2004).  This 
constitutive activity is distinct from that mediated by phosphorylation of T287 of the 
kinase, although T287 can still be autophosphorylated. 
     To determine whether EAG regulates CaMKII in a voltage-dependent manner, we 
probed extracts of cells transfected with EAG-HTEE, EAG-TATSSA or their non-
conducting counterparts for phosphorylated kinase, given that autophosphorylation is a 
reliable indicator of kinase activity.  As shown in Figure 3.2A, in extracts, the ratio of 




Figure 3.2: EAG gating regulates membrane-associated CaMKII activity. 
(A) Left, Representative blots showing EAG, phospho-CaMKII and total CaMKII in 
extracts of NIH 3T3 cells expressing the indicated EAG constructs.  Right, Averaged 
densitometric quantification of CaMKII activity, shown as the ratio of phospho:total 
CaMKII and normalized to the activity observed for vector-transfected controls (overall p 
= 0.8314, n = 4).  (B) Membrane-associated CaMKII activity.  Left, Representative blots 
for the indicated EAG constructs.  Biotinylation and precipitation were performed as 
described in Methods.  Right, Average ratio of phospho:total CaMKII analyzed as 
described in (a).  Overall p = 0.0028, n = 4.  In both (a) and (b), equal amounts of either 
extracts (a) or precipitates (b) were separated by SDS-PAGE and probed with EAG (CT), 




contrast, however, when the membrane fraction was isolated using biotinylation and 
precipitation with streptavadin, there was an approximate two-fold increase in 
membrane-associated kinase activity for the EAG-HFA and EAG-TFA conditions when 
compared to controls (Fig 3.2A,B, p < 0.05, n = 4).  In addition, there appeared to be a 
consistent, though small, decrease in CaMKII activity for EAG constructs that induce 
proliferation.  A local decrease in CaMKII activity, or a shift in localization to different 
membrane-associated complexes, could explain why mutations in the CaMKII binding 
domain inhibit the proliferation response.  Together, these results suggest that the effect 
of EAG on CaMKII activity depends on voltage-dependent conformations of the channel 
and, further, that EAG-mediated increases in kinase activity negatively regulate the 
proliferation pathway.  
     If p38 MAPK is downstream and inhibited by CaMKII in the proliferation pathway, 
then EAG-dependent regulation of p38 MAPK activity also should be voltage-dependent.  
However, we were unable to detect voltage-dependent regulation of p38 MAPK in either 
the cytoplasmic or membrane-associated fractions.  As observed previously (Hegle et al., 
2006), p38 MAPK activity was consistently increased over control levels for all EAG 
constructs examined (data not shown).  Either the effects on p38 MAPK are limited to 
molecules in close proximity to EAG or voltage-dependent regulation affects the 
localization of p38 MAPK to a compartment that is not adequately represented by the 
cytoplasmic or membrane fractions.  Lastly, it is possible that CaMKII regulates a step 
that is downstream of p38 MAPK to inhibit proliferation.   
     Further support for the role of CaMKII in EAG-induced proliferation was obtained in 
experiments examining the conservation of EAG signaling in mouse EAG channels 
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(mEAG).  As with Drosophila eag, transfection of either wild type or non-conducting 
(F466A) meag resulted in a significant increase in BrdU incorporation (Fig 3.3A; p < 
0.05, 0.001 for mEAG and mEAG-F466A, respectively, n = 4).  Recordings from NIH 
3T3 cells expressing mEAG revealed a robust outward current, which exhibited voltage-
dependent activation kinetics reminiscent of the Cole-Moore shift as expected for EAG 
channels (Cole and Moore, 1960; Ludwig et al., 1994) (Fig 3.3B).  In contrast, the 
outward currents observed in cells transfected with mEAG-F466A overlapped with the 
currents observed in vector transfected controls, and, in both cases, changes in prepulse 
voltage had an effect on kinetics that was opposite that observed for currents recorded 
from cells transfected with the wild type channel (Fig 3.3B).  
     The mEAG C-terminal cytoplasmic tail contains a stretch of amino acids with 
homology to the CaMKII binding domain in the Drosophila channel, as well as the 
CaMKII autoinhibitory domain (Fig 3.3B).  To examine whether this domain is also 
required for mEAG-mediated proliferation, two mEAG mutants, mEAG-RQEE and 
mEAG-QKEE, were generated based on homology to key residues in the other 
sequences.  Both constructs produce an outward current that is comparable to that 
observed for the wild type channel in amplitude and voltage-dependence, although 
activation is slower (Fig 3.3E).  Coverslips transfected with either mutant exhibit 
substantially reduced BrdU incorporation compared to coverslips transfected with wild 
type meag (p < 0.05, N=3; Fig 3.3D, right), indicating that the CaMKII  binding domain 
plays a critical role in proliferation induced by both the mouse and fly channels. 
     Voltage-dependent proliferation is also conserved in mEAG channels (Fig 3.3F,G). 
Because mEAG outward currents are more robust than those generated by the Drosophila  
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Figure 3.3: CaMKII-dependent signaling is conserved in mammalian EAG. 
(A) Left, Representative scans showing BrdU labeling of coverslips transfected with 
vector, meag or meag-F466A.  Right, Average fluorescence intensities for the conditions 
shown in (a), normalized to vector-transfected controls (overall p = 0.0105; n = 4).   
(B)  Left, Averaged currents elicited by ~160 ms voltage ramps from -100 to +100 mV 
for NIH 3T3 cells transfected with wild type mEAG (n = 16), mEAG-F466A (n = 6), or 
empty vector (n = 4).  Capacitative and leak currents were subtracted using a P/8 
protocol.  Right, Prepulse voltage regulation of the kinetics of mEAG current. Currents 
elicited using a voltage step to +40 mV were preceded by a 500 ms prepulse to the 
following potentials: for mEAG, -120 (dotted trace), -100 (dashed trace), -80 (dashed 
trace) and -60 mV (solid trace) in 10 mV increments; for mEAG-F466A, -120 (dotted 
trace) and -70 mV (solid trace).  (Bars, 100 ms and 50 ms for mEAG and mEAG-F466A 
respectively.)  (C) Amino acid sequence alignment of the catalytic domain of CaMKII 
with the dEAG and mEAG C-terminus.  Grey boxes indicate conserved residues.  
Outlined box identifies dEAG and mEAG residues mutated in this study.  (D) Left, 
Representative scans showing BrdU labeling of coverslips transfected with meag 
CaMKII-binding domain mutants, as indicated.  Right, Average fluorescence intensities, 
normalized to vector-transfected controls (overall p = 0.0113, n = 3).  (E) Left, 
Representative recordings from NIH 3T3 cells expressing wild type mEAG, mEAG-
RQEE or mEAG-QKEE.  (Bars, 1 nA and 100 ms.)  Right, Normalized G-V relations 
obtained for mEAG (n = 5), mEAG-RQEE (n = 3) and mEAG-QKEE (n = 3) obtained 
from tail currents enhanced using a recording solution containing 20 mM KCl.  GV 
curves were generated using the relation G = Ipeak/ (Vtail - EK), where EK was assumed to 
be -100 mV.  Conductances were normalized to the maximum conductance observed.  
Boltzmann fits had midpoints of -9.2 ± 1.4, -8.2 ± 1.4 and -7.4 ± 1.5 mV and slopes of 
22.5 ± 1.3, 21.9 ± 1.2 and 25.1 ± 1.3, for mEAG, EAG-QKEE and EAG-RQEE, 
respectively.  (F) Left, Representative recording showing the changes in membrane 
potential observed during perfusion with solutions containing the indicated K+ 
concentrations.  Right, Averaged membrane potentials (N equals at least 8 for each 
concentration) compared to the values estimated using the Goldman equation assuming a 
pK:pCl ratio of 1:0.67.  (G) Left, Proliferation-Voltage (PV) curve generated using the 
voltages estimated for different K+ concentrations based on the data in (f).  The 
Boltzmann fit to the data has a midpoint of -23.5 mV and a slope of -8.9.  The mEAG GV 
curve shown in (e) has been added for comparison.  Right, Proliferation induced by 
mEAG and the CaMKII binding mutant mEAG-RQEE, at K+ concentrations predicted to 
result in membrane potentials of -58 and -25 mV as indicated.  Only proliferation induced 
by the wild type channel is regulated by the membrane potential, in spite of the fact that 
mEAG-RQEE channels are as efficient as the mEAG in driving the membrane potential 
to more negative values.  In paired two-tailed t-tests, p = 0.0109 for mEAG and 0.5069 
for mEAG-RQEE, n = 4. 
 102




channel (Hegle et al., 2006), mEAG expression results in membrane potentials that are 
substantially more hyperpolarized (~ -45 mV) than those observed using dEAG (~ -12 
mV).  The increased working range allowed us to pursue the voltage-dependence of 
mEAG signaling using iso-osmotic substitution of K+ for Na+ in the media.  The effect of 
[K+] on the membrane potential was determined in current clamp recordings during 
perfusion of extracellular solutions containing a range of K+ concentrations; a 
representative experiment is shown in Figure 3.3F (left).  Averaged membrane potentials 
each concentration are plotted in Figure 3.3F (right) and were well-approximated using 
the Goldman equation, assuming a permeability ratio of 1.0:0.67 for K+ to Cl-, 
respectively.  
     The above measurements allowed us to estimate the resting potentials of cells in 
proliferation assays at various extracellular [K+] concentrations.  Figure 3.3G (left) 
depicts a ‘proliferation-voltage’ (PV) curve, in which normalized BrdU intensity is 
plotted as a function of voltage.  The PV curve was well-fit by a Boltzmann function with 
half maximal activation (V50) at -23.5 mV and a slope of -8.9.  Comparison of the PV and 
GV curves suggests that that proliferation is maximal when the channels are 
predominantly in a closed conformation, as previously suggested for the Drosophila 
channel (Hegle et al., 2006).  In addition, the steeper slope of the PV curve raises the 
question of subunit stoichiometry, suggesting that all four subunits may need to be closed 
for proliferation, and, conversely, that only one subunit of the channel may need to 
switch conformation for activation of CaMKII to occur.  It should be noted, however, that 
the GV curve reflects the opening of the channel and that more accurate measurement of 
the movement of the voltage sensor, by assessing gating charge movement, could 
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eliminate this difference.  Although further experiments will be needed to examine the 
validity of this suggestion, previous measurements of the charge and open probability 
valences for Drosophila channels indicate that the difference is negligible (Tang et al., 
2000).  Finally, two additional observations further support the hypothesized voltage-
dependence of signaling.  First, in contrast to Drosophila EAG, which has a minimal 
effect on membrane potential, non-conducting mEAG-F466A is less effective in 
stimulating proliferation than the wild type channel, an observation that is readily 
explained by its inability to shift the membrane potential.  Second, voltage-dependent 
proliferation is not observed for the CaMKII-binding mutant, mEAG-RQEE, in spite of 
its ability to shift the membrane potential, indicating that voltage-dependent proliferation 
requires the association of CaMKII and mEAG and is not due to a voltage-dependent 
mechanism endogenous to NIH 3T3 cells (Fig 3.3G). 
      To investigate the role of EAG signaling in vivo, we used the GAL4-UAS system 
(Phelps and Brand, 1998) to express various channel constructs in the null, eagsc29, 
background.  As observed in mammals (Jeng et al., 2005; Ludwig et al., 1994; Saganich 
et al., 2001),  Drosophila EAG is largely neuron-specific: EAG is expressed throughout 
the brain and optic lobes, and, in larvae, is enriched in the axons and terminals of motor 
neurons that synapse on the body wall muscle fibers (Sun et al., 2004; Wang et al., 
2002c).  We therefore used the neuron-specific elav promoter to drive EAG expression.  
The two primary defects observed at the larval neuromuscular junctions (NMJs) of 
eagsc29 mutants are a high frequency of spontaneous excitatory junctional potentials 
(EJPs) and increased amplitudes of both spontaneous and evoked excitatory junctional 













Figure 3.4: EAG signaling contributes to synaptic function in vivo.   
(A) Left, Representative EJCs elicited by electrical stimulation of the motor nerve for w– 
males (WT) and homozygous eagsc29 larvae, compared to EJCs observed for 
heterozygous wild type (WT-rescue), eagLAKK, and eagF456A constructs transgenically 
expressed using the neuron-specific elav promoter.  Recording solution contained 0.15 
mM Ca2+.  This low concentration of Ca2+ enhances amplitude differences presumably by 
minimizing evoked neurotransmitter release.  Bars, 0.5 μA and 100 ms.  Right, Averaged 
EJC amplitude data for w– male (WT) and eagsc29 larvae compared to transgenically 
expressed eag constructs as indicated.  Statistical comparisons are to the rescue condition 
indicated by the gray background shading, overall p < 0.0001.  N equals a minimum of 
20 muscle fibers for each condition.  (B) Left, Representative recordings of spontaneous 
EJP activity in wild type and eagsc29 larvae compared to recordings from transgenic 
larvae expressing either wild type or LAKK channels.  HL3 saline contained 0.4 mM 
external Ca2+.  Each of the 3 traces shown is a recording from a different fiber.  (Bars: 20 
mV and 500 ms).  Right, Average data for the genotypes as indicated.  Overall p < 
0.0001.  N equals a minimum of 20 muscle fibers for each condition.  Note: There are no 
spontaneous EJPs in recordings from wild type larvae.  In both (a) and (b) only data from 
muscle fibers 6 and 7 were included.  For individual comparisons to the rescue condition:  








defects are readily seen to reflect hyperexcitability of the motor nerve and/or terminals 
(Ganetzky and Wu, 1985) and have led to the suggestion that EAG current normally 
contributes to the maintenance of the resting potential, in addition to the repolarization of 
evoked action potentials.  
     In comparisons of wild type, signaling- (EAG-LAKK), and conductance- (EAG-
F456A) deficient constructs, both wild type and signaling-deficient (EAG-LAKK) 
channels restore evoked EJC amplitudes to a level that is statistically indistinguishable 
from wild type larvae (Fig 3.4A), whereas non-conducting EAG-F456A channels fail to 
rescue.  These results suggest that EAG-LAKK is reasonably well-expressed and that 
EAG current plays the predominant role in repolarizing the motor neuron action 
potential.  In contrast, whereas EAG-F456A expressing lines reduce the frequency of 
spontaneous activity to levels comparable to that observed using wild type EAG, the 
spontaneous activity observed in EAG-LAKK expressing larvae remains at a level 
comparable to that observed in eagsc29 (Fig 3.4B).  Thus, EAG signaling, not current, 
plays the predominant role in maintaining a stable level of motorneuron activity, 




     In summary, the EAG signaling mechanism described here suggests a novel function 
for the voltage sensors of ion channels that is distinct from their role in regulating ion 
flux.  EAG signaling depends on voltage-dependent conformations of the channel: 
proliferation is highest when channels are predominantly in a closed conformation and 
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the activity of membrane-associated CaMKII is inhibited.  Given that an intact CaMKII 
binding domain is essential for both EAG- and mEAG- mediated proliferation, and given  
our previous observations for p38 MAPK, our data support a model in which the 
suppression of CaMKII activity by closed EAG conformations relieves downstream 
inhibition of p38 MAPK pathway either by changing the localization or activity of a 
component in this pathway.  This pathway also may underlie the oncogenic potential of 
abnormally expressed human EAG (Farias et al., 2004; Meyer and Heinemann, 1998; 
Pardo et al., 1999; Patt et al., 2004).  
     Our experiments do not address the identity of the target(s) of EAG-CaMKII signaling 
in either NIH 3T3 fibroblasts or in vivo.  However, CaMKII has been well-established as 
a key component of synaptic plasticity and learning in a number of systems, including 
Drosophila and mammals (Griffith et al., 1993; Silva et al., 1992a,b).  Through the 
regulation of small GTPases such as Ras, CaMKII activity regulates MAPK pathways 
that activate nuclear transcription factors, such as the cAMP response element binding 
protein (CREB), that control the transcription of activity-dependent genes (Thomas and 
Huganir, 2004).  Specifically, Ras-mediated activation of p42/44 MAPK contributes to 
facilitation and long-term potentiation (LTP) (Bolshakov et al., 2000; Zhu et al., 2002), 
whereas p38 MAPK regulates long-term depression (LTD) (Guan et al., 2003; Thomas 
and Huganir, 2004; Zhu et al., 2002).  CaMKII activity also contributes to p38 MAPK 
inactivation through the regulation of ASK1 and SynGAP (Krapivinsky et al., 2004; 
Takeda et al., 2004).  It is therefore not unreasonable to hypothesize that EAG/CaMKII 
signaling may influence plasticity pathways via the downstream activation of MAPKs 
that mediate potentiation, depression, and learning, especially given that eag mutants also 
 109
have impaired associative learning, a deficiency similar to that seen in flies with inhibited 
CaMKII activity (Griffith et al., 1994). 
 
D. MATERIALS & METHODS   
D.1. Plasmids and construction 
     Wild type eag was subcloned into pCS2 and pPUAST vectors using EcoRI and XbaI 
sites flanking the coding sequence.  A modified Cavener/Kozak initiation sequence on 
eag was added via PCR as a 5’ extension on an oligonucleotide primer.  All eag mutant 
constructs, including eag-F456A, eag-T787A, eag-L782K/A783K (LAKK), eag-
R784K/Q785K (RQKK), eag-R1037L/K1040M (RLKM), eag-F731S/F734S (FFSS), 
eag-K663A/R664A (NLS1), eag-R698A/R699E (NLS-2), eag-H487E/T490E (HTEE), 
eag-T449S/A460S/T470A (TATSSA), eag-HTEE-F456A (HFA), eag-TATSSA-F456A 
(TFA), meag-F466A, meag-R746E/Q747E (RQEE) and meag-Q748E/K749E (QKEE) 
were generated by site-directed mutagenesis using QuikChange (Stratagene).  Eag-ΔCT 
was generated by introducing a stop codon at E511.  Eag-ΔNT was constructed using 
PCR by replacing the first 212 N-terminal residues with a short sequence 
(MRLHVWRV) to allow proper S1 membrane insertion.  pCDNA3 and the pCDNA3-
meag construct were gifts from Yi Zhou, University of Alabama at Birmingham.  For 
oocyte expression, mutant constructs were subcloned into pGH19-eag (Wilson et al., 
1998).  All constructs were verified by sequencing.   pPUAST-eag was co-injected along 
with the Δ2,3 recombinant helper plasmid into w- Drosophila larvae and positive 
transgenics were scored for the w+ phenotype in F1.  To assess the ability of transgenic 
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EAG to rescue neuronal activity, UAS-eag was expressed using the pan-neuronal 
(elav5147-Gal4) driver and crossed into the eagsc29 null background. 
 
D.2. Immunocytochemistry and proliferation assays 
     NIH 3T3 fibroblasts were maintained at 37°C and 5% CO2 in Dulbecco's modified 
Eagle's medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS) 
as previously described (Chouinard et al., 1995).  For transfection, coverslips were 
incubated for at least 5 hrs in DMEM containing containing 1.6 µg of the indicated 
cDNAs and 4 µl LipofectAMINE-2000 (Invitrogen).  Coverslips were then washed and 
incubated in standard media for 12 hrs.  Cell density at the time of transfection was 
critical to allow effective transfection while minimizing cell loss due to dissociation of 
cells from coverslips during subsequent growth.  Experiments using increased 
concentrations of KCl were performed by equimolar substitution of KCl for NaCl in 
DMEM prepared according to standard formula.  For BrdU labeling, 10 µM BrdU was 
added to each well for 3 hrs.  Coverslips were washed with phosphate-buffered saline 
(PBS) and fixed with a 3:7 mixture of 50 mM glycine (pH 2.0)/100% ethanol for 1 hr at 
room temperature (RT), then denatured with 4 M HCl for 15 min.  Cells were labeled 
with anti-BrdU fluorescein-conjugated antibody (Molecular Probes) for 45 min at 37 oC.  
Labeling was visualized using an Olympus BX51W1 microscope equipped with a 
Qimaging Retiga Exi camera and IPlab 3.6 software.  BrdU fluorescence was quantified 
using NIH ImageJ software as described (Hegle et al., 2006).  For quantification of BrdU 
incorporation, we scanned the regions of each coverslip with the highest cell density; this 
likely underestimates EAG-induced proliferation given that the blank areas on each 
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coverslip were excluded.  Scans were background subtracted, and the intensity of all 
pixels above background was summed across the total area of each scan.  Total intensities 
were averaged across all scans for each condition before normalizing to the average 
intensity for controls.  Normalized data were then averaged across experiments (N).  
 
D.3. Biochemistry 
     Cells grown on culture plates were transfected with 8µg of the indicated cDNAs and 
20 µl of LipofectAMINE-2000 (Invitrogen). Cells were dissociated with trypsin-EDTA 
48 hrs after transfection, washed and resuspended in PBS.  Biotinylation and precipitation 
of EAG was performed as described (Marble et al., 2005).  Briefly, cell suspensions were 
incubated in 2 mM sulfo-NHS-LC-biotin (Pierce) and the reaction was quenched by 
washing with 100 mM glycine in PBS.  Cells were lysed in PBS supplemented with 1% 
IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT and protease 
inhibitors, and the homogenate was centrifuged twice for 10 min at 20,000 x g.  Protein 
concentrations of supernatants were determined by Bradford assay and diluted to ~ 0.5 
mg/ml.  Surface proteins were precipitated with strepavidin agarose and the precipitate 
washed extensively before addition of sample loading buffer.  Blots were probed with 
antisera directed against the carboxyl-terminal domain of EAG (EAG (CT); 1:2000) in 
blocking buffer, followed by horseradish peroxidase (HRP)-conjugated secondary 
antibody (1:2000), and visualized with ECL (Amersham Biosciences).  Assays of 
CaMKII and p38 MAP kinase activity were performed using extracts prepared in buffer 
containing the following (in mM): 20 Tris (pH 7.4), 100 NaCl, 50 NaF, 1 Na3V04, 1 
EDTA, 1 DTT, 1 benzamidine, and 0.005 microcystin-LR with 1% IGEPAL CA-630, 
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0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitors.  For CaMKII activity 
blots, antisera were directed against phospho-Thr-286 (1:200) or total CaMKII (1:1000) 
(Santa Cruz).  For p38 MAPK activity blots, antisera were directed against phospho-
Thr180/Tyr182 (1:250) or total p38 MAPK (1:500) (Cell Signaling Technologies).  
Protein bands were quantified using ImageJ. 
 
D.4. Electrophysiology 
     Experiments using Xenopus oocytes were performed as described (Marble et al., 
2005).  Oocytes were typically injected with 0.1-0.2 ng of RNA; non-conducting 
constructs were injected at 1-2 ng.  The recording solution contained the following (in 
mM): 140 NaCl, 2 KCl, 1 MgCl2 and 10 Hepes (pH 7.1 with NaOH).  Pipettes had 
resistances of  0.3 - 0.6 MΩ.  For NIH 3T3 cell recordings with an Axopatch200B 
amplifier, cells maintained on plates were co-transfected with pCDNA3-EGFP and the 
indicated constructs, and were replated onto coverslips prior to recording.  Pipette 
resistances ranged from 3 to 6 MΩ.  Unless otherwise noted, the extracellular solution 
contained the following (in mM): 40 sodium aspartate, 100 NaCl, 4 KCl, 1.5 MgCl2, 1 
CaCl2, 2 glucose and 10 Hepes (pH 7.4 with NaOH).  The pipette solution contained the 
following (in mM): 35 potassium aspartate, 110 KCl, 2 MgATP, 1 NaATP, 3 sodium 
phosphocreatine, 0.1 NaGTP, 8 EGTA and 10 Hepes (pH 7.4 with KOH). Larval 
recordings were obtained from body wall muscle fibers 6 and 7 in 3rd-instar WT, eagsc29 
and eag-rescue larvae using HL3 media containing (in mM): 70 NaCl, 5 KCl, 4 MgCl2, 
10 NaHCO3, 5 trehalose, 115 sucrose and 5 Hepes (pH7.1) with either 0.4 or 0.15 mM 
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CaCl2.  Data were collected and analyzed using an AxoClamp 20B and pClamp 9 
software. All experiments were performed at room temperature.  
 
D.5. Statistics 
     Unless otherwise noted, data were analyzed using one way analysis of variance 
(ANOVA) with Bonferroni post-hoc analysis for selected conditions.  The repeated 
measures ANOVA was used for proliferation and biochemical assays.  Data are presented 

























     Voltage-dependent signaling by EAG K+ channels is a novel mechanism by which 
changes in membrane potential can directly regulate intracellular signaling pathways.  
Membrane-associated CaMKII activity is modulated by the EAG voltage sensor in a 
manner independent of channel conductance, creating a dynamic signaling complex that 
may underlie synaptic homeostasis in vivo.  The aims of this thesis were to determine the 
mechanism underlying the ability of Drosophila EAG K+ channels to stimulate 
proliferation when heterologously expressed in NIH 3T3 cells, to determine whether the 
mechanism is conserved in other EAG isoforms, and to determine whether disruption of 
this mechanism contributes to the phenotypes observed in Drosophila eag mutants.  As 
presented in Chapter II, my studies show that EAG acts as an upstream regulator of 
intracellular signaling pathways and that this function is distinct from the ability of EAG 
to conduct K+ ions.  Most importantly, EAG signaling activity is regulated by the voltage 
sensor, as revealed by experiments using depolarizing concentrations of KCl or EAG 
mutations that shift the voltage-dependence of channel gating.  
     The effects of ion channels on intracellular communication have, in the past, been 
assumed to be indirect consequences of ion conduction.  My studies on EAG contribute 
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to a growing body of evidence that voltage-gated ion channels are multifunctional 
proteins.  In contrast to most other conductance-independent functions of voltage-gated 
channels, however, the signaling activity of EAG is regulated by changes in channel 
conformation associated with the position of the voltage sensor.  This finding is 
particularly relevant to neuronal function, because it provides a novel mechanism for 
linking neuronal excitability to the activity of intracellular messengers.  A screen of 
mutations in several candidate intracellular domains shows that EAG signaling requires 
an intact CaMKII binding domain, and biochemical experiments confirm that the activity 
of membrane-associated CaMKII is regulated by EAG in a voltage-dependent manner.  
The effect of EAG on CaMKII activity is the inverse of the effect on proliferation: 
decreased CaMKII activity results in increased proliferation, while mutations of the 
channel that increase CaMKII activity decrease proliferation.  These results support a 
model in which CaMKII and EAG operate as a signaling complex that translates voltage-
sensitive conformational changes in EAG into modulation of CaMKII, in turn regulating 
downstream effectors to affect the proliferative state of the cell.  Voltage-dependent, 
conductance-independent signaling is also observed using the mammalian isoform of 
EAG, and similarly requires CaMKII binding, indicating that CaMKII-mediated EAG 
signaling is conserved.   
     Finally, in vivo experiments suggest that some of the defects observed in Drosophila 
eag mutants are due to disrupted regulation of CaMKII.  Transgenic flies expressing the 
EAG-LAKK construct, which contains mutations in the CaMKII binding domain, yield 
functional currents at the neuromuscular junction as evidenced by the ability to rescue 
EJC amplitudes as effectively as a the wild type channel, yet the frequency of 
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spontaneous activity remains high.  Conversely, transgenic expression of the non-
conducting EAG-F456A construct fails to rescue EJC amplitudes, but restores 
spontaneous activity to a level much nearer to that obtained following transgenic 
expression of the wild type channel.  These results strongly suggest that the high level of 
spontaneous activity characteristic of eag mutants is predominantly due to disrupted 
regulation and/or localization of CaMKII, and that the absence of EAG current only 
moderately contributes to this phenotype.  These results are presented in Chapter III. 
     In this chapter I suggest further experiments that would clarify specific aspects of the 
EAG signaling model, including the biophysical mechanism of signaling by the EAG 
voltage sensor, the regulation of EAG and CaMKII surface expression by the adapter 
protein Camguk, and the downstream consequences of EAG-regulated CaMKII 
activation.  In addition, I consider how these findings impact the physiological 
significance of EAG at the synapse, and discuss the implications for EAG signaling in 
cell cycle progression and oncogenesis. 
 
A. BIOPHYSICAL MECHANISMS OF EAG SIGNALING 
     In formulating a model of the biophysical mechanism of EAG signaling, one must 
consider several questions: Do individual channel conformations permit signal activation, 
or do transitions between states drive signaling?  How many EAG subunits are required?  
Moreover, how is voltage sensor movement linked to CaMKII activity?  Does the voltage 
sensor physically interact with C-terminal-bound CaMKII, or is the link indirect?  
Resolving these questions will be central to a complete understanding of the voltage-
 117
dependence of EAG signaling.  Here I propose various models of voltage-dependent 
EAG signaling and experiments that would help to distinguish between them.   
 
A.1. Kinetic models of EAG-regulated proliferation 
     Preliminary investigations showed that increasing extracellular KCl to depolarize cell 
membranes has an inhibitory effect on the proliferation induced by non-conducting EAG 
channels.  Because there is presumably no difference in K+ flux for the vector and non-
conducting EAG conditions, this result led to the hypothesis that EAG-induced 
proliferation is maximal when the channel is predominantly in a closed conformation.  
Subsequent analysis of EAG mutants with shifted voltage-dependence confirmed that 
closed channel conformations induce proliferation, whereas the open conformation 
appears inhibitory (Figs 2.3, 2.4).  In addition, mEAG-mediated proliferation sharply 
decreases upon membrane depolarization (Fig 3.3), providing further evidence that 
proliferation is attenuated at positive potentials.  Reinterpretation of this model in its 
simplest form, based on the findings with CaMKII (Fig 3.2), suggests that EAG inhibits 
CaMKII activity when at rest, and increases CaMKII activity when the channel is open.    
     Several observations suggest that this model is an oversimplification of the signaling 
mechanism.  If EAG signaling follows a Boltzmann distribution, as would be expected 
for a voltage-gated event, then the magnitude of the proliferation response (or kinase 
activity) should vary precisely in accord with changes in the half-maximal activation 
(V1/2) for the wild type, TATSSA, and HTEE EAG constructs.  At the mean resting 
potentials of -12, -18, and -28 mV for NIH 3T3 cells expressing wild type, TATSSA, and 
HTEE channels (Fig  2.4B), conductance-voltage (GV) curves indicate that roughly 68, 
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56, and 49 percent of channels are in a closed conformation, respectively.  The above 
model then predicts that proliferation response should be highest for wild type channels 
and lowest for EAG-HTEE, a trend that is not observed.  There are several possible 
mundane explanations of this discrepancy.  Most notably, the measurements obtained in 
Chapter II are single data points and therefore do not control for subtle differences in the 
expression, localization, or regulation of different EAG constructs.  
     To begin to address the above issue, we coexpressed non-conducting EAG-F456A 
with Shaker to hyperpolarize the membrane potential to a level nearer the activation 
threshold for EAG.  This was necessary because, even though Drosophila EAG channels 
are at the membrane of NIH 3T3 cells, the currents generated are minimal.  Thus the 
average resting potential of NIH 3T3 cells expressing EAG is very depolarized, limiting 
the range of potentials in which to examine signaling.  Coexpression with Shaker shifts 
the resting potential from an average of -12 mV to -45 mV, allowing proliferation to be 
assayed at potentials for which EAG should have a much lower po.  By recording the 
membrane potential of cells coexpressing EAG-F456A and Shaker at a range of 
extracellular K+ concentrations ([K+]o) and fitting the resulting data points with the 
Goldman equation, we were able to calculate appropriate values of [K+]o with which to 
measure the effects of depolarization on BrdU incorporation.  The resulting 
“proliferation-voltage” (PV) curve permits a direct comparison of proliferation and 
conductance data in NIH 3T3 cells, allowing for a more precise assessment of the basic 
model.  Our initial results showed that driving the membrane potential to more negative 
values with Shaker increases proliferation compared to that stimulated by non-conducting 
EAG alone, again suggesting that occupancy of a closed state regulates EAG induced 
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proliferation.  However, further interpretation of this result is difficult, because 
coexpression with Shaker may affect the voltage-dependence of EAG.   
     The possible confounding  effects of Shaker were circumvented through the use of 
mammalian EAG, which also exhibits conductance-independent signaling activity (Fig 
3.3A).  In contrast to the Drosophila channel, mEAG exhibits robust outward current 
when expressed in NIH 3T3 cells and is therefore able to drive the membrane to much 
more negative potentials.  Comparison of the voltage-dependence of mEAG proliferation 
with whole-cell conductance (Figure 3.3G) shows that proliferation appears to plateau at 
more negative potentials, for which mEAG conductance is close to zero.  However, a 
more exacting comparison reveals that the voltage for half-maximal activation (V1/2) of 
proliferation is -23.5 mV, which is more negative than the V1/2  for activation of current  
(-9.2 mV).  If occupancy of the open state underlies kinase activation and inhibits 
proliferation, the V1/2 for proliferation and current should be similar.  Secondly, the slope 
of the Boltzmann fit to the proliferation data (-8.9) is steeper than the slope of the 
Boltzmann fit to the mEAG current (22.5).  It should be noted that the GV curve reflects 
the opening of the channel and that more accurate measurement of the movement of the 
voltage sensor, namely by assessing gating charge movement, could account for these 
differences.  Alternatively, the differences in the PV and GV curves may offer important 
clues regarding the mechanism of voltage-dependent signaling.  
     One possible explanation of the different V1/2 for proliferation and conductance is that 
proliferation resulting from inhibition of the constitutive activity of CaMKII occurs from 
a specific closed state of the channel, as opposed to occurring from all non-open states.  
Studies of the Cole-Moore shift of EAG activation have revealed that EAG has at least 
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two closed states, designated Cslow and Cfast, and at least one open state (Schonherr et al., 
2002; Tang et al., 2000).  During hyperpolarization, a Mg2+ binding pocket forms 
between S2/S3 and S4, that, when occupied, stabilizes Cslow via allosteric hindrance of S4 
movement (Schonherr et al., 2002).  Extracellular application of Mg2+ also stabilizes 
Cslow, resulting in a delay of EAG activation kinetics (Tang et al., 2000).  A simplified 
model of EAG activation can be written 
(Cslow  Cfast)4  O 
where O is the open or activated state (modified from (Schonherr et al., 2002).  Note that 
in this model, all four subunits must move into Cfast before the channel can open to 
conduct ions. 
     In order to fully characterize the state-dependence of EAG signaling, experiments that 
isolate specific EAG conformations will be useful for comparison to proliferation or 
kinase activation at Cslow, Cfast, and O states.  Because the application of extracellular 
Mg2+ stabilizes Cslow by slowing the Cslow  Cfast transition (Tang et al., 2000), BrdU 
assays performed in the presence of various concentrations of Mg2+ may clarify the role 
of Cslow in signal activation.  If Cslow is the main determinant of signaling, proliferation 
should be higher in EAG-expressing cells exposed to Mg2+ than for control cells.  Indeed, 
preliminary experiments testing the effects of Mg2+ on EAG signaling show that 
proliferation of eag-transfected NIH 3T3 cells in the presence of 2 mM MgCl2 is 
increased by ~50% compared to that of cells in standard media (unpublished 
observations).  This result suggests that proliferation can only occur when channels 
occupy Cslow; however, because Mg2+ may affect other cellular processes, other 
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techniques, including altering the proportion of channels in Cfast (see below), would help 
to strengthen this conclusion.  
     One approach to distinguishing between the contributions of Cslow and Cfast on the 
activation of EAG signaling is the use of cysteine substitution and modification.  In 
bovine EAG (bEAG), the extracellular residues L322 and S325, which reside in the S3-
S4 linker region, are critical for the Cslow  Cfast transition.  Replacement of L322 with 
cysteine decreases both the proportion of channels in Cslow and the time constant of slow 
activation (τslow), whereas cysteine substitution at S325 has the opposite effects 
(Schonherr et al., 2002).  Homologous mutations in Drosophila EAG, L342C and 
A345C, have been generated in our lab, but the kinetic properties of these channels have 
yet to be characterized.  If L342C and A345C have similar activation kinetics as the 
bEAG mutations, these mutants may be useful for determining the relative contribution 
of Cslow and Cfast to EAG signaling.  If Cslow mediates signaling, cells expressing the 
EAG-A345C mutant should exhibit increased proliferation beyond that stimulated by 
wild type EAG, and the proliferation of cells expressing EAG-L322C should approach 
that of vector controls.  In contrast, if Cfast contributes to signaling, EAG-L322C would 
be expected to stimulate some increase in proliferation compared to control cells. 
     Replacement of these key residues with cysteines also allows for chemical 
modification of the channel by charged methanethiosulfonate compounds such as 
MTSET and MTSES.  For the bEAG mutations, application of MTSET or MTSES 
“locks” the channel into fast gating modes, effectively eliminating the Cslow state 
(Schonherr et al., 2002).  If these compounds have a similar effect on EAG-L322C and 
EAG-A345C, they may also be used to test whether Cslow or Cfast regulate signaling.  
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Sustained application of MTSET or MTSES to cells expressing these mutants would be 
expected to eliminate Cslow-mediated signaling, and the immobilization of channels by 
these compounds would also inhibit any signaling mediated by state transitions.  
Similarly, if Cfast mediates EAG signaling, MTSET or MTSES application would be 
expected to increase signaling, or at least have no inhibitory effect on proliferation.  
Preliminary experiments show that these compounds do not affect proliferation 
stimulated by wild type EAG or EAG-F456A, indicating that nonspecific effects would 
be minimal.   
     Finally, mutations could be made in the voltage-sensing residues of S4 to disrupt 
channel gating or eliminate S4 movement altogether.  Certainly, further support for 
voltage-dependent signaling could be obtained using mEAG constructs with shifted 
voltage-dependence, akin to the HTEE and TATSSA mutations made for the Drosophila 
channel.  In addition, the creation of a “constitutively active” EAG, for example by using 
cysteine mutations to force disulfide bond formation, would be useful to examine the 
effects of EAG signaling independently of voltage-dependent regulation in both NIH 3T3 
cells and flies. 
 
A.2. EAG subunit stoichiometry  
    Another aspect of the voltage-switch mechanism of EAG signaling is the question of 
subunit stoichiometry.  Must all four subunits occupy the same conformation for 
activation to occur, or is the conformation of one subunit alone sufficient for pathway 
activation?  The fact that the slope of the Boltzmann curve for proliferation (-8.9) is much 
steeper than that for normalized mEAG conductance (22.5) suggests the hypothesis that 
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the movement of one subunit may be sufficient to inhibit EAG-induced proliferation, 
whereas all four subunits must move in order to activate the channel.  As noted above, 
measurement of the gating charge movement during depolarization would provide a more 
exact comparison of EAG signaling and voltage-gated conformational shifts of the 
channel. 
     To more precisely address the subunit stoichiometry of EAG signaling, mutations of 
the positively charged S4 residues within individual EAG subunits could be introduced 
into concatameric channels.  By shifting the voltage-dependence of only one subunit or, 
alternatively, by fusing the voltage sensor of one or more subunits into a constitutively 
open or closed position, the contributions of single subunits to EAG signaling may be 
more fully resolved.   
 
A.3. The link between CaMKII and voltage sensor  
     EAG signaling is mediated through the regulation of CaMKII, both because mutation 
of the C-terminal CaMKII binding domain eliminates the effects of EAG on proliferation 
(Fig 3.1B,C), and because membrane-associated CaMKII phosphorylation is sensitive to 
different conformations of EAG (Fig 3.2).  EAG mutations that activate proliferation 
correspond to decreased CaMKII activity, while mutations that inhibit proliferation are 
associated with increased CaMKII activity.  Thus, EAG-induced proliferation appears to 
be propagated through a voltage-dependent reduction in the constitutive activity of 
CaMKII bound to the EAG C-terminus.  However, the actual mechanism linking specific 
EAG conformations to changes in CaMKII activity remains unclear.    
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     There are several possible models to explain the link between EAG gating and 
CaMKII modulation, taking into account both the specific voltage sensing mechanism of 
EAG, and the proximity of the voltage sensor to the kinase.  In the classic “axial 
translation” model of K+ channel voltage sensing, the positively charged S4 helix 
responds to changes in membrane potential by sliding or rotating within an aqueous 
gating canal formed by the other helices (Gandhi and Isacoff, 2002).  If the voltage 
sensor of EAG operates in this fashion, the movement of S4 through the gating canal may 
affect CaMKII via a variety of mechanisms.  In the direct model, the cytoplasmic end of 
S4 or the S4-S5 linker is close enough to the C-terminal-bound CaMKII to have an 
allosteric or electrostatic influence on kinase conformation, inhibiting bound CaMKII 
activity when the channel is closed.  Outward translation of S4 during channel activation 
would thus remove the inhibition at positive potentials, leading to an increase in CaMKII 
activity.  A second possibility is that S4 movement affects CaMKII conformation 
indirectly, by exerting conformational changes in the intracellular C terminus that in turn 
modulate the kinase.  A third model supposes that S4 movement affects the availability of 
the CaMKII binding domain to the kinase, occluding association at rest and allowing 
CaMKII to bind and activate when EAG is open.  These three modes of CaMKII 
regulation will be referred to as the ‘direct’, ‘indirect’ and ‘conditional binding’ models. 
     In contrast to the axial translation model of voltage-sensing, recent crystallization of 
KvAP suggests that the K+ channel voltage sensor may actually move externally, rather 
than through an enclosed gating canal.  In this model, S4 and a portion of S3 form a 
charged “paddle” that extends outward from the pore-forming helices into the lipid 
bilayer (Jiang et al., 2003a).  The paddles are thought to respond to voltage changes by 
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sweeping through the hydrophobic interior of the membrane, coupling their movement to 
conformational shifts in the pore leading to channel activation (Jiang et al., 2003b).  More 
recent studies have found that the voltage sensor does not extend as far into the 
membrane as the KvAP crystal structure suggests, but may instead lie at the protein/lipid 
interface (Cuello et al., 2004; Gandhi et al., 2003).  In either case, voltage sensor residues 
that would be obscured in the classical model may be exposed and available to directly 
induce conformational changes in C-terminal-bound CaMKII.  Alternatively, the 
movement of the sensor could indirectly influence CaMKII activation via conformational 
shifts elsewhere in the C-terminus, or affect the ability of CaMKII to bind to the channel 
altogether.  Thus, the three models proposed above would also apply to more current 
models of voltage sensing.  However, the specific residues responsible for modulating 
CaMKII activity would likely differ between the mechanisms: specifically, if the paddle 
model is correct, the residues at the tip of the paddle, which move the greatest distance, 
would be expected to exert the greatest influence on kinase activity, whereas in the axial 
translation model, residues near the cytoplasmic end of S4 or in the S4-S5 linker would 
be expected to have the greatest effect.   
     Regardless of the voltage sensor structure, the three basic models of CaMKII 
modulation described above can be experimentally distinguished.  Fluorescence 
resonance energy transfer (FRET) is a well-established technique used to examine 
interactions between nearby molecules (Kenworthy, 2001; Selvin, 1995).  FRET makes 
use of a phenomenon by which the energy of excitation of a “donor” fluorophore such as 
Cy2 is transferred to a nearby “acceptor” dye, which may or may not also be fluorescent.  
The quenching of the fluorescent donor thus indicates the presence of a nearby acceptor 
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molecule.  Because the efficiency of energy transfer is inversely proportional to the sixth 
power of the distance between molecules, this technique also allows for near-angstrom 
measurements of separation when the dyes are attached to proteins of interest (Selvin, 
1995).   
     Although EAG has not been crystallized, accessibility studies have identified key 
residues important for gating and further suggest that the EAG voltage sensor may 
operate via a mechanism very similar to that of Shaker (Schonherr et al., 2002; Silverman 
et al., 2003).  With the knowledge of voltage sensor residues accessible from the 
cytoplasmic face of the membrane, FRET would be a powerful tool to further 
characterize either direct or indirect modes of CaMKII regulation.  Specifically, if 
regulation occurs via direct interactions with the voltage sensor, one should be able to 
assess the distances between various residues of the EAG voltage sensor and CaMKII by 
attaching a donor fluorophore to accessible voltage sensor residues of EAG and 
measuring quenching in the presence of dye-labeled CaMKII.  Labeled channels would 
first be characterized in oocyte recordings to determine the effects on current and gating 
properties, and tested biochemically for the ability to regulate CaMKII activity.  If dye 
attachment does not interfere with voltage-dependent modulation of CaMKII, a library of 
FRET-ready channels could be generated by labeling residues on various EAG mutants 
known to affect CaMKII activity, such as EAG-HTEE/F456A (HFA) and EAG-
TATSSA/F456A (TFA), and other channels with altered gating properties, such as EAG-
L322C and EAG-A345C.  In tests of the indirect model of CaMKII regulation, FRET 
could be used to investigate intramolecular interactions between the EAG voltage sensor 
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and C-terminal residues, including those that form the CaMKII binding domain, thus 
determining the extent of the voltage sensor’s influence on C-terminal conformations.   
     One difficulty posed by this approach is the accessibility of FRET fluorophores to the 
EAG complex.  This may be overcome by performing the experiments in cut-open 
oocytes, excised patches or by whole-cell perfusion of transfected cells, so that the dyes 
can be directly applied to the cytoplasmic face of the membrane.  Moreover, although 
FRET would provide much information about the proximity of labeled EAG and CaMKII 
residues, if the key amino acids cannot be predicted via the available accessibility data, 
this strategy may prove to be fruitless.  Another way to identify the specific EAG 
residues important for interactions between CaMKII and the voltage sensor would be to 
first characterize voltage sensor movement using compounds such as the Cys-reactive 
probe aminophenoxazone maleimide (APM).  This compound has been used in studies of 
Shaker to report specific conformational shifts during gating events (Cohen et al., 2005).  
By comparing voltage sensor movements between EAG mutants that regulate CaMKII 
differently, it may be possible to narrow down the most probable residues involved, 
providing a clear starting point for FRET analysis.     
     In contrast to the direct versus indirect models, the conditional binding model of 
CaMKII regulation can be easily tested by coimmunoprecipitating CaMKII with EAG 
mutants known to affect signaling, such as EAG-HFA and EAG-TFA.  Preliminarily, this 
model seems less able to account for data suggesting that EAG inhibits CaMKII when in 
the closed conformation (Fig 3.2).  Nevertheless, if CaMKII coimmunoprecipi-tates with 
these channels, but does not coimmunoprecipitate with EAG-HTEE and EAG-TATSSA, 
it would indicate that the shifted voltage sensor prevents CaMKII binding.  An important 
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technical consideration that may limit the interpretation of these results is that it is 
possible that CaMKII remains associated with EAG via CMG or other scaffolding 
proteins, even if direct binding to the EAG C-terminus is occluded by the voltage sensor 
at depolarized potentials.   
     In summary, although much work is yet to be done to identify the specific biophysical 
model of voltage-dependent CaMKII regulation by EAG, the results presented in this 
thesis suggest that EAG -induced proliferation is the result of the attenuation of CaMKII 
activity by closed states of EAG.  Thus, CaMKII appears to be regulated by the voltage 
sensor, although it is unclear whether signaling is due to the inhibition of bound CaMKII 
activity or to dissociation of the kinase from the EAG C-terminus.  A combination of site-
directed mutagenesis and analysis with fluorescent probes may be able to fully resolve 
this issue. 
 
B. CELLULAR MECHANISMS OF EAG SIGNALING 
     As presented in Chapter II, the presence of EAG promotes increases in p38 MAPK 
activity as well as proliferation of NIH 3T3 cells, and EAG-induced proliferation requires 
p38 MAPK activity (Fig 2.1, 2.2).  However, p38 MAPK is likely to be several steps 
removed from the EAG signaling mechanism.  Subsequent work, discussed in Chapter 
III, suggests that the most direct effect of EAG is to regulate CaMKII activity, and that 
regulation of CaMKII activity by EAG is voltage-dependent, as expected given the 
voltage-dependence of the proliferation response.  Furthermore, CaMKII-mediated 
signaling appears to be conserved in mEAG (Fig 3.3C-E).  The separate observations for 
p38 MAPK and CaMKII can be combined into a model in which EAG-induced 
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proliferation is the result of a local attenuation of CaMKII activity near the channel.  
Inhibition of CaMKII, or a change in CaMKII localization, is important to EAG-induced 
proliferation; otherwise mutations in the CaMKII binding domain would not disrupt the 
proliferation response (Fig 3.1B-D).  Biochemical assays of CaMKII phosphorylation 
also show that membrane-associated CaMKII activity is lower in cells expressing EAG 
constructs that are predominantly closed and stimulate proliferation, and higher in cells 
expressing EAG constructs that are predominantly open and decrease proliferation (Fig 
3.2).  
     If p38 MAPK is downstream and inhibited by CaMKII in the proliferation pathway, 
then EAG-dependent regulation of p38 MAPK activity also should be voltage-dependent.  
However, voltage-dependent regulation of p38 MAPK has not been detected in either the 
cytoplasmic or membrane-associated fractions.  Thus, either the effects on p38 MAPK 
are limited to molecules in close proximity to EAG or voltage-dependent regulation 
predominantly affects the localization of p38 MAPK to a compartment that is not 
adequately represented by the cytoplasmic or membrane fractions.  Lastly, it is possible 
that CaMKII inhibits proliferation by regulating a step that is downstream of p38 MAPK.  
In either case, the uniform regulation of p38 activity for all EAG constructs tested (data 
not shown) implies that EAG has effects on two distinct intracellular signaling pathways. 
     In the sections that follow, I discuss cellular mechanisms of EAG signaling, including 
other possible targets of EAG-regulated CaMKII activity, the roles of local versus global 
pools of CaMKII, the regulation of EAG surface expression and CaMKII association, and 
the possible cytoplasmic and nuclear localization of EAG or EAG fragments. 
 
 130
B.1. Downstream targets of CaMKII 
      A major unanswered question concerns the identity of downstream effectors regulated 
by EAG-associated CaMKII activity.  According to the model proposed in Chapter III 
and above, EAG signaling is mediated via downregulation of membrane-associated 
CaMKII activity, and results in changes in the activation states or localization of 
downstream signaling molecules, including p38 MAPK.  Potential intermediates between 
CaMKII and p38 MAPK include the synaptic GTPase-activating protein (SynGAP) 
(Krapivinsky et al., 2004) and the apoptosis-signal regulating kinase (ASK1), a known 
substrate of CaMKII that also influences p38 MAPK activity (Takeda et al., 2004).  In 
addition, CaMKII activity is central to Ca2+ signaling pathways that control numerous 
cellular functions, including carbohydrate and fatty acid metabolism, muscle contraction, 
neurotransmitter release and synaptic plasticity (Braun and Schulman, 1995).  Because of 
the ubiquitous nature of CaMKII, a complete analysis of the intracellular pathways 
mediated by EAG signaling could be a time-consuming endeavor.  For example, in 
synapses alone, CaMKII has at least 28 different substrates (Yoshimura et al., 2000).  
Furthermore, the specific mechanisms by which decreased CaMKII activity upregulates 
or downregulates the activity of target proteins are complex and likely depend on the 
biochemical makeup of the cell or even that of a microdomain within a given cell.  
Indeed, it is possible that EAG regulation of bound CaMKII directly affects CaMKII 
targets that are local to EAG complexes, but has little effect on cytoplasmic substrates.  
In vivo, this type of regulation may be the consequence of the partitioning of CaMKII 
into membrane and cytoplasmic pools via EAG-Camguk interactions (see below). 
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     In pursuing possible downstream targets of CaMKII, it is also important to consider 
that proliferation may not be the function normally regulated by EAG in vivo.  Indeed, 
the effect of heterologous overexpression of EAG is cell-line specific:  while EAG-
mediated proliferation was observed in C2C12 myoblasts, as well as NIH 3T3 cells, 
expression of EAG in CHO cells had no effect on BrdU incorporation, but rather 
promoted cell death (unpublished observations).  However, both the p38 and p42/44 
MAPK pathways are implicated in learning, as well as cell cycle regulation (Ambrosino 
and Nebreda, 2001; Chang and Karin, 2001); thus it not clear at which point the pathway 
activated in NIH 3T3 cells and in vivo will diverge. 
     To date, EAG overexpression in Drosophila has not resulted in the appearance of 
visibly discernable growth defects (unpublished observations).  However, a role in 
growth cannot completely be ruled out, given that more precise indicators such as 
experiments examining the effects of EAG on patterning in imaginal discs have yet to be 
performed.  The proposed physiological role of EAG signaling is discussed in more detail 
below.  A growth-related phenotype would simplify enhancer and suppressor screens of 
transgenics to identify components in the EAG signaling pathway in vivo. 
 
B.2. Regulation of EAG surface expression by Camguk 
     If EAG signaling is mediated via changes in CaMKII activity at the membrane, it 
follows that the surface expression of EAG is an important component of signal 
regulation.  One mechanism by which EAG membrane localization may be regulated is 
via phosphorylation of T787, which appears to be enhanced through an association with 
the MAGUK adapter protein Camguk (CMG) (Marble et al., 2005).  In transfected COS-
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7 cells, CMG normally localizes to the cytoplasm, but translocates to the nucleus when 
coexpressed with Tbr-1, a T-box transcription factor that is a binding partner of CMG 
(Hsueh et al., 2000).  However, when EAG is coexpressed with CMG and Tbr-1, the 
channel competes with Tbr-1 to recruit CMG to the plasma membrane (Marble et al., 
2005) (See Appendix, Fig A.3).  This piece of evidence, along with reciprocal 
coimmunoprecipitation results, demonstrates a functional association between EAG and 
CMG.  In vitro binding assays showed that Camguk binds to a novel SH3 domain (R1037-
K1040) on the EAG C-terminus (Fig A.5).  When this domain was mutated, EAG failed to 
successfully compete with Tbr-1 for CMG, resulting in a loss of CMG labeling at the 
membrane (Fig A.6).   
     In oocytes, coexpression of CMG and EAG results in increased current and whole-cell 
conductance (Marble et al., 2005).  This enhancement is accounted for by  an increase in 
EAG surface expression, because CMG increases the amount of biotinylated EAG in 
oocyte preparations (Fig A.2).  CMG coexpression also increases the phosphorylation of 
EAG at T787, the site that has been shown to be phosphorylated by CaMKII to enhance 
current (Wang et al., 2002c), and suggests that CMG promotes the interaction between 
EAG and CaMKII (Fig A.2).  These results imply that CMG may be able to regulate 
EAG signaling in two ways: by increasing EAG membrane expression, and by promoting 
interactions between CaMKII and EAG at the membrane.  Indeed, these roles may be 
dual aspects of the same function.  If CMG is normally associated with CaMKII, 
interactions between EAG and CMG would likely function to further stabilize the EAG-
CaMKII complex.  
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     In vitro, CMG has been shown to associate with and activate CaMKII in the presence 
of Ca2+/CaM (Lu et al., 2003).  Importantly, when Ca2+/CaM is removed, CMG promotes 
CaMKII inactivation via autophosphorylation of T306, releasing the kinase and 
preventing it from being reactivated by subsequent increases in Ca2+/CaM.  This provides 
a potential mechanism by which separate pools of CaMKII may be established in vivo.  If 
CMG promotes interactions between EAG and activated CaMKII during Ca2+ influx, it 
would create a membrane compartment local to EAG in which CaMKII remains active 
even when a decline in cytoplasmic Ca2+/CaM renders the cytoplasmic pool of CaMKII 
inactive.      
     The existence of a distinct pool of CaMKII at the membrane may be important for 
interpreting the intracellular mechanism of EAG signaling.  EAG mutants with shifted 
voltage-dependence that disrupt signaling have no effect on total cellular CaMKII 
activity in NIH 3T3 extracts, yet appear to enhance CaMKII activity that immunoprecip-
itates with biotinylated membrane proteins (Fig 3.2).  
     It would be interesting to test the effects of CMG on both EAG-mediated proliferation 
and the regulation of EAG-associated CaMKII activity in NIH 3T3 cells.  Coexpressed 
CMG would be expected to promote the association between EAG and CaMKII and 
increase the number of channel complexes present on the plasma membrane.  It is likely 
that the percentage of EAG channels associated with CaMKII would be increased in the 
presence of CMG, affecting the relative sizes of the membrane-associated and 
cytoplasmic pools of CaMKII.  In this case, CMG coexpression would potentially 
increase the effect of EAG signaling at the resting potential, resulting in a much greater 
overall decrease in CaMKII signaling, increased proliferation and p38 MAPK activity.  
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     The regulation of EAG surface expression by CMG may be much more relevant to 
EAG signaling in vivo.  By promoting an overall increase in the size of the membrane-
associated pool of EAG and CaMKII, CMG would maximize the effects of EAG 
signaling.  Because EAG expression is enriched at synaptic terminals (Sun et al., 2004), 
signaling may be important for regulating homeostatic mechanisms that maintain 
synaptic fidelity, as discussed below.   
 
B.3. Subcellular localization of EAG  
     The EAG C-terminus contains three putative nuclear localization signal (NLS) 
sequences (K663-K666, R698-K714, and K1035-R1040), as well as a leucine-rich region (L893-
L908) that may function as a nuclear export signal (NES).  If any of the localization 
signals are functional, proteolytic cleavage could result in the transport of EAG-
associated signals to the nucleus.  In addition, these sequences may influence EAG 
localization by counteracting normal channel trafficking to the membrane.  Indeed, 
Figure 3.1E shows that while mutation of NLS-1 does not affect overall EAG expression 
in NIH 3T3 extracts, the biotinylated fraction is substantially increased compared to wild 
type EAG.  Similar results were observed following mutation of NLS-2 (data not shown), 
suggesting that these NLS sequences negatively affect surface expression.  These 
mutations also produced a decrease in BrdU incorporation (Fig 3.1D), a result that seems 
counterintuitive vis-à-vis the model of EAG signaling at the membrane.  However, 
increased membrane localization of EAG may effectively “dilute” EAG signaling if 
CaMKII or other downstream targets are a limiting factor in these cells.  
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     Further experiments to investigate the function of the NLS and NES domains on EAG 
signaling should include a characterization of the effects of NLS1 and NLS2 mutants on 
NIH 3T3 proliferation, as well as on p38 MAPK and CaMKII regulation.  In addition, 
NLS3 and NES mutants as well as combinatory (NLS1/2, NLS2/NES, etc.) mutations, 
should be generated and analyzed.  Because NLS2 is the most well-characterized NLS in 
EAG (the only NLS identified by ProSite and other domain search engines), it is the most 
promising candidate for examining the effects of channel localization on EAG signaling.  
NLS mutations could also be combined with EAG-HTEE, EAG-TATSSA, EAG-HFA 
and EAG-TFA to determine to what extent surface expression affects the voltage-
dependence of CaMKII activation.   
     Alternatively, the effects of NLS-mediated localization on EAG signaling may be due 
to disruption of as yet unidentified signaling components in the cytoplasm or nucleus.  
EAG antibodies on Western blots reliably indicate a ~75kD fragment in addition to the 
~180kD full-length EAG band.  This band has normally been considered a degradation 
product of EAG but may actually be the product of alternatively spliced EAG mRNA, 
consisting of part of the N-terminus and most of the C-terminus, but lacking the 
transmembrane domains (Leslie Griffith lab observations, unpublished at the time of this 
writing).  Indeed, immunocytochemical staining of EAG at a C-terminal epitope in COS-
7 cells reveals some cytoplasmic, nonnuclear labeling in addition to surface expression 
(unpublished observations).  Although the function of this smaller EAG protein is 
currently unknown, it contains the CaMKII-, Ca2+/CaM-, and cyclic nucleotide-binding 
domains and may potentially be regulated by other proteins that interact with the NLS 
and NES sequences.  It will be crucial to understand the role of this pseudo-EAG protein 
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as a potential regulator of cytoplasmic CaMKII activity.  Because it lacks a voltage-
sensing domain, it would obviously not have the same modulating function as the full-
length channel, but if is able to bind and activate CaMKII in the absence of Ca2+/CaM, it 
may be important for maintaining CaMKII activity in the cytoplasm during periods of 
low [Ca2+]i.  This protein could be cloned and expressed independently of full-length 
EAG in NIH 3T3 cells to determine any potential contribution EAG signaling.  If a 
comparison to the full-length channel reveals that this protein has some effect on 
proliferation or p38 MAPK activation, domain mutations that disrupt signaling, such as 
EAG-LAKK, could be readily introduced to further characterize its function. 
   
C. PHYSIOLOGICAL SIGNIFICANCE OF EAG SIGNALING 
     What might be the role of EAG-mediated signaling in vivo?  In Drosophila larvae, 
EAG is present throughout the nervous system, including the brain and optic lobes, and is 
enriched in the axons and endplates of motor neurons that innervate the body wall muscle 
(Sun et al., 2004; Wang et al., 2002c).  In the larval ventral ganglion, EAG expression 
overlaps with that of synaptobrevin, a soluble NSF attachment receptor (SNARE) 
protein, suggesting that it normally functions presynaptically (Sun et al., 2004).  
Drosophila eag mutants display hyperexcitability at the NMJ, characterized by both a 
high degree of spontaneous action potential firing from the motor neuron and broadened 
EJPs in the body wall muscle fibers, implying a role for EAG in maintaining the resting 
membrane potential and repolarization of the action potentials of motor neurons 
(Ganetzky and Wu, 1985).   
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     The results presented in Figure 3.4 suggest that the spontaneous EJP phenotype of eag  
mutants may be due to a disruption of EAG signaling.  EAG-LAKK mutants cannot bind 
CaMKII, resulting in significantly decreased BrdU incorporation when expressed in NIH 
3T3 cells (Fig 3.1B,D). When EAG-LAKK is neuronally expressed in the Drosophila 
eagsc29 null mutant background, it rescues the EJC amplitude phenotype as well as wild 
type EAG (Fig 3.4A), implying that EAG-LAKK is expressed at levels sufficient to allow 
repolarization of the motor neuron action potential.  However, in contrast to wild type 
EAG, EAG-LAKK fails to rescue the increased frequency of spontaneous EJPs (Fig 
3.4B).  This result implies that the spontaneous activity observed in eag mutants is the 
result of disrupted EAG signaling, rather than a lack of EAG current.  In this section I 
discuss the possible functions of EAG signaling in vivo, and suggest future directions for 
EAG signaling research. 
 
C.1. Synaptic plasticity & homeostasis  
     Drosophila eag mutants exhibit impaired associative learning in courtship 
conditioning assays, a deficiency that is also observed in flies overexpressing ala, a 
peptide corresponding to the CaMKII autoinhibitory domain.  Because larvae expressing 
ala exhibit increases in EJP frequency similar to eag mutants, and ala/eag double 
mutants do not produce an additive effect, EAG and CaMKII are likely to be part of a 
common pathway mediating synaptic plasticity and homeostasis (Griffith et al., 1994).  
This idea is substantiated by experiments showing that the EAG-CaMKII interaction 
regulates electrical stability at the larval NMJ (Fig 3.4).  Together with the finding that 
EAG modulates CaMKII activity in a voltage-dependent manner, these results suggest an 
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important role for EAG/CaMKII signaling in mediating cellular responses to changes in 
excitability.  CaMKII has been well-established as a key component of synaptic plasticity 
and learning in Drosophila and mammals (Griffith et al., 1993; Silva et al., 1992a,b).  
Through the regulation of small GTPases such as Ras, CaMKII activity regulates MAPK 
pathways that activate nuclear transcription factors, such as the cAMP response element 
binding protein (CREB), that control the transcription of activity-dependent genes 
(Thomas and Huganir, 2004).  Specifically, Ras-mediated activation of p42/44 MAPK 
leads to AMPA receptor insertion during facilitation and long-term potentiation (LTP) 
(Bolshakov et al., 2000; Zhu et al., 2002), whereas p38 MAPK activation regulates 
synaptic depression and long-term depression (LTD) via removal of AMPA receptors 
(Guan et al., 2003; Thomas and Huganir, 2004; Zhu et al., 2002).  CaMKII activity also 
contributes to p38 MAPK inactivation through the regulation of ASK1 and SynGAP, as 
noted above (Krapivinsky et al., 2004; Takeda et al., 2004).  In NIH 3T3 cells, inhibitors 
of both p38 and p42/44 MAPKs inhibited proliferation in the presence of serum 
(unpublished observations), but only p38 MAPK was essential for serum-independent 
EAG (Fig 2.2C-E).  It is therefore not unreasonable to hypothesize that EAG/CaMKII 
signaling may influence plasticity pathways via the downstream activation of MAPKs 
that mediate potentiation, depression, and learning.   
      When considering the need for homeostatic regulation of excitability, while still 
allowing for some degree of plasticity, the EAG signaling mechanism gains further 
appeal.  EAG signaling would inherently include both a negative feedback loop to limit 
electrical excitability and a positive feedback loop on CaMKII that could “tag” the 
synapse with a marker for the degree of prior activity.  Specifically, because one known 
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target of CaMKII is EAG itself, and because phosphorylation increases the surface 
expression of the channel, excitability would be limited by an increase in the 
hyperpolarizing influence of EAG.  Concomitantly, the increase in EAG surface 
expression would lead to an increase in membrane associated CaMKII that could be 
“activated” by voltage even in response to depolarizations that remain subthreshold.  
CaMKII activity and downstream targets would be modulated by EAG conformation: at 
rest, predominantly closed channels would inhibit CaMKII, leading to increased p38 
MAPK activity and sustaining synaptic depression.  During subthreshold depolarization 
events, EAG channels would begin to activate, increasing CaMKII activity, thus 
stimulating a decrease in p38 MAPK and relieving synaptic depression, while potentially 
activating p42/44 potentiation pathways.  This would allow plasticity mechanisms 
mediated by CaMKII and MAPKs to directly respond to membrane potential fluctuations 
in the absence of action potential-triggered Ca2+ influxes.  In addition, this mechanism 
may help to maintain other intracellular Ca2+ pathways between action potentials.  
Maintaining an active pool of kinase near the membrane may be important for the resting 
functions at presynaptic terminals, such as neurotransmitter vesicle docking and priming, 
that occur between excitatory events.  A proposed model of EAG/CaMKII signaling 
based on the results of this thesis is presented in Figure 4.1. 
    Future research on the physiological role of EAG signaling should include in vivo 
experiments to address synaptic potentiation and depression at the larval NMJ.  Such 
experiments would make use of transgenic larvae expressing the various EAG signaling 
mutants in the eagsc29 null background, and comparing the degree of rescue to wild type 

























Figure 4.1: Model of EAG/CaMKII signaling.  Left, EAG stimulates p38 MAPK activity from the closed conformation.  In 
NIH 3T3 cells proliferation is induced, whereas in vivo the effect may be to depress excitability.  Right, When EAG is in the open 
conformation, membrane-associated CaMKII activity is increased and inhibits proliferation.  Because p38 MAPK activity is 
unchanged, CaMKII must act on either distinct local targets or targets downstream of p38 MAPK to cause inhibition.  Solid arrows 
indicate known pathways; dashed arrows indicate possible pathways that would account for our observations.  
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amplitude and duration following stimulation by a tetanizing stimulus.  Depression would 
be measured by recording EJCs during sustained low frequency stimulation.  EAG 
mutations that disrupt signaling, such as EAG-HFA and EAG-TFA, which increase 
CAMKII activity, would likely result in normal potentiation but remove depression, 
whereas channels that are “locked” into a closed conformation might be expected to  
cause permanent depression.  Biochemically, the effects of various signaling mutants on 
the in vivo phosphorylation of CaMKII, p38 MAPK and p42/44 MAPK could be assessed 
in immunoblot assays using extracts prepared from larvae or adult heads.  The role of 
EAG signaling on associative learning in flies could be examined using courtship 
conditioning assays of signaling transgenics, and again comparing the degree of rescue of 
learning defects to that of wild type EAG.   
 
C.2. Cell cycle & oncogenesis  
     Several lines of evidence implicate EAG in promoting tumor progression.  EAG 
mRNA has been found in many human somatic cancers, include breast carcinomas,  
cervical carcinomas, neuroblastomas (Pardo et al., 1999), melanomas (Meyer and 
Heinemann, 1998) and gliomas (Patt et al., 2004), despite being absent from the 
corresponding healthy tissues.  In addition, hEAG confers oncogenic properties such as 
increased proliferation, loss of contact inhibition and substrate independence when 
heterologously overexpressed in mammalian cell lines (Pardo et al., 1999).  HEAG-
expressing cells can also stimulate tumorogenesis when transplanted into immune-
suppressed mice.  As with other oncogenic K+ channels, these effects are typically 
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rationalized as an effect of K+ efflux leading to changes in membrane potential and cell 
volume loss (Pardo et al., 2005).   
     Could voltage-dependent CaMKII signaling explain the tumor-promoting effects of 
EAG?  p42/44 MAPKs not only have a well-established role in transcriptional activation 
in response to growth factors and other mitogenic signals (Chang and Karin, 2001; 
Treisman, 1996), but also directly stimulate DNA synthesis (Graves et al., 2000) and 
regulate some cell cycle checkpoint proteins (Palmer et al., 1998).  p38 MAPK has also 
been implicated in cell cycle progression (Ambrosino and Nebreda, 2001), and is 
important for the mitogen-stimulated proliferation of T-lymphocytes (Crawley et al., 
1997).  Indeed, dEAG signaling stimulates proliferation of transfected NIH 3T3 cells (Fig 
2.1).  However, overexpression of EAG in Drosophila does not appear to result in gross 
morphological defects (unpublished observations).  To more rigorously test whether EAG 
signaling has an in vivo role in proliferation, EAG could be specifically overexpressed in 
eye imaginal discs, a technique is widely used in Drosophila to study mechanisms of 
proliferation and differentiation, to identify a possible growth phenotype.  By comparing 
potential morphological phenotypes between wild type EAG,  EAG-LAKK and the 
signaling mutants EAG-HFA and EAG-TFA, it would be possible to establish a link 
between EAG signaling and growth.  Furthermore, the tumor-promoting effects of EAG 
signaling mutants could be compared by implanting transfected cells into immune-
suppressed mice and comparing tumor growth with wild type EAG.  If signaling 
regulates EAG oncogenesis, mutations that disrupt signaling would be expected to result 
in fewer or smaller tumors than those caused by wild type EAG. 
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     Finally, hERG is a channel closely related to EAG that shares many structural 
features, including the PAS and cyclic-nucleotide binding domains.  HERG is also found 
in variety of tumors (Cherubini et al., 2000; Lastraioli et al., 2004; Pillozzi et al., 2002), 
and manages to promote both tumor growth and apoptosis (Wang et al., 2002a).  The 
results presented in Figure 3.3 show that EAG signaling is conserved in mammalian EAG 
channels.  If signaling is conserved throughout the EAG superfamily, it may also explain 
the ability of hERG to regulate the cell cycle.  Future investigations could examine 
whether EAG signaling is conserved in hERG by using BrdU incorporation and 
biochemical assays of CaMKII and p38 MAPK activation.  Furthermore, any potential 
voltage dependence of hERG signaling could similarly be examined by extracellular 
application of KCl.  Any oncogenic potential of cells overexpressing signaling-deficient 
mutants could also be studied by implantation into immune-suppressed mice, as proposed 
above for EAG.   
 
C.3. Final conclusions 
     In summary, voltage-dependent EAG signaling is a novel mechanism by which 
changes in membrane potential are directly translated to the activity of intracellular 
messenger pathways.  EAG signaling is mediated via conformation-dependent regulation 
of bound CaMKII, leading to the downstream activation of p38 MAPK and stimulation of 
proliferation in NIH 3T3 fibroblasts.  Constitutive CaMKII activity appears to be 
attenuated when EAG occupies closed states, an effect that is relieved as channel 
conformation shifts during depolarization.  Remarkably, this voltage-driven ‘switch’ is 
independent of K+ flux, because mutations of the EAG selectivity filter to block 
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conductance do not prevent modulation of CaMKII, or the downstream effects of 
signaling.   
     EAG signaling is conserved in mammalian channels and may be the primary 
contribution of EAG at the synapse, because EAG channels that do not bind CaMKII 
cannot rescue spontaneous activity at the neuromuscular junction of Drosophila eag 
mutants.  In vivo, the partitioning of CaMKII into membrane and cytoplasmic 
compartments by the scaffolding protein Camguk may allow the EAG-bound pool of 
kinase to remain active during periods of low [Ca2+]i, when cytoplasmic CaMKII activity 
is at a minimum.  Membrane associated CaMKII activity would thus be modulated 
directly in response to local subthreshold fluctuations of the membrane potential, a 
possibility that has important implications for synaptic plasticity, stability and 
neurotransmitter release.   
     In conclusion, the voltage-dependent signaling mechanism presented in this thesis is 
highly unusual for an ion channel, and suggests that the physical coupling of membrane 
potential to biochemical events may be an important, previously overlooked component 
of cellular physiology.  It is hoped that these studies will stimulate new ways of thinking 
about the functions of voltage-gated ion channels, help to refine current models of 
intracellular signaling, and lead to a better understanding of the roles of EAG and other 





CAMGUK/CASK ENHANCES ETHER À GO-GO  





     Signaling complexes are essential for the modulation of excitability within restricted 
neuronal compartments.  Adaptor proteins are the scaffold around which signaling 
complexes are organized.  Here, we demonstrate that the Camguk (CMG)/CASK adaptor 
protein functionally modulates Drosophila Ether à go-go (EAG) potassium channels.  
Coexpression of CMG with EAG in Xenopus oocytes results in a more than twofold 
average increase in EAG whole cell conductance.  This effect depends on EAG-T787, the 
residue phosphorylated by calcium/calmodulin-dependent protein kinase II (Wang et al., 
2002c).  CMG coimmunoprecipitates with wild type and EAG-T787A channels, 
indicating that T787, although necessary for the effect of CMG on EAG current, is not 
required for the formation of the EAG-CMG complex.  Both CMG and phosphorylation 
of T787 increase the surface expression of EAG channels, and in COS-7 cells, EAG 
recruits CMG to the plasma membrane.  The interaction of EAG with CMG requires a 
noncanonical Src homology 3-binding site beginning at position R1037 of the EAG 
sequence.  Mutation of basic residues, but not neighboring prolines, prevents binding and 
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prevents the increase in EAG conductance.  Our findings demonstrate that membrane-
associated guanylate kinase adaptor proteins can modulate ion channel function; in the 
case of CMG, this occurs via an increase in the surface expression and phosphorylation 
of the EAG channel.  
 
B. INTRODUCTION 
     Ether à go-go (EAG), the Drosophila ortholog of KCNH1, is the founding member of 
a family of potassium (K+) channels identified by the presence of domains with 
homology to the PAS (Per, Arnt, Sim) and cyclic nucleotide binding domains of other 
proteins (Drysdale et al., 1991; Guy et al., 1991; Morais Cabral et al., 1998; Warmke et 
al., 1991).  eag larvae exhibit spontaneous action potentials in the motor nerve and 
excitatory junctional potentials in muscle that are broadened compared to those of wild 
type larvae (Ganetzky and Wu, 1985).  EAG is present in the axons and terminals 
innervating the larval body-wall musculature (Wang et al., 2002c) and is localized with 
synaptobrevin in the central nervous system (Sun et al., 2004). 
     In addition to hyperexcitability at the neuromuscular junction, eag mutants also 
exhibit defects in associative learning (Griffith et al., 1994).  Intriguingly, there is 
substantial similarity in the electrophysiological and learning phenotypes of eag mutants 
and transgenic Drosophila expressing an inhibitory peptide of calcium and calmodulin 
(Ca2+/CaM)-dependent protein kinase II (CaMKII)  (Griffith et al., 1994), and 
phosphorylation of EAG by CaMKII results in a dramatic increase in current (Wang et 
al., 2002c).  Recent work has demonstrated that Drosophila CaMKII interacts with the 
Camguk (CMG) adaptor protein (Lu et al., 2003).  CMG is a member of the membrane-
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associated guanylate kinase (MAGUK) family of adaptor proteins and the Drosophila 
ortholog of CASK and Lin-2 (Butz et al., 1998; Dimitratos et al., 1997; Hata et al., 1996; 
Hoskins et al., 1996).  CMG/CASK/Lin-2 is unique in that the N-terminus (NT) displays 
considerable homology to CaMKII.  The kinase domain of CMG, although appearing 
nonfunctional as a kinase, associates with CaMKII in an ATP- and Ca2+/CaM-dependent 
fashion (Lu et al., 2003).  Once Ca2+ levels decline, CMG downregulates cellular 
CaMKII activity by releasing the kinase in a form that must be dephosphorylated before 
it can be activated by subsequent increases in Ca2+.  
     Given the regulation of EAG function by CaMKII, we sought to determine whether 
CMG also associates with EAG.  Intriguingly, the interaction of CMG with EAG 
promoted an increase in whole cell conductance and alterations in inactivation kinetics 
that were reminiscent of the changes in current observed as a consequence of 
phosphorylation by CaMKII.  Indeed, mutation of EAG-T787, the site phosphorylated by 
CaMKII, prevented the effects of CMG without affecting immunoprecipitation of the 
complex.  Moreover, CMG increased EAG surface expression, whereas mutation of T787 
decreased EAG surface expression, indicating that CMG and phosphorylation affect 
channel function by the same mechanism.  One possible model that could account for 
these findings is that CMG may locally increase kinase efficiency by ensuring that only 








C.1. CMG modulates EAG current 
     To determine whether the CMG adaptor protein might regulate EAG function, we 
examined EAG channels expressed in Xenopus oocytes either alone or together with an 
excess of CMG.  Figure A.1, A and B, shows examples of EAG current traces and 
average current-voltage relations obtained from a representative batch of oocytes.  In 
response to test pulses to +60 mV (holding potential, -80 mV), co-expression with CMG 
resulted in peak currents that were increased 2.7-fold over control values (Fig A.1B).  
CMG produced increases in current in 19 of 21 batches of oocytes examined.  The 
increase averaged 2.3-fold above EAG controls and was significant (p < 0.0001) when 
tested using a two-way ANOVA with oocyte batch and CMG as variables.  When CMG 
was coexpressed with Shaker, another Drosophila potassium channel, no increase in 
Shaker current was observed (data not shown).  The average peak Shaker currents in 
response to test pulses to +60 mV (holding potential, -100 mV) were 12.5 ± 0.6 μA (n = 
8) and 10.7 ± 0.8 µA (n = 10) in the absence and presence of CMG, respectively.  
     The primary effect of CMG was on EAG current amplitudes.  Analysis of the voltage-
dependence of EAG currents in an extracellular solution containing 25 mM KCl to 
enhance tail currents revealed little change in either the slope or midpoint of activation 
when EAG was coexpressed with CMG (Fig A.1C).  Scaled representative traces for the 
two conditions are shown in Figure A.1D, top.  Examination of activation and 
inactivation kinetics revealed only a modest increase in the inactivation time constant and 





Figure A.1: CMG increases EAG current and conductance.   
(A) Coexpression with CMG increases EAG current amplitudes in Xenopus oocytes.  
Macroscopic currents recorded in two electrode voltage clamp from representative 
oocytes in response to depolarizing voltage steps from -100 to 80 mV in 20 mV 
increments (holding potential, -80 mV).  Linear leakage and capacitative components 
have been subtracted.  Calibration bars apply to both sets of traces.  (B-G) Dark symbols 
and bars represent measurements obtained in the presence of CMG.  (B) Comparison of 
the average current-voltage relationships obtained for one batch of oocytes (batch refers 
to oocytes obtained from the same frog) injected with RNA encoding eag (n = 7) or eag 
together with an excess of cmg (n = 10) as indicated.  Currents were elicited by a series of 
voltage steps from -100 to 80 mV (holding potential, -80 mV).  Leak subtraction was 
performed using a P/4 protocol with pulses of opposite polarity preceding each test pulse 
(holding potential, -80 mV).  (C) Normalized conductance-voltage (GV) relations for 
wild type EAG channels, alone (n = 9) or in the presence of CMG (n = 16).  For each 
oocyte, conductance was determined using the relation G = Itail / (Vtail - EK) and 
normalized to the maximum conductance.  Measurements were made in an extracellular 
solution containing 25 mM KCl to enhance tail currents.  EK was experimentally 
determined for each oocyte. Boltzmann functions fit to the averaged data had a midpoint 
and slope of -12.2 mV and 10.3 for EAG, and a midpoint and slope of -13.6 mV and 9.2 
for EAG in the presence of CMG.  (D) Top, Scaled representative traces obtained for 
EAG alone (Ipeak = 3.0 μA) or together with CMG (Ipeak = 4.8 μA).  Currents were elicited 
by a 400 ms pulse to 40 mV from a holding potential of -80 mV.  Bottom, Kinetics of 
EAG currents in the absence and presence of CMG.  Three batches of oocytes with a 
mean fold increase in current amplitude that approximated the mean for all oocytes were 
selected for kinetic analysis.  For each oocyte, activation (left) and inactivation (middle) 
taus were obtained by fitting two exponentials plus a constant to the first 200 ms of the 
response to a 400 ms test pulse to 40 mV (holding potential, -80 mV).  The percentage of 
inactivation (inact) was determined by dividing the mean current obtained during the 
final 10 ms of the pulse by the peak current observed during the pulse.  N = 26 and 28 for 
EAG and EAG with CMG, respectively.  The effect of CMG was analyzed using a two 
way ANOVA with oocyte batch and CMG as variables (* p < 0.05; *** p < 0.001; N.S., 
not significant).  (E) CMG fails to affect EAG-T787A.  Experiments performed as in (b).  
n = 9 and 9 in the absence or presence of CMG, respectively.  (F) GV relations for EAG 
channels expressed alone or together with CMG.  Currents shown in (b) were converted 
to conductance using the relation G = Itest / (Vtest – EK).  EK  was assumed to be -80 mV.  
(G) CMG increases the average whole cell conductance in oocytes expressing the wild 
type, but not mutant, channel.  Fold increase in the whole cell conductance for the 
oocytes described in (d) and three batches of oocytes expressing EAG-T787A alone or 
with CMG.  Conductances were determined as described in (f) in response to a test pulse 
to 60 mV (holding potential, -80 mV).  To normalize for variation in channel expression 
across different batches of oocytes, the mean conductance in the presence of CMG was 
normalized to the mean conductance obtained for that batch of oocytes expressing EAG 
or EAG-T787A alone.  The number of oocytes examined for each condition is indicated 
above each bar.  The effect of CMG was statistically analyzed as described in (d).  Error 
















decrease in inactivation was observed even when comparing oocytes with similar current 
amplitudes, suggesting that the effect on kinetics was not caused by a decreased 
efficiency of the voltage clamp for larger currents. 
     Many adaptor proteins affect the function of associated proteins by colocalizing the 
proteins with other modulators.  Previous work has shown that EAG is phosphorylated by 
CaMKII activity endogenous to the oocytes even at basal Ca2+ levels (Wang et al., 
2002c).  Both the increase in current amplitude and the changes in inactivation in the 
presence of CMG are reminiscent of the changes in current observed as a consequence of 
phosphorylation.  Because CaMKII has been shown to associate with CMG in the 
presence of ATP and Ca2+/CaM (Lu et al., 2003), we sought to determine whether the 
effect of CMG on EAG currents could be mediated by phosphorylation.  As shown in 
Figure A.1E, the effect of CMG was dependent on EAG-T787, the residue previously 
shown to be phosphorylated by CaMKII in vitro and in vivo.  When threonine at position 
787 was replaced by alanine (EAG-T787A), CMG failed to increase current or affect 
inactivation.  
     The increase in current observed for wild type channels in the presence of CMG is 
most likely a result of an increase in the number of active channels given the lack of an 
appreciable change in either voltage-dependence or kinetics.  Figure A.1F displays the 
change in EAG activity in terms of the whole cell conductance for the batch of oocytes 
examined in Figure A.1B.  Figure A.1G summarizes and compares the effect of CMG on 
the whole cell conductance of oocytes expressing EAG and EAG-T787A for three 
representative oocyte batches.  If changes in open probability or single channel 
conductance do not contribute to the effect of CMG on EAG current, the average increase 
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in conductance suggests a more than twofold increase in the number of functional 
channels at the plasma membrane. 
 
C.2. EAG and CMG co-immunoprecipitate from oocyte extracts 
     When oocyte extracts were probed with EAG (CT) antisera (Fig A.2A, top blot, left 
three lanes), two protein bands were clearly identified.  The primary EAG band ranged 
between 180 and 200 kDa depending on the protein markers used (Fig A.2A, top, lanes 2 
& 3).  The second, lower molecular weight, band was also reliably observed and is most 
likely an alternate modification of the protein or a degradation product.  Both bands were 
absent in Western blots of extracts prepared from uninjected oocytes (Fig A.2A, top, lane 
1).  Immunoprecipitation reactions indicated that, in oocytes, EAG and CMG are part of 
the same protein complex.  Immunoprecipitations using anti-CMG, but not preimmune, 
sera coprecipitated the EAG protein (Fig A.2A, top, lanes 3-4).  The reverse 
immunoprecipitation reaction is shown in the bottom blot (right three lanes).  
Immunoprecipitations using anti-EAG (NT), but not preimmune, sera coprecipitated 
CMG, which was observed as a single band near the predicted molecular weight of 103 
kDa. 
 
C.3. CMG and phosphorylation regulate EAG surface expression 
     One possible explanation of the failure of CMG to enhance EAG-T787A currents in 
our electrophysiological experiments is that phosphorylation of T787 may be required for 
the association of CMG with EAG.  As shown in Figure A.2A (top and bottom, lanes 6 












Figure A.2: CMG associates with EAG and increases EAG surface expression and 
phosphorylation.  (A) Coimmunoprecipitation of EAG and CMG from Xenopus oocyte 
extracts.  Lanes 1-3 show oocyte extracts for comparison; lane 4, immunoprecipitation 
with pre-immune sera; lanes 5-6, immunoprecipitation with indicated antibody.  CMG 
associates with both wild type and EAG-T787A channels.  Top (lanes 5-6), immuno-
precipitation with CMG antisera.  Bottom (lanes 5-6), reverse immunoprecipitation with 
EAG (NT) antisera.  Similar results were observed in five experiments.  Respective loads 
were 5, 10 and 20 μl for extracts, immunoprecipitated and coimmunoprecipitated 
proteins, respectively (see Materials and Methods).  (B) CMG and phosphorylation of 
EAG-T787 both increase EAG surface expression.  Top, Oocytes were labeled with 
biotin for 30 min and then quenched with glycine as described in Materials and Methods 
before preparation of oocyte extracts.  For each condition, 600 μl of extract obtained from 
50 oocytes was used for immunoprecipitation with EAG (NT) antisera.  Proteins were 
separated by SDS-PAGE, transferred to PVDF membranes, blotted with the indicated 
antisera, and processed with ECL.  Gels were run in parallel with equal amounts of the 
precipitates.  Bottom, streptavidin-labeled bands were quantified by densitometry and 
normalized to the intensity of the EAG band in each experiment; data are presented as the 
mean ± SEM; n = 3 (* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.005).  (C) CMG increases 
phosphorylation of EAG-T787.  Top, EAG was immunoprecipitated from oocyte extracts 
with EAG (NT) antisera.  Gels were run in parallel, proteins transferred to PVDF 
membranes, which were then probed with either EAG (CT) antisera (top) or antibody 
recognizing EAG phosphorylated at T787 (bottom) (Wang et al., 2002c).  Bottom, EAG 
labeled by phospho-specific antibody.  Bands were quantified by densitometry and 
normalized to the EAG(CT)-labeled band and the corresponding region of the uninjected 
oocyte lane for each experiment; data are presented as the mean ± SEM; n = 3; p values 














complex when EAG-T787A was expressed instead of the wild type channel, indicating 
that phosphorylation is not a prerequisite for formation of the complex.  Either 
phosphorylation is required for CMG to exert an effect on EAG currents or, alternatively,  
the increase in current observed in the presence of CMG is the result of an increase in the 
efficiency of phosphorylation.   
     To begin to distinguish between these alternatives, we further investigated the 
mechanism underlying the effect of CMG on EAG current.  Oocytes were surface labeled 
with biotin and, after biotin treatment, EAG was isolated by immunoprecipitation with 
EAG (NT) antisera (Fig A.2B, top blot).  As shown in Figure A.2B (bottom blot) for a 
parallel blot of the immunoprecipitate probed with streptavidin, only the lower EAG band 
was detectably biotinylated.  More importantly, compared with EAG channels expressed 
alone, there was a clear increase in the biotinylation of EAG when CMG was 
coexpressed (bottom blot, lanes 2 and 3).  Finally, biotinylated EAG was lowest when 
expressing EAG-T787A (compare lanes 2 and 4).  Semiquantitative comparisons of band 
intensities normalized to the intensity observed for wild type EAG indicated that the 
increases in biotinylation of EAG observed as a consequence of CMG and 
phosphorylation of EAG-T787 were significant (Fig A.2B, bottom).  The average 
increase in biotinylation observed for EAG in the presence of CMG was comparable with 
the increase in whole-cell conductance observed in oocyte recordings (Fig A.1G).  In 
addition, the decrease in biotinylation observed for EAG-T787A when compared with 
wild type EAG closely approximated the previously reported decrease in current 
observed when oocytes are injected with approximately equal concentrations of RNA 
(Wang et al., 2002c).  A similar difference is observed in the experiments of Figure A.1 
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(compare the current levels in B and E).  These results suggest that CMG and 
phosphorylation of EAG-T787 increase EAG current by the same mechanism, namely by 
increasing the number of EAG channels in the plasma membrane. 
 
C.4. CMG increases phosphorylation of EAG-T787 
     To determine whether the increase in current observed in the presence of CMG is the 
result of an increase in the efficiency of phosphorylation of EAG-T787, we immuno-
precipitated EAG from oocyte extracts and probed the precipitate with an EAG antibody 
that specifically recognizes EAG phosphorylated at T787 (Wang et al., 2002c).  As 
shown in Figure A.2C (left), whereas there was no detectable difference in the overall 
level of EAG as a function of CMG (top), phosphorylation of T787 was increased when 
CMG was coexpressed (bottom).  Comparisons of the level of phosphorylation averaged 
across multiple experiments (Fig A.2C, right) indicated that the change in 
phosphorylation was significant.  In summary, the enhancement of EAG current observed 
in the presence of CMG appears, at least in part, to be caused by an increase in the 
phosphorylation of T787.  It remains unclear, however, whether phosphorylation is the 
sole mechanism underlying the increase in conductance and surface expression of EAG 
given the difference in the magnitudes of the effects.  One possible explanation of this 
difference is that phosphorylation of EAG is more likely for channels in the membrane.  
Differences in the solubility of cytoplasmic versus membrane-associated channels may 
obscure differences in phosphorylation.  Alternatively, the association with CMG and 




C.5. EAG recruits CMG to the plasma membrane in COS-7 cells 
     Additional indication of a functionally relevant interaction between EAG and CMG 
was obtained in COS-7 cells.  Our ability to examine colocalization of EAG and CMG, as 
well as changes in the surface expression of EAG, was hampered by the fact that the 
primary epitope used by the only antibody, α-EAG(CT), that recognizes EAG in 
immunocytochemical experiments appears to be occluded when CMG is bound; in 
separate experiments α-EAG(CT) was the only anti-EAG antibody examined that failed 
to coprecipitate CMG from oocyte extracts (Marble and Wilson, unpublished 
observations).  Although we were unable to examine changes in the localization of EAG, 
experiments in COS-7 cells suggested that the EAG-CMG complex may play a role in 
localizing CMG, in addition to its role in the modulation of EAG current.  Changes in the 
localization of CMG as a function of coexpression with EAG were assessed using 
another binding partner, Tbr-1, a T-box transcription factor known to associate with the 
mammalian CMG homolog CASK (Hsueh et al., 2000).  As shown in Figure A.3A, little 
or no background labeling was observed when cells were mock-transfected with empty 
vector (left top panel).  CMG expressed alone (right top panel) was localized to the 
cytoplasm and displayed a pattern consistent with a distribution to the endoplasmic 
reticulum as has been observed in the case of CASK (Hsueh et al., 2000).  Also 
consistent with previous experiments, cotransfection with Tbr-1 shifted CMG into the 
nucleus (right middle panel).  Most importantly, when EAG was coexpressed with CMG 
and Tbr-1, EAG successfully recruited a significant fraction of the CMG protein away 
from the nucleus to the cytoplasm and the plasma membrane (indicated by the arrows in 












Figure A.3: EAG-dependent translocation of CMG to the plasma membrane of 
COS-7 cells.  COS-7 cells were transiently transfected with 0.4 μg of each of the cDNAs 
indicated below each panel.  (A) The subcellular distribution of CMG as a function of co-
expressed proteins was assessed by indirect immunofluorescence using antisera directed 
against CMG, followed by rhodamine-conjugated anti-guinea pig IgG.  The left top panel 
shows the relative absence of CMG staining when cells were transfected with the empty 
pCDNA3 vector.  The distribution of CMG shifts from the cytoplasm (right top panel) to 
the nucleus (left middle panel) when Tbr-1 is coexpressed as has previously been 
reported for the CMG homolog CASK (Hsueh et al., 2000).  As shown in the bottom left 
panel, EAG competes with Tbr-1 to recruit a fraction of CMG to the plasma membrane, 
whereas Shaker fails to shift CMG from the nucleus.  GW-CMV-Tbr-1 was a gift from 
M. Sheng (Massachusetts Institute of Technology, Cambridge, MA).  Images were 
background subtracted for display using NIH Image software.  Dashed boxes indicate the 
magnified areas displayed in the insets.  Arrows within insets point to areas exhibiting 
particularly robust membrane staining.  Scale bar, 10 μm.  (B) Representative line scans 
of fluorescence intensity for key panels in (a).  In each case, the scanned segment is the 
area between the two arrowheads.  Intensity measurements were normalized to the 
highest intensity point of each image.  (C) Averaged, normalized line scan data from 
three separate experiments examining the distribution of CMG to the cytoplasm, nucleus, 
and membrane for three expression conditions: CMG (C), CMG and Tbr-1 (CT), and 
CMG,  Tbr-1, and EAG (CTE).  Note that the bottom left panel of (a) was excluded from 
the analysis, given our inability to distinguish between the nucleus and cytoplasm.  One-
way ANOVA comparisons of fluorescence intensity are between C versus CT, and CT 
versus CTE conditions (* p < 0.05; ** p < 0.01; *** p < 0.001; N.S., not significant).  














another MAGUK-interacting protein (Kim et al., 1995), failed to compete with Tbr-1 to  
alter CMG localization (bottom right panel).  Finally, plasma membrane localization of 
CMG was also observed in the presence of EAG alone (indicated by the arrows in the 
inset in the left middle panel).  Differences in CMG localization as a function of co-
expression with Tbr-1 and EAG were quantified using line scans of fluorescence intensity 
normalized to the maximum fluorescence observed in each image examined.  Figure 
A.3B shows representative line scans, taken across the segments indicated by the 
arrowheads, for the panels shown in Figure A.3A.  Figure A.3C displays line scan data 
for the cytoplasm, nucleus, and membrane averaged across three separate experiments.  
In each case, EAG produced a significant change in the localization of CMG when 
compared with the localization of CMG in the presence of Tbr-1 (see also Fig A.6E). 
 
C.6. EAG and CMG co-immunoprecipitate from Drosophila extracts 
     Immunoprecipitation reactions using protein extracts from wandering third-instar 
larvae indicated that EAG and CMG associate in vivo.  In the experiment of Figure A.4, 
CMG was immunoprecipitated and the precipitates separated by SDS-PAGE.  Blotting 
with CMG antisera identified a single band near the molecular weight predicted for 
CMG, 103 kDa (Fig A.4A), for immunoprecipitates from extracts of both wild type and 
eag null mutants (eagsc29).  More importantly, as shown in Figure A.4B, EAG was 
observed in both extracts (left panel) and CMG immunoprecipitates (right panel) from 
wild type larvae, but was absent in eagsc29 larvae.  As observed for oocytes, the primary 
EAG band was higher than the molecular weight predicted for EAG, but this band was 










Figure A.4: Native EAG and CMG coimmunoprecipitate from Drosophila extracts.  
Protein extracts were prepared from the nervous system, imaginal discs, and body muscle 
fibers of third instar larvae.  CMG antisera were used to immunopreciptate CMG and 
associating proteins from extracts prepared from the indicated genotypes.  Precipitated 
proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and then probed with 
either CMG (A) or EAG (NT) antisera (B, right), followed by HRP-conjugated anti-
guinea pig or anti-rabbit IgG, respectively.  For comparison, input extract probed with 
EAG (NT) antisera is shown in the left panel of (b).  Respective loads were 5, 10, and 20 
μl for extracts, immunoprecipitated and coimmunoprecipitated proteins, respectively (see 
Materials and Methods).  Similar results were obtained in five experiments.  Bands were 









shown).  The EAG-CMG complex also could be observed in immunoprecipitation 
reactions using membrane fractions prepared from adult fly heads (data not shown).  In 
addition, reciprocal co-immunoprecipitation of CMG using α-EAG(NT) antisera was 
possible, but only when CMG was overexpressed using the Gal4-UAS system coupled 
with the neuron-specific C155-elav driver; this is presumably because of an observed 
decrease in EAG precipitation efficiency when using α-EAG(NT) versus α-EAG(CT) 
antisera (data not shown).  These results suggest that EAG and CMG are part of a protein 
complex in vivo; however, neither these results nor our electrophysiological experiments 
in oocytes address whether the interaction between EAG and CMG is direct.  
  
C.7. In vitro binding assays identify a direct interaction between EAG and CMG      
A direct association of EAG and CMG was suggested by in vitro binding assays (Fig 
A.5).  In these assays, GST-tagged CMG or CMG domains were immobilized on 
glutathione sepharose beads and the ability to “pull-down” 6H-tagged EAG fragments 
assessed in Western blots using antibody directed against the MRSG-6H tag.  The EAG  
and CMG fragments used to map the respective EAG- and CMG-binding sites are shown 
in Figure A.5, A and B, together with a rating of their relative binding.  As shown in 
Figure A.5C for the EAG fragment 6H-EAG869-1107, nearly all of the EAG available 
associated with GST-CMG (compare lanes 1 and 3).  There was minimal background 
binding to the bead-immobilized GST tag, indicating that the association of EAG with 









Figure A.5: A direct interaction between EAG and CMG adaptor protein in in vitro 
binding assays.  (A) Schematic representation and respective binding for the EAG 
protein constructs used in mapping experiments.  For comparison, full length EAG is 
shown at the top with the primary domains as indicated, including the six putative 
transmembrane domains, pore (P), and the region with homology to cyclic nucleotide 
binding domains (CNBD).  The amino acid residues contained in each EAG construct are 
noted by the subscripted numbers on the left and the relative binding of each construct to 
full length CMG is indicated on the right.  Note that the EAG C-terminal cytoplasmic 
domain contains six SH3 binding motifs as defined by the PxxP consensus sequence.  
The locations of these potential binding sites are indicated by asterisks.  (B) Schematic 
representation and respective binding for the CMG constructs used in mapping 
experiments as described for (a).  Binding to 6H-EAG869-1107 is shown in C-F.  This 
fragment was chosen for display because there was minimal degradation during 
purification.  (C) 6H-EAG869-1107 binding to full length CMG and CMG domains.  GST-
tagged CMG fragments immobilized on glutathione Sepharose beads were assayed for 
their ability to pull-down 6H-EAG869-1107 as described in Materials and Methods.  Top, 
western blot probed with MRGS-6H antibody to detect interacting EAG fragments.  
Bottom, bound 6H-EAG869-1107 quantified by densitometry; data are presented as the 
mean ± SEM; n = 3.  (D) 6H-EAG869-1107 binding to GST-SH3 domain fusion proteins.  
Top, the ability of purified GST-SH3 domains, derived from the proteins indicated above 
each lane, to pull-down 6H-EAG869-1107 was in immunoblots by comparing the relative 
amount of associating 6H-EAG869-1107 to the amount available during the interaction 
experiment (left lane).  As shown in lanes 2 and 3, there was little or no background 
binding to either glutathione Sepharose or immobilized GST tag.  Bottom, bound 6H-
EAG869-1107 quantified by densitometry; data are presented as the mean ± SEM; n = 3.  
(E) Dose-response curves comparing the binding of CMG and the CMG SH3 domains to 
6H-EAG869-1107.  Wells were coated overnight with 6H-EAG869-1107, washed, and then 
incubated with the indicated concentrations of GST fusion protein.  Bound protein was 
detected using anti-GST antibody, followed by alkaline phosphatase-conjugated 
secondary antibody and treatment with p-nitrophenylphosphate.  Binding was determined 
by colorimetric reaction at 405 nm.  Each concentration was assayed in quadruplicate.  
Data are presented as the mean ± SEM; n = 4.  O.D., Optical Density.  (F) Effect of salt 
concentration on the 6H-EAG869-1107-CMG complex.  Experiments examining the binding 
to GST-CMG were performed as described in Materials and Methods, with the exception 
that PBS buffer was modified to include the indicated NaCl concentrations.  Complex 
formation was relatively unaffected in up to 1000 mM salt.  Bottom, bound 6H-EAG869-














     EAG C-terminal fragments associating with full length CMG associated most robustly 
with the SH3 and guanylate kinase (GUK) domains of CMG (Fig A.5C).  Although 
interactions with the GST-tagged CaMKII-like and PDZ [postsynaptic density-95 (PSD-
95)/ DLG/zona-occludens-1] domains of CMG were also observed, the SH3 and GUK  
domains came closest to approximating the binding observed to the full length CMG 
protein.  Recent structural studies have suggested that the SH3 domain of PSD-95, 
another MAGUK protein, requires the GUK domain for proper orientation of the SH3 
domain-binding pocket (McGee et al., 2001).  However, in our experiments, there was no 
additional increase in the association of EAG when using a larger CMG fragment 
including both the SH3 and GUK domains (Fig A.5B, GST-CMG584-898). 
     Additional experiments further characterized the interaction of EAG with CMG in 
regard to its specificity, affinity and mechanism.  Figure A.5D shows in vitro pull-down 
assays examining the binding of 6H-EAG869-1107 to a selection of SH3 domains fusion 
proteins immobilized on glutathione Sepharose beads.  The association of EAG with the 
CMG SH3 domain was specific because there was minimal binding to the SH3 domains 
of src and the human DLG ortholog (Fig A.5D).  Although EAG also bound to the SH3 
domain of DLG, coexpression of EAG with DLG in oocytes failed to produce an increase 
in current (data not shown).  In ELISAs (Fig A.5E), full length CMG bound 6H-EAG869-
1107 with a Kd of 1-2 nM, whereas the CMG SH3 domain displayed a Kd of ~ 20 nM.  
Thus, interactions with other domains of CMG likely contribute to the affinity of the 
interaction.  Finally, as shown in Figure A.5F, the interaction between EAG and CMG 
was resistant to increases in salt concentration.  Binding to CMG only decreased when 
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the salt concentration was increased to above 1 M, suggesting that binding is not solely 
mediated by electrostatic interactions. 
 
C.8. Mapping the EAG interaction site identifies a noncanonical SH3 binding motif   
     Additional in vitro binding experiments were performed with the aim of mapping the 
primary interaction site in EAG.  The C-terminal cytoplasmic domain of EAG contains 
six putative SH3 domain binding sites, as identified by the presence of a PxxP consensus 
sequence (Sparks et al., 1998).  Indeed, as indicated on the right of Figure A.5A, any 
EAG C-terminal fragment that contained the fourth putative SH3 binding motif directly 
associated with GST-tagged CMG.  To determine whether this region was sufficient for 
the interaction, 38 amino acids spanning spanning the fourth SH3 motif (residues 1032 – 
1070) were attached to a DHFR tag.  Because DHFR-EAG1032 – 1070  associated with CMG 
(Fig A.5A), the fourth SH3 motif appears necessary and sufficient for the interaction. 
     Two strategies were employed to definitively establish the fourth SH3 binding motif 
as the site of the interaction with CMG.  First, a peptide containing the fourth PxxP motif 
together with additional flanking amino acids (EAG1039-1054) was synthesized, cross-
linked to beads, and then examined for its ability to pull-down CMG SH3 domain that 
had been cleaved from the GST tag using thrombin.  No association was observed even 
though a 16 amino acid peptide that has been used to investigate the specificity of 
binding to the Src SH3 domain (src peptide) (Sparks et al., 1998) associated with the Src 
SH3 domain under the same experimental conditions (data not shown).  Second, 
rationalizing that the peptide may not have contained a sufficient number of flanking 
amino acids, we generated a point mutation in the first proline of the fourth SH3 binding 
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motif in the 6H-EAG869 – 1107 fragment (P1045A).  Little or no decrease in the association 
of this fragment with full length CMG was observed (Fig A.6B, compare lanes 1 and 4).       
     Recent work has established that some SH3 domains interact with a noncanonical 
binding motif characterized by an RxxK consensus sequence (Harkiolaki et al., 2003; Liu 
et al., 2003).  As shown in Figure A.6A, this sequence also is present in EAG just four 
amino acids upstream of the fourth PxxP motif.  Indeed, binding to CMG was 
substantially reduced when leucine was substituted for arginine at residue 1037 (Fig 
A.6B, lane 2, R1037L869 – 1107).  Binding to the SH3 domain was eliminated when the 
other basic residue in this motif, lysine at position 1040, was replaced by methionine (Fig 
A.6B, lane 3, K1040M). 
     To determine whether the above mutations were sufficient to disrupt the effect of 
CMG on EAG current, we returned to the oocyte expression system.  As shown in Figure 
A.6C, which compares scaled representative traces for wild type and EAG-R1037L/ 
K1040M channels, channel function was largely unaffected by mutations in the SH3 
domain binding site.  Figure A.6D shows the result of coexpressing CMG with either 
wild type EAG, EAG-R1037L, EAG-K1040M, or the double mutant, EAG-
R1037L/K1040M.  As observed in our earlier experiments, CMG produced a more than 
twofold increase in the whole-cell conductance of wild type channels.  The CMG-
mediated increase was drastically reduced for EAG-R1037L and eliminated in EAG-
K1040M and the double mutant.  Finally, the SH3 binding motif also was required for the 
effect of EAG on CMG localization in COS-7 cells.  As shown in Figure 6E, although 
wild type EAG produced the same changes in CMG localization observed in the 









Figure A.6: A noncanonical SH3 binding motif in EAG mediates the EAG-CMG 
interaction.  (A) Comparison of the amino acid sequence surrounding the fourth putative 
SH3-binding motif to the amino acid sequence of the noncanonical SH3-binding site in 
SLP-76, the Src homology 2 (SH2) domain containing a leukocyte protein of 76 kDa.  
Note that both proteins also contain prolines in the nearby sequence.  (B) In vitro binding 
assays comparing the association of 6H-EAG869-1107 and mutant EAG fragments 
(R1037L, K1040M, and R1037L/K1040M EAG) to GST-CMG, as indicated.  Top, 
immunoblotting with MRGS-6H antibody to detect interacting EAG fragments.  Middle 
and Bottom, Coomassie-stained gels showing the relative amounts of GST-CMG and 
EAG fragments present in each interaction experiment.  (C) Scaled representative traces 
obtained for wild type and EAG-R1037L/K1049M channels.  Currents were elicited by a 
400 ms test pulse to +40 mV from a holding potential of -80 mV.  Peak current 
amplitudes were 2.2 and 5.0 μA for EAG and EAG-R1037L/K1040M, respectively.  (D) 
Mutations in the EAG binding site inhibit the effect of CMG on EAG conductance.  Fold-
increase in the whole-cell conductance as a function of CMG coexpression for oocytes 
expressing wild type, R1037L, K1040M, and R1037L/K1040M EAG channels.  
Conductances were determined as described in Figure 1G in response to a test pulse to 60 
mV (holding potential, -80 mV).  To normalize for normal variations in expression across 
different batches of oocytes, the mean conductance in the presence of CMG was 
normalized to the mean conductance obtained for oocytes expressing only EAG or the 
indicated EAG mutants.  The SE and number of oocytes examined for each condition is 
indicated above each bar.  The effect of CMG was statistically analyzed using a two way 
ANOVA with oocyte batch and CMG as variables (*** p < 0.001; N.S., not significant).  
WT, Wild type. (E) Disruption of the CMG binding site also disrupts the ability to 
compete with Tbr-1 and recruit CMG out of the nucleus of COS-7 cells.  Top, 
Background subtracted images for three expression conditions: CMG and Tbr-1 (CT), 
CMG,  Tbr-1, and EAG (CTE), and CMG,  Tbr-1, and EAG-RL/KM (CTR).  
Arrowheads indicate the segments used for the line scans presented in the middle panels.  
Scale bar, 10 μm.  Middle, Representative line scans obtained as described in Figure 3C.   
Bottom, Averaged, normalized line scan data from three separate experiments examining 
the distribution of CMG to the cytoplasm, nucleus and membrane for the three expression 
conditions.  One-way ANOVA comparisons of fluorescence intensity between CT versus 
CTE and CTE versus CTR conditions were significant (*** p < 0.001).  In contrast, there 







with Tbr-1 (CTR-labeled panels).  When statistically analyzed using a one-way ANOVA, 
there was no significant difference in the distribution of CMG to the membrane, 
cytoplasm, or nucleus when comparing averaged line scan data for the CMG and Tbr-1 
(CT) and CMG, Tbr-1, and EAG-R1037L/K1040M (CTR) conditions.  Together, these 
results indicate that a direct interaction between EAG and CMG is required for the effect 
EAG on the localization of CMG, as well as the effect of CMG on EAG current. 
  
D. DISCUSSION  
     Our findings indicate that EAG is functionally regulated by an association with the 
CMG adaptor protein.  The primary effect of CMG is to increase EAG current and 
whole-cell conductance, and this increase depends on a direct association between 
proteins, because mutations of the CMG binding motif in EAG prevent the effect.  In 
addition, EAG successfully competes with another CMG/CASK-interacting protein to 
alter the localization of CMG.  Thus, another distinct function of the EAG-CMG complex 
may be to localize CMG to the plasma membrane. 
     The mechanism primarily responsible for the increase in current appears to be an 
increase in the surface expression of EAG.  Intriguingly, effects opposite those produced 
by CMG, namely decreased EAG current, decreased surface expression of EAG, and 
decreased inactivation, are observed when phosphorylation of EAG-T787 is prevented 
either by mutation of the phosphorylation site or by inhibition of CaMKII (Wang et al., 
2002c).  These findings suggest that the effect of CMG is produced by an increase in the 
phosphorylation of EAG-T787.  In agreement, CMG increased the phosphorylation of 
EAG-T787, and mutation of this site prevented the CMG-mediated increase in EAG 
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current without disrupting formation of the EAG-CMG complex.  These results suggest 
that the mechanism underlying the effect of CMG is indirect and point to a change in the 
localization or activity of either a kinase or phosphatase in the vicinity of the channel.  In 
addition, however, the possibility that CMG also directly affects the surface expression of 
phosphorylated EAG has not been ruled out.  Direct and indirect effects of CMG may 
additively affect the membrane association of EAG channels. 
     At present, the enzyme most likely responsible for mediating the effect of CMG is 
CaMKII.  EAG-T787 has previously been shown to be phosphorylated by CaMKII, 
inhibition of CaMKII has been shown to decrease EAG current, and CaMKII directly 
associates with CMG (Lu et al., 2003; Wang et al., 2002c).  However, it is not known 
whether other kinases such as protein kinase A can also phosphorylate T787, nor has the 
phosphatase responsible for dephosphorylating T787 been identified.  Our results do not 
rule out the possibility that CMG may change the localization, activity or efficiency of 
another kinase or a protein phosphatase.  Nonetheless, given that CMG interacts with 
CaMKII (Lu et al., 2003) and given that no interaction between CMG (or its orthologs) 
and other kinases or phosphatases has been identified, the most likely model accounting 
for the CMG effect on EAG is one in which a common association with CMG colocalizes 
EAG with CaMKII and increases the efficiency of phosphorylation.  
     Intriguingly, after decreases in Ca2+, the association with CMG promotes 
phosphorylation of T306 of CaMKII, rendering the kinase inactive and then releasing it 
(Lu et al., 2003).  CaMKII cannot be activated by subsequent increases in Ca2+ as long as 
phosphorylation of T306 persists.  The creation of a pool of inactive kinase predicts that 
CMG should have produced a decrease in EAG current, rather than the observed increase 
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at basal Ca2+ levels.  These observations can be reconciled, however, if the cytoplasm and 
the local membrane are considered as separate compartments.  Because CMG only 
associates with active kinase, CMG, in addition to globally increasing the pool of inactive 
kinase, may ensure that only active kinase is in the vicinity of the channel.  Alternatively, 
EAG may directly or indirectly change the effect of CMG on CaMKII.  Assuming that 
the majority of EAG is normally localized at the membrane, either alternative would 
result in an increase in active kinase at the membrane versus the cytoplasm.  The stability 
of the CMG/CaMKII complex may also be regulated by the activity history of the 
synapse.  Ca2+ influx can cause T287 phosphorylation, which, in addition to making the 
kinase activity Ca2+-independent, can decrease the off-rate of CaM by four orders of 
magnitude (Putkey and Waxham, 1996).  CaMKII with “trapped” CaM would be 
resistant to deactivation by CMG even at low intracellular Ca2+.  EAG that was localized 
at a synapse that had been previously active then would be expected to be susceptible to 
CMG regulation. 
     The common association of CMG with EAG and CaMKII suggests that CMG acts as 
the central scaffold for the complex.  However, EAG also directly associates with 
activated CaMKII (Sun et al., 2004), suggesting that EAG and CMG play equally 
important roles.  The association between EAG and CaMKII constitutively activates the 
kinase and CaMKII remains associated with EAG even once Ca2+ returns to resting levels 
(Sun et al., 2004).  Thus, the presence of EAG in the complex may alter the net effect of 
CMG on CaMKII activity.  Finally, although phosphorylation of EAG-T787 is likely to 
occur via the constitutively active kinase, this constitutive activity is considerably lower 
than that of the fully activated kinase (Sun et al., 2004).  Indeed, in our experiments, the 
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association with CMG further increased EAG currents and phosphorylation of the 
channel above and beyond the levels achieved by the CaMKII endogenous to oocytes.  
CMG may localize and then transfer CaMKII to EAG, or CaMKII holoenzyme, which 
has 12 subunits, may be able to bind to both EAG and CMG simultaneously.  In addition, 
CMG may increase the number of CaMKII molecules in the vicinity of the channel, and 
interlocking all three proteins may further stabilize an EAG-CMG-CaMKII complex. 
     The clearest demonstration of the physiological importance of CMG/CASK/LIN-2, to 
date, has been obtained in Caenorhabditis elegans, in which a complex of proteins 
including LIN-2, LIN-7 and LIN-10 localizes the receptor tyrosine kinase LET-23 to the 
basolateral surface of vulval precursor cells.  The absence of LIN-2, LIN-7 or LIN-10 
results in mislocalization of LET-23 receptors, causing a vulvaless phenotype (Kaech et 
al., 1998).  The LIN-2--LIN-7--LIN-10 complex appears evolutionarily conserved 
because a similar complex, consisting of CASK, Velis and the munc18-1 interacting 
protein Mint1, homologs of LIN-2, LIN-7 and LIN-10, respectively, has been observed in 
the mammalian central nervous system (Butz et al., 1998).  These authors suggest that 
CASK is a scaffold for proteins involved in synaptic vesicle exocytosis and cell adhesion.  
The presynaptic complex may include not only Velis and Mint1, but also N-type Ca2+ 
channels and neurexins (Hata et al., 1996; Maximov et al., 1999).  When combined with 
the previously demonstrated presynaptic localization of EAG, CMG and CaMKII (Lu et 
al., 2003; Sun et al., 2004; Wang et al., 2002c), our findings provide additional support 





E. MATERIALS AND METHODS 
E.1. Plasmids and construction  
     For protein purification, plasmids containing DNA fragments spanning the indicated 
amino acids were generated by PCR using primers containing restriction sites and bases 
to maintain reading frame during subcloning.  Glutathione S-transferase (GST) and 
6Histidine (6H) fusion constructs were generated using the pGEX-4T1 or pGEX-KG 
vectors (Amersham Biosciences, Piscataway NJ) (Guan and Dixon, 1991) or the pQE30 
vector series (Qiagen, Valencia CA), respectively.  Where indicated, sequence encoding 
dihydrofolate reductase (DHFR) was subcloned into the pQE-eag construct to aid in the 
purification and identification of the small EAG fragment.  PQE32-eag869 – 1107 was a gift 
from B. Ganetzky (University of Wisconsin, Madision, WI).  With the exception of the 
SH3 domains of CMG and Drosophila discs large (DLG), GST-SH3 domain fusion 
proteins were a gift from Brian Kay (Argonne National Laboratory, Argonne IL).  Site-
directed mutagenesis was performed using the PCR-based QuikChange mutagenesis kit 
(Stratagene, La Jolla CA).  
     For expression of EAG mutant constructs in Xenopus oocytes, Sph I and Nae I sites 
flanking the EAG SH3 domain binding site were used to subclone single site mutations 
from pQE-eag constructs into pGH19-eag  (Wilson et al., 1998).  A Kozak sequence was 
added to pGEX-cmg using PCR, and cmg, together with the Kozak sequence, was 
shuttled into pBluescript-KSM (a gift from W. Joiner and L.K. Kaczmarek, Yale 
University, New Haven, CT), which had been modified to contain the untranslated 
regions of the Xenopus β-globin gene and a more flexible cloning site. All constructs 
were verified by sequencing. 
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E.2. Protein purification 
     GST-fusion proteins were purified according to manufacturer protocols (Amersham 
Biosciences).  BL21 cells were freshly transformed with the construct of interest.  Large-
scale (1 L) cultures were grown in Luria Broth (LB) with ampicillin for 6 hrs and then 
induced for 6-12 hrs with isopropyl-β-D-thiogalactopyranoside.  Bacteria were harvested 
by centrifugation, lysed, and cellular protein solubilized in buffer containing 150 mM 
NaCl, 20 mM Tris (pH 7.4) and 1% Triton X-100 in the presence of protease inhibitors 
(0.5 mM phenylmethanesulfonyl fluoride and 0.004 mg/ml each of aprotonin, pepstatin 
A, and leupeptin).  In some cases GST-CMG was purified by incubation with 0.8 % N-
lauroylsarcosine prior to solubilization and then neutralized with twice the concentration 
of Triton X-100.  This increased the yield of CMG protein without affecting binding 
activity.  Protein suspensions were centrifuged to remove insoluble material, and the 
supernatant incubated for 60-90 min with Glutathione-Sepharose 4B beads (Amersham 
Biosciences).  Bead-immobilized proteins were extensively washed with 150 mM NaCl, 
20 mM Tris (pH 7.4) and stored as a 50% slurry at 4 °C until use.  6H fusion proteins 
were purified similarly using nickel-nitrilotriacetic acid beads (Qiagen, Valencia CA) and 
a solubilization buffer containing 500 mM NaCl, 20 mM Hepes (pH 7.8) and 1% Triton 
X-100 in the presence of protease inhibitors.  6H fusion proteins were fractionally eluted 
from beads using successively increasing concentrations of imidazole ranging from 8 to 
400 mM.  Eluted fractions were checked for the presence of the desired protein using 
SDS-PAGE, and fractions containing the protein were pooled and dialyzed overnight in 
PBS (consisting of the following, in mM: 136 NaCl, 2.7 KCl, 10 Na2HPO4, 1.8 KH2PO4, 
pH 7.4).  Dialyzed protein was stored at 4°C or frozen at -20°C prior to use. Protein 
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concentrations were determined by comparison to known concentrations of bovine serum 
albumin (BSA). 
 
E.3. Peptides and antibodies  
     Peptides used for binding studies and immunization were synthesized by Open 
Biosystems (Huntsville, AL).  An N-terminal peptide corresponding to amino acids 161- 
179 of the EAG sequence and a purified C-terminal (CT) fragment (6H-EAG1034-1174) 
were used for immunization of rabbits according to standard procedures (Open 
Biosystems).  Sera were screened against the antigens in ELISAs and in Western blots of 
purified N- or C-terminal EAG fragments as appropriate.  Purified GST-CMG152-897 was 
used for the immunization of guinea pigs as previously described (Dimitratos et al., 
1997).  Phosphospecific anti-EAG antibody was a gift from Leslie Griffith (Brandeis 
University, Waltham, MA). 
 
E.4. In vitro binding assays 
     GST fusion proteins immobilized on Sepharose beads were mixed with 6H fusion 
proteins in PBS containing 0.5% Triton X-100 and protease inhibitors (EDTA-free 
Complete tablets; F. Hoffmann-LaRoche, Basel, Switzerland) and incubated with shaking 
for 2-3 hrs at 4 °C.  Except where indicated otherwise, the protein concentrations used 
were 1-2 and 0.5-1 μM, respectively, in 100 μl buffer containing a constant 10 μl bead 
bed volume.  The beads were collected by centrifugation and then washed three times 
with PBS containing 0.1% Triton X-100, followed by three washes with 50 mM Tris, pH 
8.0, 140 mM NaCl, 0.1% Triton X-100, and a final wash with 50 mM Tris, pH 8.0.  The 
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pellets, including beads and associated proteins, were resuspended in sample buffer and 
analyzed by SDS-PAGE and Western blotting.  Blots were probed with MRGS-6H 
antibody (Qiagen) followed by horseradish peroxidase (HRP)-conjugated anti-mouse 
secondary and then visualized with ECL (Amersham Biosciences).  
 
E.5. ELISAs  
     ELISAs were performed as described previously (Garcia et al., 1998; Muller et al., 
1996) with minor modifications.  GST-CMG fusion proteins were eluted from 
glutathione Sepharose according to manufacturer protocols (Amersham Biosciences).  
6H-EAG869-1107, at a concentration of 0.16 μg/ml in BBS (125 mM borate, 75 mM NaCl 
pH 8.5), was bound to the wells of Costar (Cambridge, MA) 96-well assay plates by 
overnight incubation (4°C).  Plates were then washed extensively with BBS and blocked 
with BBS containing 1% bovine serum albumin (BBS-BSA) prior to addition of serially 
diluted CMG protein at the indicated concentrations (50 μl/well).  Each concentration 
was assayed in quadruplicate.  After overnight incubation (4°C), plates were washed four 
times and then incubated with anti-GST antibody (1:1000 in BBS-BSA).  Plates were 
washed again and incubated with alkaline phosphatase-conjugated anti-rabbit IgG 
(1:1000 in BBS-BSA).  After a final set of washes, binding to 6H-EAG869-1107 was 
determined by treating wells with FAST p-Nitrophenylphosphate (Sigma-Aldrich, St. 







     COS-7 cells were maintained at a subconfluent density at 37°C and 5% CO2 in 
DMEM supplemented with 10% fetal bovine serum (FBS).  Twenty-four hours before 
transfection, cells were plated and grown to 80% confluence on 12 mm poly-L-lysine 
coated glass coverslips (Becton-Dickinson, Franklin Lakes NJ).  For transient 
transfection, each coverslip was washed twice with Opti-MEM (Invitrogen, Carlsbad CA) 
and incubated for 10 hrs in 350 μl Opti-MEM containing 0.4 μg of each of the indicated 
cDNAs and 1.5 μl LipofectAMINE reagent (Invitrogen, Carlsbad CA), followed by 
incubation in 1 ml of DMEM with 10% FBS for 12 hrs.  Coverslips were washed with 
PBS and fixed with a 3:7 mixture of 50 mM glycine (pH 2.0) and absolute ethanol for 1 
hr at room temperature (RT).  After washing three times, cells were permeabilized with 
0.1% Triton-X 100 in PBS for 20 min (RT) and blocked for 30 min in a blocking buffer 
consisting of 10 % horse serum and 0.1% BSA in distilled deionized water.  Cells were 
then incubated with a 1:500 dilution of CMG antisera in blocking buffer for 1 hr at RT, 
washed with PBS, and incubated with a cyanine 2- or rhodamine-conjugated secondary 
antibody (Jackson ImmunoResearch, West Grove, PA) for 30 min at 37 °C.  Coverslips 
were mounted on glass slides with Gelmount medium (Biomeda, Foster City, CA).  
Results were viewed with a Zeiss (Oberkochen, Germany) LSM 510 confocal 
microscope, and images were prepared for publication with Adobe Photoshop (version 







     Body-wall muscle fibers and CNS tissue from third-instar larvae of the indicated 
genotypes were homogenized in radioimmunoprecipitation assay buffer (150 mM NaCl, 
50 mM Tris pH 8.0, 0.1% SDS, 1% IGEPAL CA-630, 0.5% sodium deoxycholate) 
containing Complete protease inhibitor on ice and solubilized for 20 min.  Cellular debris 
was removed by centrifugation (3000 x g, 5 min, 4 oC).   
     Fly head tissue was obtained from 15 ml of adult flies frozen in liquid nitrogen.  
Heads were collected by sieving and homogenized in ice cold HM buffer (1 mM EDTA, 
5 mM HEPES, pH 7.4, and Complete protease inhibitor).  Cell debris was removed by 
centrifugation, and supernatant was further centrifuged to separate membranes (15000 x 
g, 15 min).  The heavy membrane pellet was solubilized in ice-cold buffer (HM buffer 
plus 100 mM NaCl and 1 % Triton X-100) for 20 min and supernatant was precleared 
with protein-A/G agarose beads (Santa Cruz Biotechnology, Santa Cruz CA).   
     For immunoprecipitations from Xenopus oocytes, 30 oocytes for each condition were 
homogenized in 1.5 ml 100 mM NaCl, 1 mM DTT, 0.5% Triton X-100, 20 mM Tris pH 
7.4 and Complete protease inhibitor, and then solubilized on ice for 15 min.  Homogenate 
was centrifuged 20000 x g, 4 oC, for 10 min and the supernatant collected.   
     Protein concentrations of homogenates were determined using Bradford assay (Bio-
Rad, Hercules CA) and equilibrated across conditions by diluting homogenates to a 
concentration of 2 mg/ml.  A volume of 600 μl of diluted extract was used for each 
immunoprecipitation reaction.  CMG and EAG (NT) antisera were added to protein 
samples and incubated for 16 hrs at 4 oC.  Immunocomplexes were precipitated with 
protein-A/G beads for 2 hrs at 4 oC and then washed 3 times in solubilization buffer and 
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boiled for 10 min in sample loading buffer (250 mM Tris pH 6.8, 12.5% glycerol, 
0.125% bromophenol blue, 1% SDS, 3% β-mercaptoethanol).  After addition of sample 
buffer, 5, 10, and 20 μl were loaded in each lane for extracts, immunoprecipitated and co-
immunoprecipitated proteins, respectively. 
     Immunoprecipitations and cellular extracts were resolved via SDS-PAGE (8% 
acrylamide, 250 mM Tris pH 6.8, 2.5% SDS) and transferred to polyvinylidene difluoride 
(PVDF) membrane for Western blotting.  Blots were blocked (5% dry milk in TBS) and 
washed, probed with either CMG or EAG (CT) sera (1:1000 and 1:2000, respectively) 
followed by HRP-conjugated secondary antibody (1:2000) and visualized by ECL 
(Amersham Biosciences). 
     For experiments biotinylating surface membrane proteins, oocytes were washed in 
cold PBS then incubated for 30 min in 2 mM Sulfo-NHS-LC-Biotin (Pierce, Rockford, 
IL) in PBS.  The labeling reaction was quenched with 3 washes of 100 mM glycine in 
PBS.  Fifty oocytes were homogenized in 1 ml of Buffer H (100 mM NaCl, 0.5% Triton 
X-100, 20 mM Tris, pH 7.4) supplemented with Complete protease inhibitor, 1 mM 
orthovanadate, 1 mM benzamidine, 1% phosphatase inhibitor cocktail 1 (Sigma), 2 μM 
microcystin LR and 5 mM 2-glycerol-phosphate. 
     Volume intensities of protein bands were quantified using Quantity One software 
(Bio-Rad).  Experimental values (n ≥ 3) were corrected for background by subtracting 
values obtained for uninjected lanes, and then were normalized to the value obtained for 





E.8. Electrophysiology   
     For expression in Xenopus oocytes, plasmids were linearized and RNA transcribed 
using the appropriate RNA polymerase according to manufacturer instructions (Message 
Machine; Ambion, Austin TX).  RNA concentrations were quantified with spectro-
photometric readings using an average reading for three or four dilutions of RNA.  
     The follicular membrane of stage V-VI oocytes was removed by incubation in Ca2+-
free OR2 solution (containing the following, in mM: 82.5 NaCl, 2.5 KCl, 1 MgCl2, 5 
Hepes, pH to 7.6 with NaOH) containing collagenase (2 mg/ml; Type 1A Sigma) for ~2 h 
at RT with gentle agitation.  Oocytes were injected with premixed stocks of eag and cmg 
RNA.  Individual oocytes were injected with 0.1-0.2 ng eag RNA and an excess of cmg 
RNA.  In some oocyte batches (oocytes from the same frog), the capacity of oocytes to 
translate the eag constructs was verified by performing parallel injections of a larger 
volume of the same RNA mix and observing a linear increase in EAG current amplitude.  
After RNA injections, oocytes were maintained in L-15 media (containing the following: 
50% L-15, 15 mM Hepes, 50 mg/ml gentamycin, and 5 mg/ml BSA, pH to 7.4  with 
NaOH) at 18 oC for 3-5 days.  Recordings were performed using a Turbo TEC-10C 
amplifier (NPI Electronics, Tamm, Germany) and pCLAMP8 software (Molecular 
Devices, Union City, CA).  The extracellular recording solution contained the following 
(in mM): 140 NaCl, 2 KCl, 1 MgCl2, 10 Hepes, pH 7.1 with NaOH.  Pipettes were filled 
with 2 M KCl and had resistances of 0.3 - 0.6 MΩ. Experiments were performed at RT.  
     Amplitude measurements refer to the peak currents observed during test pulses to the 
indicated voltages.  Activation and inactivation time constants were determined by fitting 
traces (excluding capacitative transients) with two exponentials and a steady state.  
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Unless otherwise noted, measurements were statistically compared using a two-way 













































Abdul, M., and Hoosein, N. (2002a). Expression and activity of potassium ion channels 
in human prostate cancer. Cancer Lett 186, 99-105. 
Abdul, M., and Hoosein, N. (2002b). Voltage-gated sodium ion channels in prostate 
cancer: expression and activity. Anticancer Res 22, 1727-1730. 
Abdul, M., Santo, A., and Hoosein, N. (2003). Activity of potassium channel-blockers in 
breast cancer. Anticancer Res 23, 3347-3351. 
Accili, E. A., Proenza, C., Baruscotti, M., and DiFrancesco, D. (2002). From funny 
current to HCN channels: 20 years of excitation. News Physiol Sci 17, 32-37. 
Allen, D. H., Lepple-Wienhues, A., and Cahalan, M. D. (1997). Ion channel phenotype of 
melanoma cell lines. J Membr Biol 155, 27-34. 
Ambrosino, C., and Nebreda, A. R. (2001). Cell cycle regulation by p38 MAP kinases. 
Biol Cell 93, 47-51. 
Amigorena, S., Choquet, D., Teillaud, J. L., Korn, H., and Fridman, W. H. (1990). Ion 
channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell 
cycle. Possible involvement of K+ channels. J Immunol 144, 2038-2045. 
An, W. F., Bowlby, M. R., Betty, M., Cao, J., Ling, H. P., Mendoza, G., Hinson, J. W., 
Mattsson, K. I., Strassle, B. W., Trimmer, J. S., and Rhodes, K. J. (2000). Modulation of 
A-type potassium channels by a family of calcium sensors. Nature 403, 553-556. 
Arcangeli, A., Bianchi, L., Becchetti, A., Faravelli, L., Coronnello, M., Mini, E., 
Olivotto, M., and Wanke, E. (1995). A novel inward-rectifying K+ current with a cell-
cycle dependence governs the resting potential of mammalian neuroblastoma cells. J 
Physiol 489 ( Pt 2), 455-471. 
Artym, V. V., and Petty, H. R. (2002). Molecular proximity of Kv1.3 voltage-gated 
potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: 
effects of cell adherence and channel blockers. J Gen Physiol 120, 29-37. 
Ayali, A., and Harris-Warrick, R. M. (1999). Monoamine control of the pacemaker 
kernel and cycle frequency in the lobster pyloric network. J Neurosci 19, 6712-6722. 
 184
 
Bauer, C. K., and Schwarz, J. R. (2001). Physiology of EAG K+ channels. J Membr Biol 
182, 1-15. 
Beaumont, V., Zhong, N., Froemke, R. C., Ball, R. W., and Zucker, R. S. (2002). 
Temporal synaptic tagging by I(h) activation and actin: involvement in long-term 
facilitation and cAMP-induced synaptic enhancement. Neuron 33, 601-613. 
Beaumont, V., and Zucker, R. S. (2000). Enhancement of synaptic transmission by cyclic 
AMP modulation of presynaptic Ih channels. Nat Neurosci 3, 133-141. 
Berchtold, M. W., Brinkmeier, H., and Muntener, M. (2000). Calcium ion in skeletal 
muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80, 1215-
1265. 
Bernal, J., and Ehrlich, B. E. (1993). Guanine nucleotides modulate calcium currents in a 
marine Paramecium. J Exp Biol 176, 117-133. 
Bernstein, J. (1902). Untersuchungen zur Thermodynamik der bioelektrischen Strome. 
Erster Theil. Pflugers Arch 92, 521-562. 
Bhunia, A. K., Piontek, K., Boletta, A., Liu, L., Qian, F., Xu, P. N., Germino, F. J., and 
Germino, G. G. (2002). PKD1 induces p21(waf1) and regulation of the cell cycle via 
direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 
109, 157-168. 
Bianchi, L., Kwok, S. M., Driscoll, M., and Sesti, F. (2003). A potassium channel-MiRP 
complex controls neurosensory function in Caenorhabditis elegans. J Biol Chem 278, 
12415-12424. 
Bianchi, L., Wible, B., Arcangeli, A., Taglialatela, M., Morra, F., Castaldo, P., Crociani, 
O., Rosati, B., Faravelli, L., Olivotto, M., and Wanke, E. (1998). herg encodes a K+ 
current highly conserved in tumors of different histogenesis: a selective advantage for 
cancer cells? Cancer Res 58, 815-822. 
Bildl, W., Strassmaier, T., Thurm, H., Andersen, J., Eble, S., Oliver, D., Knipper, M., 
Mann, M., Schulte, U., Adelman, J. P., and Fakler, B. (2004). Protein kinase CK2 is 
coassembled with small conductance Ca(2+)-activated K+ channels and regulates 
channel gating. Neuron 43, 847-858. 
Bolshakov, V. Y., Carboni, L., Cobb, M. H., Siegelbaum, S. A., and Belardetti, F. (2000). 
Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 
synapses. Nat Neurosci 3, 1107-1112. 
Bortner, C. D., Hughes, F. M., Jr., and Cidlowski, J. A. (1997). A primary role for K+ 
and Na+ efflux in the activation of apoptosis. J Biol Chem 272, 32436-32442. 
 185
 
Brackenbury, W. J., and Djamgoz, M. B. (2006). Activity-dependent regulation of 
voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol 
573, 343-356. 
Braun, A. P., and Schulman, H. (1995). The multifunctional calcium/calmodulin-
dependent protein kinase: from form to function. Annu Rev Physiol 57, 417-445. 
Bruggemann, A., Stuhmer, W., and Pardo, L. A. (1997). Mitosis-promoting factor-
mediated suppression of a cloned delayed rectifier potassium channel expressed in 
Xenopus oocytes. Proc Natl Acad Sci U S A 94, 537-542. 
Butz, S., Okamoto, M., and Sudhof, T. C. (1998). A tripartite protein complex with the 
potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell 94, 773-782. 
Buxbaum, J. D. (2004). A role for calsenilin and related proteins in multiple aspects of 
neuronal function. Biochem Biophys Res Commun 322, 1140-1144. 
Buxbaum, J. D., Choi, E. K., Luo, Y., Lilliehook, C., Crowley, A. C., Merriam, D. E., 
and Wasco, W. (1998). Calsenilin: a calcium-binding protein that interacts with the 
presenilins and regulates the levels of a presenilin fragment. Nat Med 4, 1177-1181. 
Cahalan, M. D., Wulff, H., and Chandy, K. G. (2001). Molecular properties and 
physiological roles of ion channels in the immune system. J Clin Immunol 21, 235-252. 
Cai, S. Q., Hernandez, L., Wang, Y., Park, K. H., and Sesti, F. (2005). MPS-1 is a K+ 
channel beta-subunit and a serine/threonine kinase. Nat Neurosci 8, 1503-1509. 
Camacho, J., Sanchez, A., Stuhmer, W., and Pardo, L. A. (2000). Cytoskeletal 
interactions determine the electrophysiological properties of human EAG potassium 
channels. Pflugers Arch 441, 167-174. 
Carrion, A. M., Link, W. A., Ledo, F., Mellstrom, B., and Naranjo, J. R. (1999). DREAM 
is a Ca2+-regulated transcriptional repressor. Nature 398, 80-84. 
Catterall, W. A. (2000). Structure and regulation of voltage-gated Ca2+ channels. Annu 
Rev Cell Dev Biol 16, 521-555. 
Cayabyab, F. S., and Schlichter, L. C. (2002). Regulation of an ERG K+ current by Src 
tyrosine kinase. J Biol Chem 277, 13673-13681. 
Chandy, G. K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., and Cahalan, M. 
D. (2004). K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci 
25, 280-289. 
Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., McLaughlin, C., and Gupta, S. (1984). 
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp 
Med 160, 369-385. 
 186
 
Chang, L., and Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature 
410, 37-40. 
Chauvet, V., Tian, X., Husson, H., Grimm, D. H., Wang, T., Hiesberger, T., Igarashi, P., 
Bennett, A. M., Ibraghimov-Beskrovnaya, O., Somlo, S., and Caplan, M. J. (2004). 
Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C 
terminus. J Clin Invest 114, 1433-1443. 
Chen, C., Corbley, M. J., Roberts, T. M., and Hess, P. (1988). Voltage-sensitive calcium 
channels in normal and transformed 3T3 fibroblasts. Science 239, 1024-1026. 
Cheng, H. Y., Pitcher, G. M., Laviolette, S. R., Whishaw, I. Q., Tong, K. I., Kockeritz, L. 
K., Wada, T., Joza, N. A., Crackower, M., Goncalves, J., et al. (2002). DREAM is a 
critical transcriptional repressor for pain modulation. Cell 108, 31-43. 
Cherubini, A., Taddei, G. L., Crociani, O., Paglierani, M., Buccoliero, A. M., Fontana, 
L., Noci, I., Borri, P., Borrani, E., Giachi, M., et al. (2000). HERG potassium channels 
are more frequently expressed in human endometrial cancer as compared to non-
cancerous endometrium. Br J Cancer 83, 1722-1729. 
Chouinard, S. W., Wilson, G. F., Schlimgen, A. K., and Ganetzky, B. (1995). A 
potassium channel beta subunit related to the aldo-keto reductase superfamily is encoded 
by the Drosophila hyperkinetic locus. Proc Natl Acad Sci U S A 92, 6763-6767. 
Chung, S. K., Reinhart, P. H., Martin, B. L., Brautigan, D., and Levitan, I. B. (1991). 
Protein kinase activity closely associated with a reconstituted calcium-activated 
potassium channel. Science 253, 560-562. 
Cohen, B. E., Pralle, A., Yao, X., Swaminath, G., Gandhi, C. S., Jan, Y. N., Kobilka, B. 
K., Isacoff, E. Y., and Jan, L. Y. (2005). A fluorescent probe designed for studying 
protein conformational change. Proc Natl Acad Sci U S A 102, 965-970. 
Cole, K. S., and Curtis, H. J. (1939). Electrical impedance of the squid giant axon during 
activity. J Gen Physiol 22, 37-64. 
Cole, K. S., and Moore, J. W. (1960). Potassium ion current in the squid giant axon: 
dynamic characteristic. Biophys J 1, 1-14. 
Cosens, D. J., and Manning, A. (1969). Abnormal electroretinogram from a Drosophila 
mutant. Nature 224, 285-287. 
Crawley, J. B., Rawlinson, L., Lali, F. V., Page, T. H., Saklatvala, J., and Foxwell, B. M. 
(1997). T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase 
activation. J Biol Chem 272, 15023-15027. 
Crews, S. T., and Fan, C. M. (1999). Remembrance of things PAS: regulation of 
development by bHLH-PAS proteins. Curr Opin Genet Dev 9, 580-587. 
 187
 
Crociani, O., Guasti, L., Balzi, M., Becchetti, A., Wanke, E., Olivotto, M., Wymore, R. 
S., and Arcangeli, A. (2003). Cell cycle-dependent expression of HERG1 and HERG1B 
isoforms in tumor cells. J Biol Chem 278, 2947-2955. 
Cuello, L. G., Cortes, D. M., and Perozo, E. (2004). Molecular architecture of the KvAP 
voltage-dependent K+ channel in a lipid bilayer. Science 306, 491-495. 
Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., and Keating, 
M. T. (1995). A molecular basis for cardiac arrhythmia: HERG mutations cause long QT 
syndrome. Cell 80, 795-803. 
Curtis, H. J., and Cole, K. S. (1942). Membrane resting and action potentials from the 
squid giant axon. J Cell Comp Physiol 19, 135-144. 
Davis, T. H., Chen, C., and Isom, L. L. (2004). Sodium channel beta1 subunits promote 
neurite outgrowth in cerebellar granule neurons. J Biol Chem 279, 51424-51432. 
DeCoursey, T. E., Chandy, K. G., Gupta, S., and Cahalan, M. D. (1984). Voltage-gated 
K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307, 465-468. 
Deisseroth, K., Heist, E. K., and Tsien, R. W. (1998). Translocation of calmodulin to the 
nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392, 198-202. 
Dimitratos, S. D., Woods, D. F., and Bryant, P. J. (1997). Camguk, Lin-2, and CASK: 
novel membrane-associated guanylate kinase homologs that also contain CaM kinase 
domains. Mechanisms of Development 63, 127-130. 
Dineley, K. T., Weeber, E. J., Atkins, C., Adams, J. P., Anderson, A. E., and Sweatt, J. D. 
(2001). Leitmotifs in the biochemistry of LTP induction: amplification, integration and 
coordination. J Neurochem 77, 961-971. 
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., and Greenberg, M. E. (2001). 
Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the 
MAP kinase pathway. Science 294, 333-339. 
Doyle, D. A., Morais Cabral, J., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., 
Chait, B. T., and MacKinnon, R. (1998). The structure of the potassium channel: 
molecular basis of K+ conduction and selectivity. Science 280, 69-77. 
Drysdale, R., Warmke, J., Kreber, R., and Ganetzky, B. (1991). Molecular 
characterization of eag: a gene affecting potassium channels in Drosophila melanogaster. 
Genetics 127, 497-505. 
Dubin, A. E., Liles, M. M., and Harris, G. L. (1998). The K+ channel gene ether a go-go 
is required for the transduction of a subset of odorants in adult Drosophila melanogaster. 
J Neurosci 18, 5603-5613. 
 188
 
Duncan, L. M., Deeds, J., Hunter, J., Shao, J., Holmgren, L. M., Woolf, E. A., Tepper, R. 
I., and Shyjan, A. W. (1998). Down-regulation of the novel gene melastatin correlates 
with potential for melanoma metastasis. Cancer Res 58, 1515-1520. 
Engel, J. E., and Wu, C. F. (1998). Genetic dissection of functional contributions of 
specific potassium channel subunits in habituation of an escape circuit in Drosophila. J 
Neurosci 18, 2254-2267. 
Engeland, B., Neu, A., Ludwig, J., Roeper, J., and Pongs, O. (1998). Cloning and 
functional expression of rat ether-a-go-go-like K+ channel genes. J Physiol 513 ( Pt 3), 
647-654. 
Fadool, D. A., Tucker, K., Perkins, R., Fasciani, G., Thompson, R. N., Parsons, A. D., 
Overton, J. M., Koni, P. A., Flavell, R. A., and Kaczmarek, L. K. (2004). Kv1.3 channel 
gene-targeted deletion produces "Super-Smeller Mice" with altered glomeruli, interacting 
scaffolding proteins, and biophysics. Neuron 41, 389-404. 
Fanger, C. M., Ghanshani, S., Logsdon, N. J., Rauer, H., Kalman, K., Zhou, J., 
Beckingham, K., Chandy, K. G., Cahalan, M. D., and Aiyar, J. (1999). Calmodulin 
mediates calcium-dependent activation of the intermediate conductance KCa channel, 
IKCa1. J Biol Chem 274, 5746-5754. 
Farias, L. M., Ocana, D. B., Diaz, L., Larrea, F., Avila-Chavez, E., Cadena, A., Hinojosa, 
L. M., Lara, G., Villanueva, L. A., Vargas, C., et al. (2004). Ether a go-go potassium 
channels as human cervical cancer markers. Cancer Res 64, 6996-7001. 
Fatt, P., and Katz, B. (1953a). The effect of inhibitory nerve impulses on a crustacean 
muscle fibre. J Physiol 121, 374-389. 
Fatt, P., and Katz, B. (1953b). The electrical properties of crustacean muscle fibres. J 
Physiol 120, 171-204. 
Fixemer, T., Wissenbach, U., Flockerzi, V., and Bonkhoff, H. (2003). Expression of the 
Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic 
marker for tumor progression. Oncogene 22, 7858-7861. 
Flucher, B. E., and Franzini-Armstrong, C. (1996). Formation of junctions involved in 
excitation-contraction coupling in skeletal and cardiac muscle. Proc Natl Acad Sci U S A 
93, 8101-8106. 
Fordyce, C. B., Jagasia, R., Zhu, X., and Schlichter, L. C. (2005). Microglia Kv1.3 
channels contribute to their ability to kill neurons. J Neurosci 25, 7139-7149. 
Fraser, S. P., Diss, J. K., Chioni, A. M., Mycielska, M. E., Pan, H., Yamaci, R. F., Pani, 
F., Siwy, Z., Krasowska, M., Grzywna, Z., et al. (2005). Voltage-gated sodium channel 




Fraser, S. P., Diss, J. K., Lloyd, L. J., Pani, F., Chioni, A. M., George, A. J., and 
Djamgoz, M. B. (2004). T-lymphocyte invasiveness: control by voltage-gated Na+ 
channel activity. FEBS Lett 569, 191-194. 
Fraser, S. P., Salvador, V., Manning, E. A., Mizal, J., Altun, S., Raza, M., Berridge, R. J., 
and Djamgoz, M. B. (2003). Contribution of functional voltage-gated Na+ channel 
expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. 
Lateral motility. J Cell Physiol 195, 479-487. 
Freedman, B. D., Price, M. A., and Deutsch, C. J. (1992). Evidence for voltage 
modulation of IL-2 production in mitogen-stimulated human peripheral blood 
lymphocytes. J Immunol 149, 3784-3794. 
Frings, S., Brull, N., Dzeja, C., Angele, A., Hagen, V., Kaupp, U. B., and Baumann, A. 
(1998). Characterization of ether-a-go-go channels present in photoreceptors reveals 
similarity to IKx, a K+ current in rod inner segments. J Gen Physiol 111, 583-599. 
Fu, H., Xia, K., Pallas, D. C., Cui, C., Conroy, K., Narsimhan, R. P., Mamon, H., Collier, 
R. J., and Roberts, T. M. (1994). Interaction of the protein kinase Raf-1 with 14-3-3 
proteins. Science 266, 126-129. 
Gandhi, C. S., Clark, E., Loots, E., Pralle, A., and Isacoff, E. Y. (2003). The orientation 
and molecular movement of a k(+) channel voltage-sensing domain. Neuron 40, 515-525. 
Gandhi, C. S., and Isacoff, E. Y. (2002). Molecular models of voltage sensing. J Gen 
Physiol 120, 455-463. 
Ganetzky, B., Robertson, G. A., Wilson, G. F., Trudeau, M. C., and Titus, S. A. (1999). 
The eag family of K+ channels in Drosophila and mammals. Ann N Y Acad Sci 868, 
356-369. 
Ganetzky, B., and Wu, C. F. (1983). Neurogenetic analysis of potassium currents in 
Drosophila: synergistic effects on neuromuscular transmission in double mutants. J 
Neurogenet 1, 17-28. 
Ganetzky, B., and Wu, C. F. (1985). Genes and membrane excitability in Drosophila. 
Trends Neurosci 8, 322-326. 
Garcia, E. P., Mehta, S., Blair, L. A., Wells, D. G., Shang, J., Fukushima, T., Fallon, J. 
R., Garner, C. C., and Marshall, J. (1998). SAP90 binds and clusters kainate receptors 
causing incomplete desensitization. Neuron 21, 727-739. 
Garcia-Ferreiro, R. E., Kerschensteiner, D., Major, F., Monje, F., Stuhmer, W., and 
Pardo, L. A. (2004). Mechanism of block of hEag1 K+ channels by imipramine and 
astemizole. J Gen Physiol 124, 301-317. 
 190
 
Garrido, J. J., Giraud, P., Carlier, E., Fernandes, F., Moussif, A., Fache, M. P., Debanne, 
D., and Dargent, B. (2003). A targeting motif involved in sodium channel clustering at 
the axonal initial segment. Science 300, 2091-2094. 
Goldstein, S. A., Bockenhauer, D., O'Kelly, I., and Zilberberg, N. (2001). Potassium leak 
channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2, 175-184. 
Gomez-Ospina, N., Tsuruta, F., Barreto-Chang, O., Hu, L., and Dolmetsch, R. (2006). 
The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a 
transcription factor. Cell 127, 591-606. 
Grabner, M., Dirksen, R. T., Suda, N., and Beam, K. G. (1999). The II-III loop of the 
skeletal muscle dihydropyridine receptor is responsible for the Bi-directional coupling 
with the ryanodine receptor. J Biol Chem 274, 21913-21919. 
Graves, L. M., Guy, H. I., Kozlowski, P., Huang, M., Lazarowski, E., Pope, R. M., 
Collins, M. A., Dahlstrand, E. N., Earp, H. S., 3rd, and Evans, D. R. (2000). Regulation 
of carbamoyl phosphate synthetase by MAP kinase. Nature 403, 328-332. 
Griffith, L. C., Verselis, L. M., Aitken, K. M., Kyriacou, C. P., Danho, W., and 
Greenspan, R. J. (1993). Inhibition of calcium/calmodulin-dependent protein kinase in 
Drosophila disrupts behavioral plasticity. Neuron 10, 501-509. 
Griffith, L. C., Wang, J., Zhong, Y., Wu, C. F., and Greenspan, R. J. (1994). 
Calcium/calmodulin-dependent protein kinase II and potassium channel subunit eag 
similarly affect plasticity in Drosophila. Proc Natl Acad Sci U S A 91, 10044-10048. 
Grimm, D. H., Karihaloo, A., Cai, Y., Somlo, S., Cantley, L. G., and Caplan, M. J. 
(2006). Polycystin-2 regulates proliferation and branching morphogenesis in kidney 
epithelial cells. J Biol Chem 281, 137-144. 
Guan, K. L., and Dixon, J. E. (1991). Eukaryotic proteins expressed in Escherichia coli: 
an improved thrombin cleavage and purification procedure of fusion proteins with 
glutathione S-transferase. Analytical Biochemistry 192, 262-267. 
Guan, Z., Kim, J. H., Lomvardas, S., Holick, K., Xu, S., Kandel, E. R., and Schwartz, J. 
H. (2003). p38 MAP kinase mediates both short-term and long-term synaptic depression 
in aplysia. J Neurosci 23, 7317-7325. 
Guillemin, K., and Krasnow, M. A. (1997). The hypoxic response: huffing and HIFing. 
Cell 89, 9-12. 
Gulbis, J. M., Mann, S., and MacKinnon, R. (1999). Structure of a voltage-dependent K+ 
channel beta subunit. Cell 97, 943-952. 
Gutman, G. A., Chandy, K. G., Adelman, J. P., Aiyar, J., Bayliss, D. A., Clapham, D. E., 
Covarriubias, M., Desir, G. V., Furuichi, K., Ganetzky, B., et al. (2003). International 
 191
 
Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium 
channels. Pharmacol Rev 55, 583-586. 
Guy, H. R., Durell, S. R., Warmke, J., Drysdale, R., and Ganetzky, B. (1991). Similarities 
in amino acid sequences of Drosophila eag and cyclic nucleotide-gated channels. Science 
254, 730. 
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. 
P., Guggino, W. B., and Germino, G. G. (2000). Co-assembly of polycystin-1 and -2 
produces unique cation-permeable currents. Nature 408, 990-994. 
Hanks, S. K., Quinn, A. M., and Hunter, T. (1988). The protein kinase family: conserved 
features and deduced phylogeny of the catalytic domains. Science 241, 42-52. 
Hardingham, G. E., and Bading, H. (2003). The Yin and Yang of NMDA receptor 
signalling. Trends Neurosci 26, 81-89. 
Harkiolaki, M., Lewitzky, M., Gilbert, R. J., Jones, E. Y., Bourette, R. P., Mouchiroud, 
G., Sondermann, H., Moarefi, I., and Feller, S. M. (2003). Structural basis for SH3 
domain-mediated high-affinity binding between Mona/Gads and SLP-76. EMBO Journal 
22, 2571-2582. 
Hartshorne, R. P., and Catterall, W. A. (1984). The sodium channel from rat brain. 
Purification and subunit composition. J Biol Chem 259, 1667-1675. 
Hata, Y., Butz, S., and Sudhof, T. C. (1996). CASK: a novel dlg/PSD95 homolog with an 
N-terminal calmodulin-dependent protein kinase domain identified by interaction with 
neurexins. Journal of Neuroscience 16, 2488-2494. 
Heginbotham, L., Lu, Z., Abramson, T., and MacKinnon, R. (1994). Mutations in the K+ 
channel signature sequence. Biophys J 66, 1061-1067. 
Hegle, A. P., Marble, D. D., and Wilson, G. F. (2006). A voltage-driven switch for ion-
independent signaling by ether-a-go-go K+ channels. Proc Natl Acad Sci U S A 103, 
2886-2891. 
Hell, J. W., Westenbroek, R. E., Breeze, L. J., Wang, K. K., Chavkin, C., and Catterall, 
W. A. (1996). N-methyl-D-aspartate receptor-induced proteolytic conversion of 
postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad 
Sci U S A 93, 3362-3367. 
Hille, B. (2001). Ion channels of excitable membranes, 3rd edn (Sunderland, MA, 
Sinauer Associates). 
Hodgkin, A. L., and Huxley, A. F. (1945). Resting and action potentials in single nerve 
fibres. J Physiol 104, 176-195. 
 192
 
Hodgkin, A. L., and Huxley, A. F. (1952a). The components of membrane conductance 
in the giant axon of Loligo. J Physiol 116, 473-496. 
Hodgkin, A. L., and Huxley, A. F. (1952b). Currents carried by sodium and potassium 
ions through the membrane of the giant axon of Loligo. J Physiol 116, 449-472. 
Hodgkin, A. L., and Huxley, A. F. (1952c). The dual effect of membrane potential on 
sodium conductance in the giant axon of Loligo. J Physiol 116, 497-506. 
Hodgkin, A. L., and Huxley, A. F. (1952d). A quantitative description of membrane 
current and its application to conduction and excitation in nerve. J Physiol 117, 500-544. 
Hodgkin, A. L., Huxley, A. F., and Katz, B. (1952). Measurement of current-voltage 
relations in the membrane of the giant axon of Loligo. J Physiol 116, 424-448. 
Hodgkin, A. L., and Katz, B. (1949). The effect of sodium ions on the electrical activity 
of the giant axon of the squid. J Physiol 108, 37-77. 
Hoenderop, J. G., Nilius, B., and Bindels, R. J. (2005). Calcium absorption across 
epithelia. Physiol Rev 85, 373-422. 
Holmes, T. C., Berman, K., Swartz, J. E., Dagan, D., and Levitan, I. B. (1997). 
Expression of voltage-gated potassium channels decreases cellular protein tyrosine 
phosphorylation. J Neurosci 17, 8964-8974. 
Holmes, T. C., Fadool, D. A., Ren, R., and Levitan, I. B. (1996). Association of Src 
tyrosine kinase with a human potassium channel mediated by SH3 domain. Science 274, 
2089-2091. 
Hoshi, T., Zagotta, W. N., and Aldrich, R. W. (1990). Biophysical and molecular 
mechanisms of Shaker potassium channel inactivation. Science 250, 533-538. 
Hoskins, R., Hajnal, A. F., Harp, S. A., and Kim, S. K. (1996). The C. elegans vulval 
induction gene lin-2 encodes a member of the MAGUK family of cell junction proteins. 
Development 122, 97-111. 
Hsueh, Y. P., Wang, T. F., Yang, F. C., and Sheng, M. (2000). Nuclear translocation and 
transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. 
Nature 404, 298-302. 
Huang, C. L. (2004). The transient receptor potential superfamily of ion channels. J Am 
Soc Nephrol 15, 1690-1699. 
Hulme, J. T., Ahn, M., Hauschka, S. D., Scheuer, T., and Catterall, W. A. (2002). A 
novel leucine zipper targets AKAP15 and cyclic AMP-dependent protein kinase to the C 




Hulme, J. T., Konoki, K., Lin, T. W., Gritsenko, M. A., Camp, D. G., 2nd, Bigelow, D. 
J., and Catterall, W. A. (2005). Sites of proteolytic processing and noncovalent 
association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle. Proc 
Natl Acad Sci U S A 102, 5274-5279. 
Isom, L. L., De Jongh, K. S., and Catterall, W. A. (1994). Auxiliary subunits of voltage-
gated ion channels. Neuron 12, 1183-1194. 
Jaramillo, A. M., Zheng, X., Zhou, Y., Amado, D. A., Sheldon, A., Sehgal, A., and 
Levitan, I. B. (2004). Pattern of distribution and cycling of SLOB, Slowpoke channel 
binding protein, in Drosophila. BMC Neurosci 5, 3. 
Jeng, C. J., Chang, C. C., and Tang, C. Y. (2005). Differential localization of rat Eag1 
and Eag2 K+ channels in hippocampal neurons. Neuroreport 16, 229-233. 
Jiang, Y., Lee, A., Chen, J., Ruta, V., Cadene, M., Chait, B. T., and MacKinnon, R. 
(2003a). X-ray structure of a voltage-dependent K+ channel. Nature 423, 33-41. 
Jiang, Y., Ruta, V., Chen, J., Lee, A., and MacKinnon, R. (2003b). The principle of 
gating charge movement in a voltage-dependent K+ channel. Nature 423, 42-48. 
Joiner, W. J., Khanna, R., Schlichter, L. C., and Kaczmarek, L. K. (2001). Calmodulin 
regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. J Biol Chem 
276, 37980-37985. 
Kaczmarek, L. K. (2006). Non-conducting functions of voltage-gated ion channels. Nat 
Rev Neurosci 7, 761-771. 
Kaech, S. M., Whitfield, C. W., and Kim, S. K. (1998). The LIN-2/LIN-7/LIN-10 
complex mediates basolateral membrane localization of the C. elegans EGF receptor 
LET-23 in vulval epithelial cells. Cell 94, 761-771. 
Kagan, A., Melman, Y. F., Krumerman, A., and McDonald, T. V. (2002). 14-3-3 
amplifies and prolongs adrenergic stimulation of HERG K+ channel activity. Embo J 21, 
1889-1898. 
Kaplan, W. D., and Trout, W. E., 3rd (1969). The behavior of four neurological mutants 
of Drosophila. Genetics 61, 399-409. 
Karim, F. D., and Rubin, G. M. (1998). Ectopic expression of activated Ras1 induces 
hyperplastic growth and increased cell death in Drosophila imaginal tissues. 
Development 125, 1-9. 
Keen, J. E., Khawaled, R., Farrens, D. L., Neelands, T., Rivard, A., Bond, C. T., 
Janowsky, A., Fakler, B., Adelman, J. P., and Maylie, J. (1999). Domains responsible for 
constitutive and Ca(2+)-dependent interactions between calmodulin and small 
conductance Ca(2+)-activated potassium channels. J Neurosci 19, 8830-8838. 
 194
 
Kenworthy, A. K. (2001). Imaging protein-protein interactions using fluorescence 
resonance energy transfer microscopy. Methods 24, 289-296. 
Kim, D. Y., Carey, B. W., Wang, H., Ingano, L. A., Binshtok, A. M., Wertz, M. H., 
Pettingell, W. H., He, P., Lee, V. M., Woolf, C. J., and Kovacs, D. M. (2007). BACE1 
regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9, 755-764. 
Kim, D. Y., Ingano, L. A., Carey, B. W., Pettingell, W. H., and Kovacs, D. M. (2005). 
Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel 
beta2-subunit regulates cell adhesion and migration. J Biol Chem 280, 23251-23261. 
Kim, E., Niethammer, M., Rothschild, A., Jan, Y. N., and Sheng, M. (1995). Clustering 
of Shaker-type K+ channels by interaction with a family of membrane-associated 
guanylate kinases. Nature 378, 85-88. 
Krapivinsky, G., Medina, I., Krapivinsky, L., Gapon, S., and Clapham, D. E. (2004). 
SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and 
NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 43, 563-574. 
Kurokawa, J., Motoike, H. K., Rao, J., and Kass, R. S. (2004). Regulatory actions of the 
A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA 
phosphorylation. Proc Natl Acad Sci U S A 101, 16374-16378. 
Lastraioli, E., Guasti, L., Crociani, O., Polvani, S., Hofmann, G., Witchel, H., Bencini, 
L., Calistri, M., Messerini, L., Scatizzi, M., et al. (2004). herg1 gene and HERG1 protein 
are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer 
Res 64, 606-611. 
Lecain, E., Sauvaget, E., Crisanti, P., Van Den Abbeele, T., and Huy, P. T. (1999). 
Potassium channel ether a go-go mRNA expression in the spiral ligament of the rat. Hear 
Res 133, 133-138. 
Levitan, I. B. (1999). It is calmodulin after all! Mediator of the calcium modulation of 
multiple ion channels. Neuron 22, 645-648. 
Levitan, I. B. (2006). Signaling protein complexes associated with neuronal ion channels. 
Nat Neurosci 9, 305-310. 
Lewis, R. S., and Cahalan, M. D. (1995). Potassium and calcium channels in 
lymphocytes. Annu Rev Immunol 13, 623-653. 
Liman, E. R., Hess, P., Weaver, F., and Koren, G. (1991). Voltage-sensing residues in the 
S4 region of a mammalian K+ channel. Nature 353, 752-756. 
Lin, C. S., Boltz, R. C., Blake, J. T., Nguyen, M., Talento, A., Fischer, P. A., Springer, 
M. S., Sigal, N. H., Slaughter, R. S., Garcia, M. L., and et al. (1993). Voltage-gated 
potassium channels regulate calcium-dependent pathways involved in human T 
lymphocyte activation. J Exp Med 177, 637-645. 
 195
 
Liu, Q., Berry, D., Nash, P., Pawson, T., McGlade, C. J., and Li, S. S. (2003). Structural 
basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 
peptide: a novel mode of peptide recognition. Molecular Cell 11, 471-481. 
Lu, C. S., Hodge, J. J., Mehren, J., Sun, X. X., and Griffith, L. C. (2003). Regulation of 
the Ca2+/CaM-responsive pool of CaMKII by scaffold-dependent autophosphorylation. 
Neuron 40, 1185-1197. 
Ludwig, J., Terlau, H., Wunder, F., Bruggemann, A., Pardo, L. A., Marquardt, A., 
Stuhmer, W., and Pongs, O. (1994). Functional expression of a rat homologue of the 
voltage gated either a go-go potassium channel reveals differences in selectivity and 
activation kinetics between the Drosophila channel and its mammalian counterpart. Embo 
J 13, 4451-4458. 
MacFarlane, S. N., and Sontheimer, H. (2000). Modulation of Kv1.5 currents by Src 
tyrosine phosphorylation: potential role in the differentiation of astrocytes. J Neurosci 20, 
5245-5253. 
MacLean, J. N., Zhang, Y., Goeritz, M. L., Casey, R., Oliva, R., Guckenheimer, J., and 
Harris-Warrick, R. M. (2005). Activity-independent coregulation of IA and Ih in 
rhythmically active neurons. J Neurophysiol 94, 3601-3617. 
MacLean, J. N., Zhang, Y., Johnson, B. R., and Harris-Warrick, R. M. (2003). Activity-
independent homeostasis in rhythmically active neurons. Neuron 37, 109-120. 
Malhotra, J. D., Kazen-Gillespie, K., Hortsch, M., and Isom, L. L. (2000). Sodium 
channel beta subunits mediate homophilic cell adhesion and recruit ankyrin to points of 
cell-cell contact. J Biol Chem 275, 11383-11388. 
Malhotra, J. D., Thyagarajan, V., Chen, C., and Isom, L. L. (2004). Tyrosine-
phosphorylated and nonphosphorylated sodium channel beta1 subunits are differentially 
localized in cardiac myocytes. J Biol Chem 279, 40748-40754. 
Marble, D. D., Hegle, A. P., Snyder, E. D., 2nd, Dimitratos, S., Bryant, P. J., and Wilson, 
G. F. (2005). Camguk/CASK enhances Ether-a-go-go potassium current by a 
phosphorylation-dependent mechanism. J Neurosci 25, 4898-4907. 
Maximov, A., Sudhof, T. C., and Bezprozvanny, I. (1999). Association of neuronal 
calcium channels with modular adaptor proteins. Journal of Biological Chemistry 274, 
24453-24456. 
Mayford, M., Bach, M. E., Huang, Y. Y., Wang, L., Hawkins, R. D., and Kandel, E. R. 
(1996). Control of memory formation through regulated expression of a CaMKII 
transgene. Science 274, 1678-1683. 
McEwen, D. P., and Isom, L. L. (2004). Heterophilic interactions of sodium channel 




McGee, A. W., Dakoji, S. R., Olsen, O., Bredt, D. S., Lim, W. A., and Prehoda, K. E. 
(2001). Structure of the SH3-guanylate kinase module from PSD-95 suggests a 
mechanism for regulated assembly of MAGUK scaffolding proteins. Molecular Cell 8, 
1291-1301. 
Meyer, R., and Heinemann, S. H. (1998). Characterization of an eag-like potassium 
channel in human neuroblastoma cells. J Physiol 508 ( Pt 1), 49-56. 
Meyer, R., Schonherr, R., Gavrilova-Ruch, O., Wohlrab, W., and Heinemann, S. H. 
(1999). Identification of ether a go-go and calcium-activated potassium channels in 
human melanoma cells. J Membr Biol 171, 107-115. 
Mochida, S., Yokoyama, C. T., Kim, D. K., Itoh, K., and Catterall, W. A. (1998). 
Evidence for a voltage-dependent enhancement of neurotransmitter release mediated via 
the synaptic protein interaction site of N-type Ca2+ channels. Proc Natl Acad Sci U S A 
95, 14523-14528. 
Morais Cabral, J. H., Lee, A., Cohen, S. L., Chait, B. T., Li, M., and Mackinnon, R. 
(1998). Crystal structure and functional analysis of the HERG potassium channel N 
terminus: a eukaryotic PAS domain. Cell 95, 649-655. 
Morozov, A., Muzzio, I. A., Bourtchouladze, R., Van-Strien, N., Lapidus, K., Yin, D., 
Winder, D. G., Adams, J. P., Sweatt, J. D., and Kandel, E. R. (2003). Rap1 couples 
cAMP signaling to a distinct pool of p42/44MAPK regulating excitability, synaptic 
plasticity, learning, and memory. Neuron 39, 309-325. 
Mu, D., Chen, L., Zhang, X., See, L. H., Koch, C. M., Yen, C., Tong, J. J., Spiegel, L., 
Nguyen, K. C., Servoss, A., et al. (2003). Genomic amplification and oncogenic 
properties of the KCNK9 potassium channel gene. Cancer Cell 3, 297-302. 
Muller, B. M., Kistner, U., Kindler, S., Chung, W. J., Kuhlendahl, S., Fenster, S. D., Lau, 
L. F., Veh, R. W., Huganir, R. L., Gundelfinger, E. D., and Garner, C. C. (1996). 
SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in 
vivo. Neuron 17, 255-265. 
Mumm, J. S., and Kopan, R. (2000). Notch signaling: from the outside in. Dev Biol 228, 
151-165. 
Murata, H., Tajima, N., Nagashima, Y., Yao, M., Baba, M., Goto, M., Kawamoto, S., 
Yamamoto, I., Okuda, K., and Kanno, H. (2002). Von Hippel-Lindau tumor suppressor 
protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer 
Res 62, 7004-7011. 
Murata, Y., Iwasaki, H., Sasaki, M., Inaba, K., and Okamura, Y. (2005). 




Mycielska, M. E., Fraser, S. P., Szatkowski, M., and Djamgoz, M. B. (2003). 
Contribution of functional voltage-gated Na+ channel expression to cell behaviors 
involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity. 
J Cell Physiol 195, 461-469. 
Nakai, J., Dirksen, R. T., Nguyen, H. T., Pessah, I. N., Beam, K. G., and Allen, P. D. 
(1996). Enhanced dihydropyridine receptor channel activity in the presence of ryanodine 
receptor. Nature 380, 72-75. 
Nakanishi, K., Zhang, F., Baxter, D. A., Eskin, A., and Byrne, J. H. (1997). Role of 
calcium-calmodulin-dependent protein kinase II in modulation of sensorimotor synapses 
in Aplysia. J Neurophysiol 78, 409-416. 
Occhiodoro, T., Bernheim, L., Liu, J. H., Bijlenga, P., Sinnreich, M., Bader, C. R., and 
Fischer-Lougheed, J. (1998). Cloning of a human ether-a-go-go potassium channel 
expressed in myoblasts at the onset of fusion. FEBS Lett 434, 177-182. 
Onganer, P. U., and Djamgoz, M. B. (2005). Small-cell lung cancer (human): potentiation 
of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro. J 
Membr Biol 204, 67-75. 
Pal, S., Hartnett, K. A., Nerbonne, J. M., Levitan, E. S., and Aizenman, E. (2003). 
Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 23, 
4798-4802. 
Palmer, A., Gavin, A. C., and Nebreda, A. R. (1998). A link between MAP kinase and 
p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the 
p34(cdc2) inhibitory kinase Myt1. Embo J 17, 5037-5047. 
Pan, Z., Kao, T., Horvath, Z., Lemos, J., Sul, J. Y., Cranstoun, S. D., Bennett, V., 
Scherer, S. S., and Cooper, E. C. (2006). A common ankyrin-G-based mechanism retains 
KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 26, 2599-
2613. 
Paolini, C., Fessenden, J. D., Pessah, I. N., and Franzini-Armstrong, C. (2004). Evidence 
for conformational coupling between two calcium channels. Proc Natl Acad Sci U S A 
101, 12748-12752. 
Papazian, D. M., Timpe, L. C., Jan, Y. N., and Jan, L. Y. (1991). Alteration of voltage-
dependence of Shaker potassium channel by mutations in the S4 sequence. Nature 349, 
305-310. 
Pardo, L. A. (2004). Voltage-gated potassium channels in cell proliferation. Physiology 
(Bethesda) 19, 285-292. 
Pardo, L. A., Bruggemann, A., Camacho, J., and Stuhmer, W. (1998). Cell cycle-related 
changes in the conducting properties of r-eag K+ channels. J Cell Biol 143, 767-775. 
 198
 
Pardo, L. A., Contreras-Jurado, C., Zientkowska, M., Alves, F., and Stuhmer, W. (2005). 
Role of voltage-gated potassium channels in cancer. J Membr Biol 205, 115-124. 
Pardo, L. A., del Camino, D., Sanchez, A., Alves, F., Bruggemann, A., Beckh, S., and 
Stuhmer, W. (1999). Oncogenic potential of EAG K(+) channels. Embo J 18, 5540-5547. 
Patt, S., Preussat, K., Beetz, C., Kraft, R., Schrey, M., Kalff, R., Schonherr, K., and 
Heinemann, S. H. (2004). Expression of ether a go-go potassium channels in human 
gliomas. Neurosci Lett 368, 249-253. 
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and 
Cobb, M. H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and 
physiological functions. Endocrine Reviews 22, 153-183. 
Pei, L., Wiser, O., Slavin, A., Mu, D., Powers, S., Jan, L. Y., and Hoey, T. (2003). 
Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl 
Acad Sci U S A 100, 7803-7807. 
Pemberton, K. E., Hill-Eubanks, L. J., and Jones, S. V. P. (2000). Modulation of low-
threshold T-type calcium channels by the five muscarinic receptor subtypes in NIH 3T3 
cells. Pflugers Archives -- European Journal of Physiology 440, 452-461. 
Perraud, A. L., Fleig, A., Dunn, C. A., Bagley, L. A., Launay, P., Schmitz, C., Stokes, A. 
J., Zhu, Q., Bessman, M. J., Penner, R., et al. (2001). ADP-ribose gating of the calcium-
permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411, 595-599. 
Peterson, B. Z., DeMaria, C. D., Adelman, J. P., and Yue, D. T. (1999). Calmodulin is the 
Ca2+ sensor for Ca2+ -dependent inactivation of L-type calcium channels. Neuron 22, 
549-558. 
Phelps, C. B., and Brand, A. H. (1998). Ectopic gene expression in Drosophila using 
GAL4 system. Methods 14, 367-379. 
Pillozzi, S., Brizzi, M. F., Balzi, M., Crociani, O., Cherubini, A., Guasti, L., Bartolozzi, 
B., Becchetti, A., Wanke, E., Bernabei, P. A., et al. (2002). HERG potassium channels 
are constitutively expressed in primary human acute myeloid leukemias and regulate cell 
proliferation of normal and leukemic hemopoietic progenitors. Leukemia 16, 1791-1798. 
Pitt, G. S., Zuhlke, R. D., Hudmon, A., Schulman, H., Reuter, H., and Tsien, R. W. 
(2001). Molecular basis of calmodulin tethering and Ca2+-dependent inactivation of L-
type Ca2+ channels. J Biol Chem 276, 30794-30802. 
Prakriya, M., Feske, S., Gwack, Y., Srikanth, S., Rao, A., and Hogan, P. G. (2006). Orai1 
is an essential pore subunit of the CRAC channel. Nature 443, 230-233. 
Preisig-Muller, R., Schlichthorl, G., Goerge, T., Heinen, S., Bruggemann, A., Rajan, S., 
Derst, C., Veh, R. W., and Daut, J. (2002). Heteromerization of Kir2.x potassium 
 199
 
channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci U S A 
99, 7774-7779. 
Preussat, K., Beetz, C., Schrey, M., Kraft, R., Wolfl, S., Kalff, R., and Patt, S. (2003). 
Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. 
Neurosci Lett 346, 33-36. 
Price, M., Lee, S. C., and Deutsch, C. (1989). Charybdotoxin inhibits proliferation and 
interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S 
A 86, 10171-10175. 
Putkey, J. A., and Waxham, M. N. (1996). A peptide model for calmodulin trapping by 
calcium/calmodulin-dependent protein kinase II. Journal of Biological Chemistry 271, 
29619-29623. 
Qin, N., Olcese, R., Bransby, M., Lin, T., and Birnbaumer, L. (1999). Ca2+-induced 
inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc Natl Acad Sci U S A 
96, 2435-2438. 
Ramsey, I. S., Moran, M. M., Chong, J. A., and Clapham, D. E. (2006). A voltage-gated 
proton-selective channel lacking the pore domain. Nature 440, 1213-1216. 
Ratcliffe, C. F., Westenbroek, R. E., Curtis, R., and Catterall, W. A. (2001). Sodium 
channel beta1 and beta3 subunits associate with neurofascin through their extracellular 
immunoglobulin-like domain. J Cell Biol 154, 427-434. 
Reinhart, P. H., and Levitan, I. B. (1995). Kinase and phosphatase activities intimately 
associated with a reconstituted calcium-dependent potassium channel. J Neurosci 15, 
4572-4579. 
Rettig, J., Heinemann, S. H., Wunder, F., Lorra, C., Parcej, D. N., Dolly, J. O., and 
Pongs, O. (1994). Inactivation properties of voltage-gated K+ channels altered by 
presence of beta-subunit. Nature 369, 289-294. 
Rettig, J., Sheng, Z. H., Kim, D. K., Hodson, C. D., Snutch, T. P., and Catterall, W. A. 
(1996). Isoform-specific interaction of the alpha1A subunits of brain Ca2+ channels with 
the presynaptic proteins syntaxin and SNAP-25. Proc Natl Acad Sci U S A 93, 7363-
7368. 
Riazanova, L. V., Pavur, K. S., Petrov, A. N., Dorovkov, M. V., and Riazanov, A. G. 
(2001). [Novel type of signaling molecules: protein kinases covalently linked to ion 
channels]. Mol Biol (Mosk) 35, 321-332. 
Rios, E., and Brum, G. (1987). Involvement of dihydropyridine receptors in excitation-
contraction coupling in skeletal muscle. Nature 325, 717-720. 
Rios, E., and Pizarro, G. (1991). Voltage sensor of excitation-contraction coupling in 
skeletal muscle. Physiol Rev 71, 849-908. 
 200
 
Robertson, G. A., Warmke, J. M., and Ganetzky, B. (1996). Potassium currents expressed 
from Drosophila and mouse eag cDNAs in Xenopus oocytes. Neuropharmacology 35, 
841-850. 
Rosen, L. B., Ginty, D. D., Weber, M. J., and Greenberg, M. E. (1994). Membrane 
depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. 
Neuron 12, 1207-1221. 
Rouzaire-Dubois, B., and Dubois, J. M. (1998). K+ channel block-induced mammalian 
neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 
510 ( Pt 1), 93-102. 
Runnels, L. W., Yue, L., and Clapham, D. E. (2001). TRP-PLIK, a bifunctional protein 
with kinase and ion channel activities. Science 291, 1043-1047. 
Ryazanova, L. V., Dorovkov, M. V., Ansari, A., and Ryazanov, A. G. (2004). 
Characterization of the protein kinase activity of TRPM7/ChaK1, a protein kinase fused 
to the transient receptor potential ion channel. J Biol Chem 279, 3708-3716. 
Saganich, M. J., Machado, E., and Rudy, B. (2001). Differential expression of genes 
encoding subthreshold-operating voltage-gated K+ channels in brain. J Neurosci 21, 
4609-4624. 
Saimi, Y., and Kung, C. (2002). Calmodulin as an ion channel subunit. Annu Rev Physiol 
64, 289-311. 
Sano, Y., Inamura, K., Miyake, A., Mochizuki, S., Yokoi, H., Matsushime, H., and 
Furuichi, K. (2001). Immunocyte Ca2+ influx system mediated by LTRPC2. Science 
293, 1327-1330. 
Sasaki, M., Takagi, M., and Okamura, Y. (2006). A voltage sensor-domain protein is a 
voltage-gated proton channel. Science 312, 589-592. 
Savignac, M., Pintado, B., Gutierrez-Adan, A., Palczewska, M., Mellstrom, B., and 
Naranjo, J. R. (2005). Transcriptional repressor DREAM regulates T-lymphocyte 
proliferation and cytokine gene expression. Embo J 24, 3555-3564. 
Schlingmann, K. P., Weber, S., Peters, M., Niemann Nejsum, L., Vitzthum, H., Klingel, 
K., Kratz, M., Haddad, E., Ristoff, E., Dinour, D., et al. (2002). Hypomagnesemia with 
secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM 
gene family. Nat Genet 31, 166-170. 
Schmitz, C., Dorovkov, M. V., Zhao, X., Davenport, B. J., Ryazanov, A. G., and Perraud, 
A. L. (2005). The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J 
Biol Chem 280, 37763-37771. 
 201
 
Schmitz, C., Perraud, A. L., Fleig, A., and Scharenberg, A. M. (2004). Dual-function ion 
channel/protein kinases: novel components of vertebrate magnesium regulatory 
mechanisms. Pediatr Res 55, 734-737. 
Schmitz, C., Perraud, A. L., Johnson, C. O., Inabe, K., Smith, M. K., Penner, R., 
Kurosaki, T., Fleig, A., and Scharenberg, A. M. (2003). Regulation of vertebrate cellular 
Mg2+ homeostasis by TRPM7. Cell 114, 191-200. 
Schneider, M. F. (1981). Membrane charge movement and depolarization-contraction 
coupling. Annu Rev Physiol 43, 507-517. 
Schneider, M. F., and Chandler, W. K. (1973). Voltage dependent charge movement of 
skeletal muscle: a possible step in excitation-contraction coupling. Nature 242, 244-246. 
Schonherr, R., and Heinemann, S. H. (1996). Molecular determinants for activation and 
inactivation of HERG, a human inward rectifier potassium channel. J Physiol 493 ( Pt 3), 
635-642. 
Schonherr, R., Lober, K., and Heinemann, S. H. (2000). Inhibition of human ether a go-
go potassium channels by Ca(2+)/calmodulin. Embo J 19, 3263-3271. 
Schonherr, R., Mannuzzu, L. M., Isacoff, E. Y., and Heinemann, S. H. (2002). 
Conformational switch between slow and fast gating modes: allosteric regulation of 
voltage sensor mobility in the EAG K+ channel. Neuron 35, 935-949. 
Schopperle, W. M., Holmqvist, M. H., Zhou, Y., Wang, J., Wang, Z., Griffith, L. C., 
Keselman, I., Kusinitz, F., Dagan, D., and Levitan, I. B. (1998). Slob, a novel protein that 
interacts with the Slowpoke calcium-dependent potassium channel. Neuron 20, 565-573. 
Schultz, J. E., Klumpp, S., Benz, R., Schurhoff-Goeters, W. J., and Schmid, A. (1992). 
Regulation of adenylyl cyclase from Paramecium by an intrinsic potassium conductance. 
Science 255, 600-603. 
Schwarz, E. C., Wissenbach, U., Niemeyer, B. A., Strauss, B., Philipp, S. E., Flockerzi, 
V., and Hoth, M. (2006). TRPV6 potentiates calcium-dependent cell proliferation. Cell 
Calcium 39, 163-173. 
Scully, A. L., and Kay, S. A. (2000). Time flies for Drosophila. Cell 100, 297-300. 
Selverston, A. I., and Moulins, M. (1985). Oscillatory neural networks. Annu Rev 
Physiol 47, 29-48. 
Selvin, P. R. (1995). Fluorescence resonance energy transfer. Methods Enzymol 246, 
300-334. 
Sheng, M., McFadden, G., and Greenberg, M. E. (1990). Membrane depolarization and 
calcium induce c-fos transcription via phosphorylation of transcription factor CREB. 
Neuron 4, 571-582. 
 202
 
Sheng, Z. H., Yokoyama, C. T., and Catterall, W. A. (1997). Interaction of the synprint 
site of N-type Ca2+ channels with the C2B domain of synaptotagmin I. Proc Natl Acad 
Sci U S A 94, 5405-5410. 
Shieh, C. C., Coghlan, M., Sullivan, J. P., and Gopalakrishnan, M. (2000). Potassium 
channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52, 
557-594. 
Sidell, N., and Schlichter, L. (1986). Retinoic acid blocks potassium channels in human 
lymphocytes. Biochem Biophys Res Commun 138, 560-567. 
Silva, A. J., Paylor, R., Wehner, J. M., and Tonegawa, S. (1992a). Impaired spatial 
learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257, 206-211. 
Silva, A. J., Stevens, C. F., Tonegawa, S., and Wang, Y. (1992b). Deficient hippocampal 
long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 257, 
201-206. 
Silverman, W. R., Roux, B., and Papazian, D. M. (2003). Structural basis of two-stage 
voltage-dependent activation in K+ channels. Proc Natl Acad Sci U S A 100, 2935-2940. 
Smith, P. L., and Yellen, G. (2002). Fast and slow voltage sensor movements in HERG 
potassium channels. J Gen Physiol 119, 275-293. 
Soroceanu, L., Manning, T. J., Jr., and Sontheimer, H. (1999). Modulation of glioma cell 
migration and invasion using Cl(-) and K(+) ion channel blockers. J Neurosci 19, 5942-
5954. 
Sparks, A. B., Rider, J. E., Kay, B. K., Curriculum in, G., and Molecular Biology, U. o. 
N. C. a. C. H. U. S. A. (1998). Mapping the specificity of SH3 domains with phage-
displayed random-peptide libraries. Methods in molecular biology (Clifton, NJ) 84. 
Srinivasan, J., Schachner, M., and Catterall, W. A. (1998). Interaction of voltage-gated 
sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc 
Natl Acad Sci U S A 95, 15753-15757. 
Stansfeld, C. E., Roper, J., Ludwig, J., Weseloh, R. M., Marsh, S. J., Brown, D. A., and 
Pongs, O. (1996). Elevation of intracellular calcium by muscarinic receptor activation 
induces a block of voltage-activated rat ether-a-go-go channels in a stably transfected cell 
line. Proc Natl Acad Sci U S A 93, 9910-9914. 
Storey, N. M., Gomez-Angelats, M., Bortner, C. D., Armstrong, D. L., and Cidlowski, J. 
A. (2003). Stimulation of Kv1.3 potassium channels by death receptors during apoptosis 
in Jurkat T lymphocytes. J Biol Chem 278, 33319-33326. 
Sun, X. X., Hodge, J. J., Zhou, Y., Nguyen, M., and Griffith, L. C. (2004). The eag 
potassium channel binds and locally activates calcium/calmodulin-dependent protein 
kinase II. J Biol Chem 279, 10206-10214. 
 203
 
Sutton, K. G., McRory, J. E., Guthrie, H., Murphy, T. H., and Snutch, T. P. (1999). P/Q-
type calcium channels mediate the activity-dependent feedback of syntaxin-1A. Nature 
401, 800-804. 
Sweatt, J. D. (2004). Mitogen-activated protein kinases in synaptic plasticity and 
memory. Curr Opin Neurobiol 14, 311-317. 
Takeda, K., Matsuzawa, A., Nishitoh, H., Tobiume, K., Kishida, S., Ninomiya-Tsuji, J., 
Matsumoto, K., and Ichijo, H. (2004). Involvement of ASK1 in Ca2+-induced p38 MAP 
kinase activation. EMBO Rep 5, 161-166. 
Tanabe, T., Beam, K. G., Powell, J. A., and Numa, S. (1988). Restoration of excitation-
contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine 
receptor complementary DNA. Nature 336, 134-139. 
Tang, C. Y., Bezanilla, F., and Papazian, D. M. (2000). Extracellular Mg(2+) modulates 
slow gating transitions and the opening of Drosophila ether-a-Go-Go potassium channels. 
J Gen Physiol 115, 319-338. 
Taylor, B. L., and Zhulin, I. B. (1999). PAS domains: internal sensors of oxygen, redox 
potential, and light. Microbiol Mol Biol Rev 63, 479-506. 
Terlau, H., Ludwig, J., Steffan, R., Pongs, O., Stuhmer, W., and Heinemann, S. H. 
(1996). Extracellular Mg2+ regulates activation of rat eag potassium channel. Pflugers 
Arch 432, 301-312. 
Thomas, G. M., and Huganir, R. L. (2004). MAPK cascade signalling and synaptic 
plasticity. Nat Rev Neurosci 5, 173-183. 
Treisman, R. (1996). Regulation of transcription by MAP kinase cascades. Curr Opin 
Cell Biol 8, 205-215. 
Trimarchi, J. R., Liu, L., Smith, P. J., and Keefe, D. L. (2002). Apoptosis recruits two-
pore domain potassium channels used for homeostatic volume regulation. Am J Physiol 
Cell Physiol 282, C588-594. 
Trudeau, M. C., Titus, S. A., Branchaw, J. L., Ganetzky, B., and Robertson, G. A. (1999). 
Functional analysis of a mouse brain Elk-type K+ channel. J Neurosci 19, 2906-2918. 
Trudeau, M. C., Warmke, J. W., Ganetzky, B., and Robertson, G. A. (1995). HERG, a 
human inward rectifier in the voltage-gated potassium channel family. Science 269, 92-
95. 
Vautier, F., Belachew, S., Chittajallu, R., and Gallo, V. (2004). Shaker-type potassium 




Vianna, M. R., Alonso, M., Viola, H., Quevedo, J., de Paris, F., Furman, M., de Stein, M. 
L., Medina, J. H., and Izquierdo, I. (2000). Role of hippocampal signaling pathways in 
long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7, 
333-340. 
Wang, H., Zhang, Y., Cao, L., Han, H., Wang, J., Yang, B., Nattel, S., and Wang, Z. 
(2002a). HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer 
Res 62, 4843-4848. 
Wang, J., Zhou, Y., Wen, H., and Levitan, I. B. (1999). Simultaneous binding of two 
protein kinases to a calcium-dependent potassium channel. J Neurosci 19, RC4. 
Wang, J. W., Soll, D. R., and Wu, C. F. (2002b). Morphometric description of the 
wandering behavior in Drosophila larvae: a phenotypic analysis of K+ channel mutants. J 
Neurogenet 16, 45-63. 
Wang, Z., Wilson, G. F., and Griffith, L. C. (2002c). Calcium/calmodulin-dependent 
protein kinase II phosphorylates and regulates the Drosophila eag potassium channel. J 
Biol Chem 277, 24022-24029. 
Warmke, J., Drysdale, R., and Ganetzky, B. (1991). A distinct potassium channel 
polypeptide encoded by the Drosophila eag locus. Science 252, 1560-1562. 
Warmke, J. W., and Ganetzky, B. (1994). A family of potassium channel genes related to 
eag in Drosophila and mammals. Proc Natl Acad Sci U S A 91, 3438-3442. 
Wei, X., Neely, A., Lacerda, A. E., Olcese, R., Stefani, E., Perez-Reyes, E., and 
Birnbaumer, L. (1994). Modification of Ca2+ channel activity by deletions at the 
carboxyl terminus of the cardiac alpha 1 subunit. J Biol Chem 269, 1635-1640. 
Weng, J., Cao, Y., Moss, N., and Zhou, M. (2006). Modulation of voltage-dependent 
Shaker family potassium channels by an aldo-keto reductase. J Biol Chem 281, 15194-
15200. 
Wilson, G. F., and Chiu, S. Y. (1993). Mitogenic factors regulate ion channels in 
Schwann cells cultured from newborn rat sciatic nerve. J Physiol 470, 501-520. 
Wilson, G. F., Wang, Z., Chouinard, S. W., Griffith, L. C., and Ganetzky, B. (1998). 
Interaction of the K channel beta subunit, Hyperkinetic, with eag family members. J Biol 
Chem 273, 6389-6394. 
Wilson, P. D., and Falkenstein, D. (1995). The pathology of human renal cystic disease. 
Curr Top Pathol 88, 1-50. 
Wonderlin, W. F., and Strobl, J. S. (1996). Potassium channels, proliferation and G1 
progression. J Membr Biol 154, 91-107. 
 205
 
Wong, H. K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, 
M., De Strooper, B., Saftig, P., and Nukina, N. (2005). beta Subunits of voltage-gated 
sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving 
enzyme (BACE1) and gamma-secretase. J Biol Chem 280, 23009-23017. 
Wong, W., and Scott, J. D. (2004). AKAP signalling complexes: focal points in space 
and time. Nat Rev Mol Cell Biol 5, 959-970. 
Woodfork, K. A., Wonderlin, W. F., Peterson, V. A., and Strobl, J. S. (1995). Inhibition 
of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast 
cancer cells in tissue culture. J Cell Physiol 162, 163-171. 
Wu, C. F., Ganetzky, B., Haugland, F. N., and Liu, A. X. (1983). Potassium currents in 
Drosophila: different components affected by mutations of two genes. Science 220, 1076-
1078. 
Xia, X., Hirschberg, B., Smolik, S., Forte, M., and Adelman, J. P. (1998a). dSLo 
interacting protein 1, a novel protein that interacts with large-conductance calcium-
activated potassium channels. J Neurosci 18, 2360-2369. 
Xia, X. M., Fakler, B., Rivard, A., Wayman, G., Johnson-Pais, T., Keen, J. E., Ishii, T., 
Hirschberg, B., Bond, C. T., Lutsenko, S., et al. (1998b). Mechanism of calcium gating in 
small-conductance calcium-activated potassium channels. Nature 395, 503-507. 
Xiao, Z. C., Ragsdale, D. S., Malhotra, J. D., Mattei, L. N., Braun, P. E., Schachner, M., 
and Isom, L. L. (1999). Tenascin-R is a functional modulator of sodium channel beta 
subunits. J Biol Chem 274, 26511-26517. 
Yao, X., and Kwan, H. Y. (1999). Activity of voltage-gated K+ channels is associated 
with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer. Life Sci 65, 
55-62. 
Yeromin, A. V., Zhang, S. L., Jiang, W., Yu, Y., Safrina, O., and Cahalan, M. D. (2006). 
Molecular identification of the CRAC channel by altered ion selectivity in a mutant of 
Orai. Nature 443, 226-229. 
Yokoyama, C. T., Sheng, Z. H., and Catterall, W. A. (1997). Phosphorylation of the 
synaptic protein interaction site on N-type calcium channels inhibits interactions with 
SNARE proteins. J Neurosci 17, 6929-6938. 
Yoshimura, Y., Aoi, C., and Yamauchi, T. (2000). Investigation of protein substrates of 
Ca(2+)/calmodulin-dependent protein kinase II translocated to the postsynaptic density. 
Brain Res Mol Brain Res 81, 118-128. 
Yu, F. H., and Catterall, W. A. (2004). The VGL-chanome: a protein superfamily 
specialized for electrical signaling and ionic homeostasis. Sci STKE 2004, re15. 
 206
 
Yu, S. P., Yeh, C. H., Sensi, S. L., Gwag, B. J., Canzoniero, L. M., Farhangrazi, Z. S., 
Ying, H. S., Tian, M., Dugan, L. L., and Choi, D. W. (1997). Mediation of neuronal 
apoptosis by enhancement of outward potassium current. Science 278, 114-117. 
Zeng, H., Fei, H., and Levitan, I. B. (2004). The slowpoke channel binding protein Slob 
from Drosophila melanogaster exhibits regulatable protein kinase activity. Neurosci Lett 
365, 33-38. 
Zhang, C., and Zhou, Z. (2002). Ca(2+)-independent but voltage-dependent secretion in 
mammalian dorsal root ganglion neurons. Nat Neurosci 5, 425-430. 
Zhang, W., Hirschler-Laszkiewicz, I., Tong, Q., Conrad, K., Sun, S. C., Penn, L., Barber, 
D. L., Stahl, R., Carey, D. J., Cheung, J. Y., and Miller, B. A. (2006). TRPM2 is an ion 
channel that modulates hematopoietic cell death through activation of caspases and 
PARP cleavage. Am J Physiol Cell Physiol 290, C1146-1159. 
Zhang, Y., Oliva, R., Gisselmann, G., Hatt, H., Guckenheimer, J., and Harris-Warrick, R. 
M. (2003). Overexpression of a hyperpolarization-activated cation current (Ih) channel 
gene modifies the firing activity of identified motor neurons in a small neural network. J 
Neurosci 23, 9059-9067. 
Zhong, N., Beaumont, V., and Zucker, R. S. (2004). Calcium influx through HCN 
channels does not contribute to cAMP-enhanced transmission. J Neurophysiol 92, 644-
647. 
Zhong, N., and Zucker, R. S. (2004). Roles of Ca2+, hyperpolarization and cyclic 
nucleotide-activated channel activation, and actin in temporal synaptic tagging. J 
Neurosci 24, 4205-4212. 
Zhou, Y., Schopperle, W. M., Murrey, H., Jaramillo, A., Dagan, D., Griffith, L. C., and 
Levitan, I. B. (1999). A dynamically regulated 14-3-3, Slob, and Slowpoke potassium 
channel complex in Drosophila presynaptic nerve terminals. Neuron 22, 809-818. 
Zhu, J. J., Qin, Y., Zhao, M., Van Aelst, L., and Malinow, R. (2002). Ras and Rap control 
AMPA receptor trafficking during synaptic plasticity. Cell 110, 443-455. 
Zou, A., Lin, Z., Humble, M., Creech, C. D., Wagoner, P. K., Krafte, D., Jegla, T. J., and 
Wickenden, A. D. (2003). Distribution and functional properties of human KCNH8 
(Elk1) potassium channels. Am J Physiol Cell Physiol 285, C1356-1366. 
Zuhlke, R. D., Pitt, G. S., Deisseroth, K., Tsien, R. W., and Reuter, H. (1999). 
Calmodulin supports both inactivation and facilitation of L-type calcium channels. 
Nature 399, 159-162. 
 
 207
